id	sid	tid	token	lemma	pos
hls-5011	1	1	hrev_master	hrev_master	NOUN
hls-5011	2	1	[	[	X
hls-5011	2	2	page	page	NOUN
hls-5011	2	3	10	10	NUM
hls-5011	2	4	]	]	PUNCT
hls-5011	3	1	[	[	X
hls-5011	3	2	healthcare	healthcare	NOUN
hls-5011	3	3	in	in	ADP
hls-5011	3	4	low	low	ADJ
hls-5011	3	5	-	-	PUNCT
hls-5011	3	6	resource	resource	NOUN
hls-5011	3	7	settings	setting	NOUN
hls-5011	3	8	2015	2015	NUM
hls-5011	3	9	;	;	PUNCT
hls-5011	3	10	3:5011	3:5011	NUM
hls-5011	3	11	]	]	X
hls-5011	3	12	incremental	incremental	ADJ
hls-5011	3	13	detection	detection	NOUN
hls-5011	3	14	of	of	ADP
hls-5011	3	15	pulmonary	pulmonary	ADJ
hls-5011	3	16	tuberculosis	tuberculosis	NOUN
hls-5011	3	17	among	among	ADP
hls-5011	3	18	presumptive	presumptive	ADJ
hls-5011	3	19	patients	patient	NOUN
hls-5011	3	20	by	by	ADP
hls-5011	3	21	genexpert	genexpert	ADJ
hls-5011	3	22	mtb	mtb	PROPN
hls-5011	3	23	/	/	SYM
hls-5011	3	24	rif	rif	PROPN
hls-5011	3	25	®	®	NOUN
hls-5011	3	26	over	over	ADP
hls-5011	3	27	fluorescent	fluorescent	ADJ
hls-5011	3	28	microscopy	microscopy	NOUN
hls-5011	3	29	in	in	ADP
hls-5011	3	30	mwanza	mwanza	PROPN
hls-5011	3	31	,	,	PUNCT
hls-5011	3	32	tanzania	tanzania	PROPN
hls-5011	3	33	:	:	PUNCT
hls-5011	3	34	an	an	DET
hls-5011	3	35	operational	operational	ADJ
hls-5011	3	36	study	study	NOUN
hls-5011	3	37	jeremiah	jeremiah	PROPN
hls-5011	3	38	seni,1	seni,1	PROPN
hls-5011	3	39	benson	benson	PROPN
hls-5011	3	40	r.	r.	PROPN
hls-5011	3	41	kidenya,1	kidenya,1	PROPN
hls-5011	3	42	mercy	mercy	NOUN
hls-5011	3	43	anga,1	anga,1	NOUN
hls-5011	3	44	anthony	anthony	PROPN
hls-5011	3	45	kapesa,1	kapesa,1	PROPN
hls-5011	3	46	john	john	PROPN
hls-5011	3	47	r.	r.	PROPN
hls-5011	3	48	meda,2	meda,2	PROPN
hls-5011	3	49	richard	richard	PROPN
hls-5011	3	50	mutakyawa,3,4	mutakyawa,3,4	PROPN
hls-5011	3	51	zahra	zahra	PROPN
hls-5011	3	52	h.	h.	PROPN
hls-5011	3	53	mkomwa,4	mkomwa,4	PROPN
hls-5011	3	54	fidelis	fidelis	PROPN
hls-5011	3	55	marcel,3	marcel,3	VERB
hls-5011	3	56	john	john	PROPN
hls-5011	3	57	m.	m.	PROPN
hls-5011	3	58	changalucha,5	changalucha,5	PROPN
hls-5011	4	1	stephen	stephen	PROPN
hls-5011	4	2	e.	e.	PROPN
hls-5011	4	3	mshana1	mshana1	PROPN
hls-5011	5	1	1department	1department	NUM
hls-5011	5	2	of	of	ADP
hls-5011	5	3	microbiology	microbiology	NOUN
hls-5011	5	4	and	and	CCONJ
hls-5011	5	5	immunology	immunology	NOUN
hls-5011	5	6	,	,	PUNCT
hls-5011	5	7	catholic	catholic	PROPN
hls-5011	5	8	university	university	PROPN
hls-5011	5	9	of	of	ADP
hls-5011	5	10	health	health	PROPN
hls-5011	5	11	and	and	CCONJ
hls-5011	5	12	allied	ally	VERB
hls-5011	5	13	sciences	science	NOUN
hls-5011	5	14	bugando	bugando	ADV
hls-5011	5	15	,	,	PUNCT
hls-5011	5	16	mwanza	mwanza	VERB
hls-5011	5	17	2department	2department	NUM
hls-5011	5	18	of	of	ADP
hls-5011	5	19	internal	internal	ADJ
hls-5011	5	20	medicine	medicine	NOUN
hls-5011	5	21	,	,	PUNCT
hls-5011	5	22	university	university	NOUN
hls-5011	5	23	of	of	ADP
hls-5011	5	24	dodoma	dodoma	PROPN
hls-5011	5	25	3sekou	3sekou	PROPN
hls-5011	5	26	toure	toure	NOUN
hls-5011	5	27	regional	regional	ADJ
hls-5011	5	28	referral	referral	ADJ
hls-5011	5	29	hospital	hospital	NOUN
hls-5011	5	30	,	,	PUNCT
hls-5011	5	31	mwanza	mwanza	PROPN
hls-5011	5	32	4path	4path	NUM
hls-5011	5	33	tanzania	tanzania	PROPN
hls-5011	5	34	,	,	PUNCT
hls-5011	5	35	dar	dar	PROPN
hls-5011	5	36	es	es	NOUN
hls-5011	5	37	salaam	salaam	PROPN
hls-5011	6	1	5national	5national	PROPN
hls-5011	6	2	institute	institute	NOUN
hls-5011	6	3	for	for	ADP
hls-5011	6	4	medical	medical	ADJ
hls-5011	6	5	research	research	NOUN
hls-5011	6	6	,	,	PUNCT
hls-5011	6	7	mwanza	mwanza	PROPN
hls-5011	6	8	medical	medical	ADJ
hls-5011	6	9	research	research	NOUN
hls-5011	6	10	centre	centre	PROPN
hls-5011	6	11	,	,	PUNCT
hls-5011	6	12	tanzania	tanzania	PROPN
hls-5011	6	13	abstract	abstract	ADJ
hls-5011	6	14	laboratory	laboratory	NOUN
hls-5011	6	15	confirmation	confirmation	NOUN
hls-5011	6	16	among	among	ADP
hls-5011	6	17	presumptive	presumptive	ADJ
hls-5011	6	18	tuberculosis	tuberculosis	NOUN
hls-5011	6	19	(	(	PUNCT
hls-5011	6	20	ptb	ptb	PROPN
hls-5011	6	21	)	)	PUNCT
hls-5011	6	22	patients	patient	NOUN
hls-5011	6	23	is	be	AUX
hls-5011	6	24	pivotal	pivotal	ADJ
hls-5011	6	25	in	in	ADP
hls-5011	6	26	ensuring	ensure	VERB
hls-5011	6	27	prompt	prompt	ADJ
hls-5011	6	28	management	management	NOUN
hls-5011	6	29	.	.	PUNCT
hls-5011	7	1	limited	limited	ADJ
hls-5011	7	2	information	information	NOUN
hls-5011	7	3	exists	exist	VERB
hls-5011	7	4	in	in	ADP
hls-5011	7	5	tanzania	tanzania	NOUN
hls-5011	7	6	regarding	regard	VERB
hls-5011	7	7	the	the	DET
hls-5011	7	8	performance	performance	NOUN
hls-5011	7	9	of	of	ADP
hls-5011	7	10	genexpert	genexpert	ADJ
hls-5011	7	11	mtb	mtb	PROPN
hls-5011	7	12	/	/	SYM
hls-5011	7	13	rif	rif	PROPN
hls-5011	7	14	®	®	NOUN
hls-5011	7	15	in	in	ADP
hls-5011	7	16	comparison	comparison	NOUN
hls-5011	7	17	with	with	ADP
hls-5011	7	18	conventional	conventional	ADJ
hls-5011	7	19	methods	method	NOUN
hls-5011	7	20	.	.	PUNCT
hls-5011	8	1	an	an	DET
hls-5011	8	2	operational	operational	ADJ
hls-5011	8	3	study	study	NOUN
hls-5011	8	4	was	be	AUX
hls-5011	8	5	conducted	conduct	VERB
hls-5011	8	6	involving	involve	VERB
hls-5011	8	7	806	806	NUM
hls-5011	8	8	ptb	ptb	PROPN
hls-5011	8	9	patients	patient	NOUN
hls-5011	8	10	at	at	ADP
hls-5011	8	11	sekou	sekou	PROPN
hls-5011	8	12	toure	toure	NOUN
hls-5011	8	13	hospital	hospital	NOUN
hls-5011	8	14	in	in	ADP
hls-5011	8	15	mwanza	mwanza	PROPN
hls-5011	8	16	,	,	PUNCT
hls-5011	8	17	tanzania	tanzania	PROPN
hls-5011	8	18	from	from	ADP
hls-5011	8	19	june	june	PROPN
hls-5011	8	20	to	to	ADP
hls-5011	8	21	november	november	PROPN
hls-5011	8	22	2013	2013	NUM
hls-5011	8	23	.	.	PUNCT
hls-5011	9	1	patients	patient	NOUN
hls-5011	9	2	’	'	PUNCT
hls-5011	9	3	information	information	NOUN
hls-5011	9	4	was	be	AUX
hls-5011	9	5	obtained	obtain	VERB
hls-5011	9	6	and	and	CCONJ
hls-5011	9	7	their	their	PRON
hls-5011	9	8	respective	respective	ADJ
hls-5011	9	9	sputum	sputum	NOUN
hls-5011	9	10	samples	sample	NOUN
hls-5011	9	11	analyzed	analyze	VERB
hls-5011	9	12	by	by	ADP
hls-5011	9	13	lightemitting	lightemitte	VERB
hls-5011	9	14	diode	diode	NOUN
hls-5011	9	15	fluorescent	fluorescent	ADJ
hls-5011	9	16	microscopy	microscopy	NOUN
hls-5011	9	17	(	(	PUNCT
hls-5011	9	18	led	lead	VERB
hls-5011	9	19	fm	fm	PROPN
hls-5011	9	20	)	)	PUNCT
hls-5011	9	21	and	and	CCONJ
hls-5011	9	22	genexpert	genexpert	PROPN
hls-5011	9	23	mtb	mtb	PROPN
hls-5011	9	24	/	/	SYM
hls-5011	9	25	rif	rif	PROPN
hls-5011	9	26	®	®	PROPN
hls-5011	9	27	.	.	PUNCT
hls-5011	10	1	the	the	DET
hls-5011	10	2	mean	mean	ADJ
hls-5011	10	3	age	age	NOUN
hls-5011	10	4	of	of	ADP
hls-5011	10	5	study	study	NOUN
hls-5011	10	6	participants	participant	NOUN
hls-5011	10	7	was	be	AUX
hls-5011	10	8	39.6±16.0	39.6±16.0	NUM
hls-5011	10	9	years	year	NOUN
hls-5011	10	10	,	,	PUNCT
hls-5011	10	11	with	with	ADP
hls-5011	10	12	males	male	NOUN
hls-5011	10	13	accounting	account	VERB
hls-5011	10	14	for	for	ADP
hls-5011	10	15	50.5	50.5	NUM
hls-5011	10	16	%	%	NOUN
hls-5011	10	17	.	.	PUNCT
hls-5011	11	1	the	the	DET
hls-5011	11	2	majority	majority	NOUN
hls-5011	11	3	of	of	ADP
hls-5011	11	4	patients	patient	NOUN
hls-5011	11	5	(	(	PUNCT
hls-5011	11	6	97.5	97.5	NUM
hls-5011	11	7	%	%	NOUN
hls-5011	11	8	)	)	PUNCT
hls-5011	11	9	were	be	AUX
hls-5011	11	10	new	new	ADJ
hls-5011	11	11	cases	case	NOUN
hls-5011	11	12	.	.	PUNCT
hls-5011	12	1	the	the	DET
hls-5011	12	2	proportions	proportion	NOUN
hls-5011	12	3	of	of	ADP
hls-5011	12	4	ptb	ptb	PROPN
hls-5011	12	5	patients	patient	NOUN
hls-5011	12	6	confirmed	confirm	VERB
hls-5011	12	7	by	by	ADP
hls-5011	12	8	led	lead	VERB
hls-5011	12	9	fm	fm	PROPN
hls-5011	12	10	and	and	CCONJ
hls-5011	12	11	genexpert	genexpert	PROPN
hls-5011	12	12	mtb	mtb	PROPN
hls-5011	12	13	/	/	SYM
hls-5011	12	14	rif	rif	PROPN
hls-5011	12	15	®	®	NOUN
hls-5011	12	16	were	be	AUX
hls-5011	12	17	14.1	14.1	NUM
hls-5011	12	18	%	%	NOUN
hls-5011	12	19	(	(	PUNCT
hls-5011	12	20	114/806	114/806	NUM
hls-5011	12	21	)	)	PUNCT
hls-5011	12	22	and	and	CCONJ
hls-5011	12	23	23.7	23.7	NUM
hls-5011	12	24	%	%	NOUN
hls-5011	12	25	(	(	PUNCT
hls-5011	12	26	191/806	191/806	PROPN
hls-5011	12	27	)	)	PUNCT
hls-5011	12	28	respectively	respectively	ADV
hls-5011	12	29	,	,	PUNCT
hls-5011	12	30	resulting	result	VERB
hls-5011	12	31	into	into	ADP
hls-5011	12	32	a	a	DET
hls-5011	12	33	9.6	9.6	NUM
hls-5011	12	34	%	%	NOUN
hls-5011	12	35	incremental	incremental	ADJ
hls-5011	12	36	detection	detection	NOUN
hls-5011	12	37	rate	rate	NOUN
hls-5011	12	38	by	by	ADP
hls-5011	12	39	genexpert	genexpert	ADJ
hls-5011	12	40	mtb	mtb	PROPN
hls-5011	12	41	/	/	SYM
hls-5011	12	42	rif	rif	PROPN
hls-5011	12	43	®	®	NOUN
hls-5011	12	44	over	over	ADP
hls-5011	12	45	led	lead	VERB
hls-5011	12	46	fm	fm	PROPN
hls-5011	12	47	.	.	PUNCT
hls-5011	13	1	the	the	DET
hls-5011	13	2	detection	detection	NOUN
hls-5011	13	3	rate	rate	NOUN
hls-5011	13	4	among	among	ADP
hls-5011	13	5	hiv	hiv	PROPN
hls-5011	13	6	positive	positive	ADJ
hls-5011	13	7	individuals	individual	NOUN
hls-5011	13	8	was	be	AUX
hls-5011	13	9	also	also	ADV
hls-5011	13	10	higher	high	ADJ
hls-5011	13	11	[	[	X
hls-5011	13	12	23.6	23.6	NUM
hls-5011	13	13	%	%	NOUN
hls-5011	13	14	(	(	PUNCT
hls-5011	13	15	63/267	63/267	NUM
hls-5011	13	16	)	)	PUNCT
hls-5011	13	17	vs	vs	ADP
hls-5011	13	18	14.2	14.2	NUM
hls-5011	13	19	%	%	NOUN
hls-5011	13	20	(	(	PUNCT
hls-5011	13	21	38/267	38/267	NUM
hls-5011	13	22	)	)	PUNCT
hls-5011	13	23	,	,	PUNCT
hls-5011	13	24	respectively	respectively	ADV
hls-5011	13	25	]	]	PUNCT
hls-5011	13	26	,	,	PUNCT
hls-5011	13	27	with	with	ADP
hls-5011	13	28	an	an	DET
hls-5011	13	29	incremental	incremental	ADJ
hls-5011	13	30	detection	detection	NOUN
hls-5011	13	31	of	of	ADP
hls-5011	13	32	9.4	9.4	NUM
hls-5011	13	33	%	%	NOUN
hls-5011	13	34	.	.	PUNCT
hls-5011	14	1	the	the	DET
hls-5011	14	2	incremental	incremental	ADJ
hls-5011	14	3	detection	detection	NOUN
hls-5011	14	4	of	of	ADP
hls-5011	14	5	ptb	ptb	PROPN
hls-5011	14	6	by	by	ADP
hls-5011	14	7	genexpert	genexpert	PROPN
hls-5011	14	8	mtb	mtb	PROPN
hls-5011	14	9	/	/	SYM
hls-5011	14	10	rif	rif	PROPN
hls-5011	14	11	®	®	NOUN
hls-5011	14	12	over	over	ADP
hls-5011	14	13	led	lead	VERB
hls-5011	14	14	fm	fm	NOUN
hls-5011	14	15	calls	call	NOUN
hls-5011	14	16	for	for	ADP
hls-5011	14	17	expansion	expansion	NOUN
hls-5011	14	18	of	of	ADP
hls-5011	14	19	its	its	PRON
hls-5011	14	20	use	use	NOUN
hls-5011	14	21	to	to	PART
hls-5011	14	22	increase	increase	VERB
hls-5011	14	23	detection	detection	NOUN
hls-5011	14	24	of	of	ADP
hls-5011	14	25	smear	smear	NOUN
hls-5011	14	26	negative	negative	PROPN
hls-5011	14	27	ptb	ptb	PROPN
hls-5011	14	28	among	among	ADP
hls-5011	14	29	people	people	NOUN
hls-5011	14	30	living	live	VERB
hls-5011	14	31	with	with	ADP
hls-5011	14	32	hiv	hiv	PROPN
hls-5011	14	33	.	.	PUNCT
hls-5011	15	1	introduction	introduction	NOUN
hls-5011	15	2	the	the	DET
hls-5011	15	3	escalating	escalate	VERB
hls-5011	15	4	burden	burden	NOUN
hls-5011	15	5	of	of	ADP
hls-5011	15	6	tuberculosis	tuberculosis	NOUN
hls-5011	15	7	(	(	PUNCT
hls-5011	15	8	tb	tb	NOUN
hls-5011	15	9	)	)	PUNCT
hls-5011	15	10	in	in	ADP
hls-5011	15	11	tanzania	tanzania	PROPN
hls-5011	15	12	in	in	ADP
hls-5011	15	13	the	the	DET
hls-5011	15	14	midst	midst	NOUN
hls-5011	15	15	of	of	ADP
hls-5011	15	16	high	high	ADJ
hls-5011	15	17	prevalence	prevalence	NOUN
hls-5011	15	18	of	of	ADP
hls-5011	15	19	hiv	hiv	PROPN
hls-5011	15	20	/	/	SYM
hls-5011	15	21	aids	aids	PROPN
hls-5011	15	22	poses	pose	VERB
hls-5011	15	23	a	a	DET
hls-5011	15	24	negative	negative	ADJ
hls-5011	15	25	social	social	ADJ
hls-5011	15	26	and	and	CCONJ
hls-5011	15	27	economic	economic	ADJ
hls-5011	15	28	impact	impact	NOUN
hls-5011	15	29	in	in	ADP
hls-5011	15	30	this	this	DET
hls-5011	15	31	developing	develop	VERB
hls-5011	15	32	country	country	NOUN
hls-5011	15	33	which	which	PRON
hls-5011	15	34	is	be	AUX
hls-5011	15	35	ranked	rank	VERB
hls-5011	15	36	22nd	22nd	NOUN
hls-5011	15	37	among	among	ADP
hls-5011	15	38	countries	country	NOUN
hls-5011	15	39	accounting	account	VERB
hls-5011	15	40	for	for	ADP
hls-5011	15	41	80	80	NUM
hls-5011	15	42	%	%	NOUN
hls-5011	15	43	of	of	ADP
hls-5011	15	44	the	the	DET
hls-5011	15	45	global	global	ADJ
hls-5011	15	46	burden	burden	NOUN
hls-5011	15	47	of	of	ADP
hls-5011	15	48	tb.1	tb.1	PROPN
hls-5011	15	49	-	-	SYM
hls-5011	15	50	3	3	NUM
hls-5011	15	51	to	to	PART
hls-5011	15	52	avert	avert	VERB
hls-5011	15	53	continuous	continuous	ADJ
hls-5011	15	54	transmission	transmission	NOUN
hls-5011	15	55	,	,	PUNCT
hls-5011	15	56	morbidity	morbidity	NOUN
hls-5011	15	57	and	and	CCONJ
hls-5011	15	58	mortality	mortality	NOUN
hls-5011	15	59	attributable	attributable	ADJ
hls-5011	15	60	to	to	ADP
hls-5011	15	61	tb	tb	NOUN
hls-5011	15	62	,	,	PUNCT
hls-5011	15	63	laboratory	laboratory	NOUN
hls-5011	15	64	confirmation	confirmation	NOUN
hls-5011	15	65	among	among	ADP
hls-5011	15	66	presumptive	presumptive	ADJ
hls-5011	15	67	pulmonary	pulmonary	ADJ
hls-5011	15	68	tuberculosis	tuberculosis	NOUN
hls-5011	15	69	(	(	PUNCT
hls-5011	15	70	ptb	ptb	PROPN
hls-5011	15	71	)	)	PUNCT
hls-5011	15	72	patients	patient	NOUN
hls-5011	15	73	is	be	AUX
hls-5011	15	74	pivotal	pivotal	ADJ
hls-5011	15	75	in	in	ADP
hls-5011	15	76	ensuring	ensure	VERB
hls-5011	15	77	prompt	prompt	ADJ
hls-5011	15	78	management.2,4	management.2,4	PROPN
hls-5011	15	79	ziehl	ziehl	PROPN
hls-5011	15	80	-	-	PUNCT
hls-5011	15	81	neelsen	neelsen	PROPN
hls-5011	15	82	(	(	PUNCT
hls-5011	15	83	zn)-based	zn)-base	VERB
hls-5011	15	84	light	light	ADJ
hls-5011	15	85	microscopy	microscopy	NOUN
hls-5011	15	86	which	which	PRON
hls-5011	15	87	is	be	AUX
hls-5011	15	88	the	the	DET
hls-5011	15	89	main	main	ADJ
hls-5011	15	90	stay	stay	NOUN
hls-5011	15	91	and	and	CCONJ
hls-5011	15	92	universally	universally	ADV
hls-5011	15	93	available	available	ADJ
hls-5011	15	94	diagnostic	diagnostic	ADJ
hls-5011	15	95	technique	technique	NOUN
hls-5011	15	96	in	in	ADP
hls-5011	15	97	tanzania	tanzania	PROPN
hls-5011	15	98	and	and	CCONJ
hls-5011	15	99	other	other	ADJ
hls-5011	15	100	developing	develop	VERB
hls-5011	15	101	countries	country	NOUN
hls-5011	15	102	has	have	AUX
hls-5011	15	103	long	long	ADV
hls-5011	15	104	been	be	AUX
hls-5011	15	105	shown	show	VERB
hls-5011	15	106	to	to	PART
hls-5011	15	107	have	have	VERB
hls-5011	15	108	low	low	ADJ
hls-5011	15	109	performance.5,6	performance.5,6	NOUN
hls-5011	15	110	in	in	ADP
hls-5011	15	111	the	the	DET
hls-5011	15	112	light	light	NOUN
hls-5011	15	113	of	of	ADP
hls-5011	15	114	this	this	PRON
hls-5011	15	115	,	,	PUNCT
hls-5011	15	116	the	the	DET
hls-5011	15	117	world	world	PROPN
hls-5011	15	118	health	health	NOUN
hls-5011	15	119	organization	organization	NOUN
hls-5011	15	120	(	(	PUNCT
hls-5011	15	121	who	who	PRON
hls-5011	15	122	)	)	PUNCT
hls-5011	15	123	has	have	AUX
hls-5011	15	124	recommended	recommend	VERB
hls-5011	15	125	scaling	scale	VERB
hls-5011	15	126	up	up	ADP
hls-5011	15	127	the	the	DET
hls-5011	15	128	use	use	NOUN
hls-5011	15	129	of	of	ADP
hls-5011	15	130	light	light	NOUN
hls-5011	15	131	-	-	PUNCT
hls-5011	15	132	emitting	emit	VERB
hls-5011	15	133	diode	diode	NOUN
hls-5011	15	134	fluorescent	fluorescent	ADJ
hls-5011	15	135	microscopy	microscopy	NOUN
hls-5011	15	136	(	(	PUNCT
hls-5011	15	137	led	lead	VERB
hls-5011	15	138	fm	fm	PROPN
hls-5011	15	139	)	)	PUNCT
hls-5011	15	140	which	which	PRON
hls-5011	15	141	is	be	AUX
hls-5011	15	142	on	on	ADP
hls-5011	15	143	average	average	ADJ
hls-5011	15	144	10	10	NUM
hls-5011	15	145	%	%	NOUN
hls-5011	15	146	more	more	ADV
hls-5011	15	147	sensitive	sensitive	ADJ
hls-5011	15	148	in	in	ADP
hls-5011	15	149	detection	detection	NOUN
hls-5011	15	150	of	of	ADP
hls-5011	15	151	tb	tb	NOUN
hls-5011	15	152	compared	compare	VERB
hls-5011	15	153	to	to	ADP
hls-5011	15	154	the	the	DET
hls-5011	15	155	conventional	conventional	ADJ
hls-5011	15	156	zn	zn	PROPN
hls-5011	15	157	-	-	PUNCT
hls-5011	15	158	based	base	VERB
hls-5011	15	159	light	light	ADJ
hls-5011	15	160	microscopy	microscopy	NOUN
hls-5011	15	161	using	use	VERB
hls-5011	15	162	culture	culture	NOUN
hls-5011	15	163	as	as	ADP
hls-5011	15	164	a	a	DET
hls-5011	15	165	gold	gold	NOUN
hls-5011	15	166	standard.5,7,8	standard.5,7,8	NOUN
hls-5011	15	167	this	this	PRON
hls-5011	15	168	notwithstanding	notwithstanding	ADV
hls-5011	15	169	,	,	PUNCT
hls-5011	15	170	led	lead	VERB
hls-5011	15	171	fm	fm	PROPN
hls-5011	15	172	coverage	coverage	NOUN
hls-5011	15	173	is	be	AUX
hls-5011	15	174	still	still	ADV
hls-5011	15	175	low	low	ADJ
hls-5011	15	176	in	in	ADP
hls-5011	15	177	developing	develop	VERB
hls-5011	15	178	countries.2	countries.2	NOUN
hls-5011	15	179	to	to	PART
hls-5011	15	180	address	address	VERB
hls-5011	15	181	the	the	DET
hls-5011	15	182	low	low	ADJ
hls-5011	15	183	performance	performance	NOUN
hls-5011	15	184	of	of	ADP
hls-5011	15	185	microscopy	microscopy	NOUN
hls-5011	15	186	-	-	PUNCT
hls-5011	15	187	based	base	VERB
hls-5011	15	188	detection	detection	NOUN
hls-5011	15	189	methods	method	NOUN
hls-5011	15	190	for	for	ADP
hls-5011	15	191	tb	tb	NOUN
hls-5011	15	192	,	,	PUNCT
hls-5011	15	193	a	a	DET
hls-5011	15	194	number	number	NOUN
hls-5011	15	195	of	of	ADP
hls-5011	15	196	molecular	molecular	ADJ
hls-5011	15	197	based	base	VERB
hls-5011	15	198	diagnostic	diagnostic	ADJ
hls-5011	15	199	methods	method	NOUN
hls-5011	15	200	have	have	AUX
hls-5011	15	201	been	be	AUX
hls-5011	15	202	validated	validate	VERB
hls-5011	15	203	by	by	ADP
hls-5011	15	204	who	who	PRON
hls-5011	15	205	to	to	PART
hls-5011	15	206	increase	increase	VERB
hls-5011	15	207	coverage	coverage	NOUN
hls-5011	15	208	and	and	CCONJ
hls-5011	15	209	enhance	enhance	VERB
hls-5011	15	210	timely	timely	ADJ
hls-5011	15	211	detection	detection	NOUN
hls-5011	15	212	of	of	ADP
hls-5011	15	213	ptb	ptb	PROPN
hls-5011	15	214	patients,8	patients,8	PROPN
hls-5011	15	215	-	-	PUNCT
hls-5011	15	216	10	10	NUM
hls-5011	15	217	but	but	CCONJ
hls-5011	15	218	their	their	PRON
hls-5011	15	219	utility	utility	NOUN
hls-5011	15	220	is	be	AUX
hls-5011	15	221	unevenly	unevenly	ADV
hls-5011	15	222	appreciated	appreciate	VERB
hls-5011	15	223	across	across	ADP
hls-5011	15	224	countries	country	NOUN
hls-5011	15	225	mainly	mainly	ADV
hls-5011	15	226	due	due	ADP
hls-5011	15	227	to	to	ADP
hls-5011	15	228	the	the	DET
hls-5011	15	229	installation	installation	NOUN
hls-5011	15	230	and	and	CCONJ
hls-5011	15	231	running	running	NOUN
hls-5011	15	232	costs	cost	NOUN
hls-5011	15	233	as	as	ADV
hls-5011	15	234	well	well	ADV
hls-5011	15	235	as	as	ADP
hls-5011	15	236	lack	lack	NOUN
hls-5011	15	237	of	of	ADP
hls-5011	15	238	expertize.10,11	expertize.10,11	NOUN
hls-5011	15	239	recently	recently	ADV
hls-5011	15	240	,	,	PUNCT
hls-5011	15	241	who	who	PRON
hls-5011	15	242	endorsed	endorse	VERB
hls-5011	15	243	a	a	DET
hls-5011	15	244	new	new	ADJ
hls-5011	15	245	rapid	rapid	ADJ
hls-5011	15	246	molecular	molecular	ADJ
hls-5011	15	247	test	test	NOUN
hls-5011	15	248	called	call	VERB
hls-5011	15	249	genexpert	genexpert	PROPN
hls-5011	15	250	mtb	mtb	PROPN
hls-5011	15	251	/	/	SYM
hls-5011	15	252	rif	rif	PROPN
hls-5011	15	253	®	®	NOUN
hls-5011	15	254	(	(	PUNCT
hls-5011	15	255	cepheid	cepheid	PROPN
hls-5011	15	256	,	,	PUNCT
hls-5011	15	257	sunnyvale	sunnyvale	PROPN
hls-5011	15	258	,	,	PUNCT
hls-5011	15	259	ca	ca	PROPN
hls-5011	15	260	,	,	PUNCT
hls-5011	15	261	usa).9	usa).9	PUNCT
hls-5011	15	262	the	the	DET
hls-5011	15	263	dual	dual	ADJ
hls-5011	15	264	function	function	NOUN
hls-5011	15	265	of	of	ADP
hls-5011	15	266	the	the	DET
hls-5011	15	267	machine	machine	NOUN
hls-5011	15	268	in	in	ADP
hls-5011	15	269	simultaneously	simultaneously	ADV
hls-5011	15	270	diagnosing	diagnose	VERB
hls-5011	15	271	tb	tb	ADP
hls-5011	15	272	and	and	CCONJ
hls-5011	15	273	identifying	identify	VERB
hls-5011	15	274	resistance	resistance	NOUN
hls-5011	15	275	to	to	ADP
hls-5011	15	276	one	one	NUM
hls-5011	15	277	of	of	ADP
hls-5011	15	278	the	the	DET
hls-5011	15	279	core	core	NOUN
hls-5011	15	280	first	first	ADJ
hls-5011	15	281	line	line	NOUN
hls-5011	15	282	anti	anti	ADJ
hls-5011	15	283	-	-	ADJ
hls-5011	15	284	tb	tb	ADP
hls-5011	15	285	drug	drug	NOUN
hls-5011	15	286	,	,	PUNCT
hls-5011	15	287	rifampicin	rifampicin	VERB
hls-5011	15	288	along	along	ADP
hls-5011	15	289	with	with	ADP
hls-5011	15	290	its	its	PRON
hls-5011	15	291	high	high	ADJ
hls-5011	15	292	sensitivity	sensitivity	NOUN
hls-5011	15	293	and	and	CCONJ
hls-5011	15	294	specificity	specificity	NOUN
hls-5011	15	295	,	,	PUNCT
hls-5011	15	296	has	have	AUX
hls-5011	15	297	revolutionized	revolutionize	VERB
hls-5011	15	298	the	the	DET
hls-5011	15	299	diagnosis	diagnosis	NOUN
hls-5011	15	300	of	of	ADP
hls-5011	15	301	tb	tb	ADP
hls-5011	15	302	globally.9,12	globally.9,12	NOUN
hls-5011	15	303	-	-	PUNCT
hls-5011	15	304	15	15	NUM
hls-5011	15	305	the	the	DET
hls-5011	15	306	performance	performance	NOUN
hls-5011	15	307	of	of	ADP
hls-5011	15	308	genexpert	genexpert	ADJ
hls-5011	15	309	mtb	mtb	PROPN
hls-5011	15	310	/	/	SYM
hls-5011	15	311	rif	rif	PROPN
hls-5011	15	312	®	®	NOUN
hls-5011	15	313	has	have	AUX
hls-5011	15	314	been	be	AUX
hls-5011	15	315	shown	show	VERB
hls-5011	15	316	to	to	PART
hls-5011	15	317	be	be	AUX
hls-5011	15	318	better	well	ADJ
hls-5011	15	319	compared	compare	VERB
hls-5011	15	320	to	to	ADP
hls-5011	15	321	led	lead	VERB
hls-5011	15	322	fm	fm	PROPN
hls-5011	15	323	in	in	ADP
hls-5011	15	324	both	both	PRON
hls-5011	15	325	smear	smear	VERB
hls-5011	15	326	positive	positive	ADJ
hls-5011	15	327	and	and	CCONJ
hls-5011	15	328	negative	negative	ADJ
hls-5011	15	329	people	people	NOUN
hls-5011	15	330	living	live	VERB
hls-5011	15	331	with	with	ADP
hls-5011	15	332	hiv	hiv	PROPN
hls-5011	15	333	(	(	PUNCT
hls-5011	15	334	plwh	plwh	NOUN
hls-5011	15	335	)	)	PUNCT
hls-5011	15	336	,	,	PUNCT
hls-5011	15	337	though	though	SCONJ
hls-5011	15	338	variability	variability	NOUN
hls-5011	15	339	exists	exist	VERB
hls-5011	15	340	depending	depend	VERB
hls-5011	15	341	on	on	ADP
hls-5011	15	342	the	the	DET
hls-5011	15	343	population	population	NOUN
hls-5011	15	344	involved.16	involved.16	PROPN
hls-5011	15	345	-	-	PUNCT
hls-5011	15	346	18	18	NUM
hls-5011	15	347	the	the	DET
hls-5011	15	348	rifampin	rifampin	NOUN
hls-5011	15	349	resistance	resistance	NOUN
hls-5011	15	350	has	have	AUX
hls-5011	15	351	been	be	AUX
hls-5011	15	352	shown	show	VERB
hls-5011	15	353	to	to	PART
hls-5011	15	354	vary	vary	VERB
hls-5011	15	355	in	in	ADP
hls-5011	15	356	different	different	ADJ
hls-5011	15	357	countries	country	NOUN
hls-5011	15	358	from	from	ADP
hls-5011	15	359	0	0	NUM
hls-5011	15	360	%	%	NOUN
hls-5011	15	361	in	in	ADP
hls-5011	15	362	mbeya	mbeya	PROPN
hls-5011	15	363	(	(	PUNCT
hls-5011	15	364	tanzania	tanzania	PROPN
hls-5011	15	365	)	)	PUNCT
hls-5011	15	366	,	,	PUNCT
hls-5011	15	367	10	10	NUM
hls-5011	15	368	%	%	NOUN
hls-5011	15	369	in	in	ADP
hls-5011	15	370	harare	harare	PROPN
hls-5011	15	371	(	(	PUNCT
hls-5011	15	372	zimbabwe	zimbabwe	PROPN
hls-5011	15	373	)	)	PUNCT
hls-5011	15	374	to	to	ADP
hls-5011	15	375	as	as	ADV
hls-5011	15	376	high	high	ADJ
hls-5011	15	377	as	as	ADP
hls-5011	15	378	35.1	35.1	NUM
hls-5011	15	379	%	%	NOUN
hls-5011	15	380	in	in	ADP
hls-5011	15	381	moldova.16,19	moldova.16,19	NOUN
hls-5011	15	382	in	in	ADP
hls-5011	15	383	response	response	NOUN
hls-5011	15	384	to	to	ADP
hls-5011	15	385	who	who	PRON
hls-5011	15	386	call	call	VERB
hls-5011	15	387	to	to	PART
hls-5011	15	388	scale	scale	VERB
hls-5011	15	389	up	up	ADP
hls-5011	15	390	the	the	DET
hls-5011	15	391	utilization	utilization	NOUN
hls-5011	15	392	of	of	ADP
hls-5011	15	393	this	this	DET
hls-5011	15	394	new	new	ADJ
hls-5011	15	395	diagnostic	diagnostic	NOUN
hls-5011	15	396	,	,	PUNCT
hls-5011	15	397	the	the	DET
hls-5011	15	398	ministry	ministry	PROPN
hls-5011	15	399	of	of	ADP
hls-5011	15	400	health	health	PROPN
hls-5011	15	401	in	in	ADP
hls-5011	15	402	the	the	DET
hls-5011	15	403	united	united	PROPN
hls-5011	15	404	republic	republic	PROPN
hls-5011	15	405	of	of	ADP
hls-5011	15	406	tanzania	tanzania	PROPN
hls-5011	15	407	,	,	PUNCT
hls-5011	15	408	through	through	ADP
hls-5011	15	409	the	the	DET
hls-5011	15	410	national	national	ADJ
hls-5011	15	411	tuberculosis	tuberculosis	NOUN
hls-5011	15	412	and	and	CCONJ
hls-5011	15	413	leprosy	leprosy	NOUN
hls-5011	15	414	control	control	NOUN
hls-5011	15	415	program	program	NOUN
hls-5011	15	416	(	(	PUNCT
hls-5011	15	417	ntlp)3,9	ntlp)3,9	ADJ
hls-5011	15	418	and	and	CCONJ
hls-5011	15	419	other	other	ADJ
hls-5011	15	420	developmental	developmental	ADJ
hls-5011	15	421	partners	partner	NOUN
hls-5011	15	422	,	,	PUNCT
hls-5011	15	423	has	have	AUX
hls-5011	15	424	cordially	cordially	ADV
hls-5011	15	425	rolled	roll	VERB
hls-5011	15	426	out	out	ADP
hls-5011	15	427	the	the	DET
hls-5011	15	428	genexpert	genexpert	ADJ
hls-5011	15	429	mtb	mtb	PROPN
hls-5011	15	430	/	/	SYM
hls-5011	15	431	rif	rif	PROPN
hls-5011	15	432	®	®	NOUN
hls-5011	15	433	machines	machine	NOUN
hls-5011	15	434	to	to	ADP
hls-5011	15	435	various	various	ADJ
hls-5011	15	436	regions	region	NOUN
hls-5011	15	437	.	.	PUNCT
hls-5011	16	1	apparently	apparently	ADV
hls-5011	16	2	the	the	DET
hls-5011	16	3	target	target	NOUN
hls-5011	16	4	groups	group	NOUN
hls-5011	16	5	are	be	AUX
hls-5011	16	6	smear	smear	NOUN
hls-5011	16	7	negative	negative	ADJ
hls-5011	16	8	plwh	plwh	PROPN
hls-5011	16	9	,	,	PUNCT
hls-5011	16	10	ptb	ptb	PROPN
hls-5011	16	11	patient	patient	NOUN
hls-5011	16	12	who	who	PRON
hls-5011	16	13	recently	recently	ADV
hls-5011	16	14	contacted	contact	VERB
hls-5011	16	15	multidrug	multidrug	NOUN
hls-5011	16	16	resistant	resistant	ADJ
hls-5011	16	17	tuberculosis	tuberculosis	NOUN
hls-5011	16	18	(	(	PUNCT
hls-5011	16	19	mdr	mdr	NOUN
hls-5011	16	20	)	)	PUNCT
hls-5011	16	21	patient	patient	NOUN
hls-5011	16	22	and	and	CCONJ
hls-5011	16	23	children.3	children.3	PROPN
hls-5011	16	24	in	in	ADP
hls-5011	16	25	tanzania	tanzania	PROPN
hls-5011	16	26	,	,	PUNCT
hls-5011	16	27	mwanza	mwanza	ADJ
hls-5011	16	28	region	region	NOUN
hls-5011	16	29	is	be	AUX
hls-5011	16	30	second	second	ADJ
hls-5011	16	31	to	to	ADP
hls-5011	16	32	dar	dar	PROPN
hls-5011	16	33	es	es	X
hls-5011	16	34	salaam	salaam	NOUN
hls-5011	16	35	in	in	ADP
hls-5011	16	36	terms	term	NOUN
hls-5011	16	37	of	of	ADP
hls-5011	16	38	tb	tb	ADP
hls-5011	16	39	case	case	NOUN
hls-5011	16	40	notification	notification	NOUN
hls-5011	16	41	rates	rate	NOUN
hls-5011	16	42	emphasizing	emphasize	VERB
hls-5011	16	43	the	the	DET
hls-5011	16	44	need	need	NOUN
hls-5011	16	45	to	to	PART
hls-5011	16	46	have	have	AUX
hls-5011	16	47	reliable	reliable	ADJ
hls-5011	16	48	diagnostic	diagnostic	ADJ
hls-5011	16	49	methods	method	NOUN
hls-5011	16	50	in	in	ADP
hls-5011	16	51	place.3	place.3	NOUN
hls-5011	16	52	despite	despite	SCONJ
hls-5011	16	53	this	this	PRON
hls-5011	16	54	,	,	PUNCT
hls-5011	16	55	limited	limited	ADJ
hls-5011	16	56	information	information	NOUN
hls-5011	16	57	exists	exist	VERB
hls-5011	16	58	in	in	ADP
hls-5011	16	59	this	this	DET
hls-5011	16	60	region	region	NOUN
hls-5011	16	61	regarding	regard	VERB
hls-5011	16	62	the	the	DET
hls-5011	16	63	performance	performance	NOUN
hls-5011	16	64	of	of	ADP
hls-5011	16	65	the	the	DET
hls-5011	16	66	recently	recently	ADV
hls-5011	16	67	introduced	introduce	VERB
hls-5011	16	68	genexpert	genexpert	PROPN
hls-5011	16	69	mtb	mtb	PROPN
hls-5011	16	70	/	/	SYM
hls-5011	16	71	rif	rif	PROPN
hls-5011	16	72	®	®	NOUN
hls-5011	16	73	in	in	ADP
hls-5011	16	74	comparison	comparison	NOUN
hls-5011	16	75	with	with	ADP
hls-5011	16	76	led	lead	VERB
hls-5011	16	77	fm	fm	PROPN
hls-5011	16	78	for	for	ADP
hls-5011	16	79	the	the	DET
hls-5011	16	80	diagnosis	diagnosis	NOUN
hls-5011	16	81	of	of	ADP
hls-5011	16	82	tb	tb	NOUN
hls-5011	16	83	.	.	PUNCT
hls-5011	17	1	furthermore	furthermore	ADV
hls-5011	17	2	,	,	PUNCT
hls-5011	17	3	the	the	DET
hls-5011	17	4	magnitude	magnitude	NOUN
hls-5011	17	5	of	of	ADP
hls-5011	17	6	rifampicin	rifampicin	NOUN
hls-5011	17	7	(	(	PUNCT
hls-5011	17	8	rif	rif	PROPN
hls-5011	17	9	)	)	PUNCT
hls-5011	17	10	resistance	resistance	NOUN
hls-5011	17	11	remains	remain	VERB
hls-5011	17	12	to	to	PART
hls-5011	17	13	be	be	AUX
hls-5011	17	14	explored	explore	VERB
hls-5011	17	15	in	in	ADP
hls-5011	17	16	this	this	DET
hls-5011	17	17	setting	setting	NOUN
hls-5011	17	18	.	.	PUNCT
hls-5011	18	1	therefore	therefore	ADV
hls-5011	18	2	,	,	PUNCT
hls-5011	18	3	the	the	DET
hls-5011	18	4	present	present	ADJ
hls-5011	18	5	study	study	NOUN
hls-5011	18	6	aimed	aim	VERB
hls-5011	18	7	at	at	ADP
hls-5011	18	8	determining	determine	VERB
hls-5011	18	9	the	the	DET
hls-5011	18	10	incremental	incremental	ADJ
hls-5011	18	11	detection	detection	NOUN
hls-5011	18	12	of	of	ADP
hls-5011	18	13	tb	tb	NOUN
hls-5011	18	14	among	among	ADP
hls-5011	18	15	ptb	ptb	PROPN
hls-5011	18	16	patients	patient	NOUN
hls-5011	18	17	by	by	ADP
hls-5011	18	18	genexpert	genexpert	PROPN
hls-5011	18	19	mtb	mtb	PROPN
hls-5011	18	20	/	/	SYM
hls-5011	18	21	rif	rif	NOUN
hls-5011	18	22	®	®	NOUN
hls-5011	18	23	and	and	CCONJ
hls-5011	18	24	led	lead	VERB
hls-5011	18	25	fm	fm	NOUN
hls-5011	18	26	at	at	ADP
hls-5011	18	27	sekou	sekou	PROPN
hls-5011	18	28	toure	toure	NOUN
hls-5011	18	29	regional	regional	ADJ
hls-5011	18	30	referral	referral	ADJ
hls-5011	18	31	hospital	hospital	NOUN
hls-5011	18	32	(	(	PUNCT
hls-5011	18	33	srrh	srrh	ADJ
hls-5011	18	34	)	)	PUNCT
hls-5011	18	35	in	in	ADP
hls-5011	18	36	mwanza	mwanza	PROPN
hls-5011	18	37	,	,	PUNCT
hls-5011	18	38	tanzania	tanzania	PROPN
hls-5011	18	39	so	so	SCONJ
hls-5011	18	40	as	as	SCONJ
hls-5011	18	41	to	to	PART
hls-5011	18	42	offer	offer	VERB
hls-5011	18	43	baseline	baseline	NOUN
hls-5011	18	44	information	information	NOUN
hls-5011	18	45	crucial	crucial	ADJ
hls-5011	18	46	for	for	ADP
hls-5011	18	47	future	future	ADJ
hls-5011	18	48	assessment	assessment	NOUN
hls-5011	18	49	of	of	ADP
hls-5011	18	50	the	the	DET
hls-5011	18	51	diagnostic	diagnostic	ADJ
hls-5011	18	52	performance	performance	NOUN
hls-5011	18	53	of	of	ADP
hls-5011	18	54	the	the	DET
hls-5011	18	55	facility	facility	NOUN
hls-5011	18	56	as	as	ADV
hls-5011	18	57	well	well	ADV
hls-5011	18	58	as	as	ADP
hls-5011	18	59	the	the	DET
hls-5011	18	60	utility	utility	NOUN
hls-5011	18	61	of	of	ADP
hls-5011	18	62	the	the	DET
hls-5011	18	63	new	new	ADJ
hls-5011	18	64	technique	technique	NOUN
hls-5011	18	65	in	in	ADP
hls-5011	18	66	this	this	DET
hls-5011	18	67	local	local	ADJ
hls-5011	18	68	setting	setting	NOUN
hls-5011	18	69	.	.	PUNCT
hls-5011	19	1	healthcare	healthcare	NOUN
hls-5011	19	2	in	in	ADP
hls-5011	19	3	low	low	ADJ
hls-5011	19	4	-	-	PUNCT
hls-5011	19	5	resource	resource	NOUN
hls-5011	19	6	settings	setting	NOUN
hls-5011	19	7	2015	2015	NUM
hls-5011	19	8	;	;	PUNCT
hls-5011	19	9	volume	volume	NOUN
hls-5011	19	10	3:5011	3:5011	NUM
hls-5011	19	11	correspondence	correspondence	NOUN
hls-5011	19	12	:	:	PUNCT
hls-5011	19	13	jeremiah	jeremiah	PROPN
hls-5011	19	14	seni	seni	PROPN
hls-5011	19	15	,	,	PUNCT
hls-5011	19	16	department	department	NOUN
hls-5011	19	17	of	of	ADP
hls-5011	19	18	microbiology	microbiology	NOUN
hls-5011	19	19	and	and	CCONJ
hls-5011	19	20	immunology	immunology	NOUN
hls-5011	19	21	,	,	PUNCT
hls-5011	19	22	catholic	catholic	PROPN
hls-5011	19	23	university	university	PROPN
hls-5011	19	24	of	of	ADP
hls-5011	19	25	health	health	PROPN
hls-5011	19	26	and	and	CCONJ
hls-5011	19	27	allied	ally	VERB
hls-5011	19	28	sciences	sciences	PROPN
hls-5011	19	29	,	,	PUNCT
hls-5011	19	30	p.o	p.o	PROPN
hls-5011	19	31	.	.	PROPN
hls-5011	19	32	box	box	PROPN
hls-5011	19	33	1464	1464	NUM
hls-5011	19	34	,	,	PUNCT
hls-5011	19	35	bugando	bugando	ADV
hls-5011	19	36	,	,	PUNCT
hls-5011	19	37	mwanza	mwanza	ADJ
hls-5011	19	38	,	,	PUNCT
hls-5011	19	39	tanzania	tanzania	PROPN
hls-5011	19	40	.	.	PUNCT
hls-5011	20	1	tel	tel	ADP
hls-5011	20	2	:	:	PUNCT
hls-5011	20	3	+255.78.4593000	+255.78.4593000	ADJ
hls-5011	20	4	fax	fax	NOUN
hls-5011	20	5	:	:	PUNCT
hls-5011	20	6	+255.28.2502678	+255.28.2502678	ADJ
hls-5011	20	7	.	.	PUNCT
hls-5011	21	1	e	e	X
hls-5011	21	2	-	-	NOUN
hls-5011	21	3	mail	mail	NOUN
hls-5011	21	4	:	:	PUNCT
hls-5011	21	5	senijj80@gmail.com	senijj80@gmail.com	X
hls-5011	21	6	key	key	ADJ
hls-5011	21	7	words	word	NOUN
hls-5011	21	8	:	:	PUNCT
hls-5011	21	9	tuberculosis	tuberculosis	NOUN
hls-5011	21	10	detection	detection	NOUN
hls-5011	21	11	;	;	PUNCT
hls-5011	21	12	genexpert	genexpert	PROPN
hls-5011	21	13	mtb	mtb	PROPN
hls-5011	21	14	/	/	SYM
hls-5011	21	15	rif	rif	PROPN
hls-5011	21	16	®	®	NOUN
hls-5011	21	17	;	;	PUNCT
hls-5011	21	18	mwanza	mwanza	ADJ
hls-5011	21	19	;	;	PUNCT
hls-5011	21	20	tanzania	tanzania	PROPN
hls-5011	21	21	.	.	PUNCT
hls-5011	22	1	contributions	contribution	NOUN
hls-5011	22	2	:	:	PUNCT
hls-5011	22	3	js	js	PROPN
hls-5011	22	4	,	,	PUNCT
hls-5011	22	5	brk	brk	PROPN
hls-5011	22	6	,	,	PUNCT
hls-5011	22	7	ma	ma	PROPN
hls-5011	22	8	and	and	CCONJ
hls-5011	22	9	sem	sem	PROPN
hls-5011	22	10	conceived	conceive	VERB
hls-5011	22	11	and	and	CCONJ
hls-5011	22	12	designed	design	VERB
hls-5011	22	13	the	the	DET
hls-5011	22	14	study	study	NOUN
hls-5011	22	15	;	;	PUNCT
hls-5011	22	16	ma	ma	PROPN
hls-5011	22	17	and	and	CCONJ
hls-5011	22	18	fm	fm	PROPN
hls-5011	22	19	carried	carry	VERB
hls-5011	22	20	out	out	ADP
hls-5011	22	21	the	the	DET
hls-5011	22	22	laboratory	laboratory	NOUN
hls-5011	22	23	procedures	procedure	NOUN
hls-5011	22	24	;	;	PUNCT
hls-5011	22	25	js	js	PROPN
hls-5011	22	26	,	,	PUNCT
hls-5011	22	27	brk	brk	PROPN
hls-5011	22	28	,	,	PUNCT
hls-5011	22	29	ma	ma	PROPN
hls-5011	22	30	,	,	PUNCT
hls-5011	22	31	ak	ak	PROPN
hls-5011	22	32	and	and	CCONJ
hls-5011	22	33	jrm	jrm	PROPN
hls-5011	22	34	analyzed	analyze	VERB
hls-5011	22	35	data	datum	NOUN
hls-5011	22	36	;	;	PUNCT
hls-5011	22	37	js	js	PROPN
hls-5011	22	38	wrote	write	VERB
hls-5011	22	39	the	the	DET
hls-5011	22	40	first	first	ADJ
hls-5011	22	41	draft	draft	NOUN
hls-5011	22	42	of	of	ADP
hls-5011	22	43	the	the	DET
hls-5011	22	44	manuscript	manuscript	NOUN
hls-5011	22	45	;	;	PUNCT
hls-5011	22	46	ak	ak	PROPN
hls-5011	22	47	,	,	PUNCT
hls-5011	22	48	jrm	jrm	PROPN
hls-5011	22	49	,	,	PUNCT
hls-5011	22	50	rm	rm	PROPN
hls-5011	22	51	,	,	PUNCT
hls-5011	22	52	zhm	zhm	PROPN
hls-5011	22	53	,	,	PUNCT
hls-5011	22	54	jc	jc	PROPN
hls-5011	22	55	and	and	CCONJ
hls-5011	22	56	sem	sem	PROPN
hls-5011	22	57	critically	critically	ADV
hls-5011	22	58	reviewed	review	VERB
hls-5011	22	59	the	the	DET
hls-5011	22	60	manuscript	manuscript	NOUN
hls-5011	22	61	.	.	PUNCT
hls-5011	23	1	all	all	DET
hls-5011	23	2	authors	author	NOUN
hls-5011	23	3	have	have	AUX
hls-5011	23	4	read	read	VERB
hls-5011	23	5	and	and	CCONJ
hls-5011	23	6	approved	approve	VERB
hls-5011	23	7	the	the	DET
hls-5011	23	8	final	final	ADJ
hls-5011	23	9	draft	draft	NOUN
hls-5011	23	10	of	of	ADP
hls-5011	23	11	the	the	DET
hls-5011	23	12	manuscript	manuscript	NOUN
hls-5011	23	13	.	.	PUNCT
hls-5011	24	1	conflict	conflict	NOUN
hls-5011	24	2	of	of	ADP
hls-5011	24	3	interest	interest	NOUN
hls-5011	24	4	:	:	PUNCT
hls-5011	24	5	the	the	DET
hls-5011	24	6	authors	author	NOUN
hls-5011	24	7	declare	declare	VERB
hls-5011	24	8	no	no	DET
hls-5011	24	9	potential	potential	ADJ
hls-5011	24	10	conflict	conflict	NOUN
hls-5011	24	11	of	of	ADP
hls-5011	24	12	interest	interest	NOUN
hls-5011	24	13	.	.	PUNCT
hls-5011	25	1	acknowledgements	acknowledgement	NOUN
hls-5011	25	2	:	:	PUNCT
hls-5011	25	3	the	the	DET
hls-5011	25	4	authors	author	NOUN
hls-5011	25	5	are	be	AUX
hls-5011	25	6	sincerely	sincerely	ADV
hls-5011	25	7	thankful	thankful	ADJ
hls-5011	25	8	to	to	ADP
hls-5011	25	9	the	the	DET
hls-5011	25	10	patients	patient	NOUN
hls-5011	25	11	who	who	PRON
hls-5011	25	12	participated	participate	VERB
hls-5011	25	13	in	in	ADP
hls-5011	25	14	the	the	DET
hls-5011	25	15	study	study	NOUN
hls-5011	25	16	,	,	PUNCT
hls-5011	25	17	srrh	srrh	PROPN
hls-5011	25	18	administration	administration	NOUN
hls-5011	25	19	for	for	ADP
hls-5011	25	20	allowing	allow	VERB
hls-5011	25	21	conduction	conduction	NOUN
hls-5011	25	22	of	of	ADP
hls-5011	25	23	this	this	DET
hls-5011	25	24	study	study	NOUN
hls-5011	25	25	.	.	PUNCT
hls-5011	26	1	mr	mr	PROPN
hls-5011	26	2	.	.	PROPN
hls-5011	26	3	othman	othman	PROPN
hls-5011	26	4	sade	sade	PROPN
hls-5011	26	5	and	and	CCONJ
hls-5011	26	6	other	other	ADJ
hls-5011	26	7	laboratory	laboratory	NOUN
hls-5011	26	8	staffs	staff	NOUN
hls-5011	26	9	working	work	VERB
hls-5011	26	10	in	in	ADP
hls-5011	26	11	the	the	DET
hls-5011	26	12	tb	tb	NOUN
hls-5011	26	13	section	section	NOUN
hls-5011	26	14	at	at	ADP
hls-5011	26	15	srrh	srrh	NOUN
hls-5011	26	16	for	for	ADP
hls-5011	26	17	their	their	PRON
hls-5011	26	18	technical	technical	ADJ
hls-5011	26	19	support	support	NOUN
hls-5011	26	20	.	.	PUNCT
hls-5011	27	1	the	the	DET
hls-5011	27	2	genexpert	genexpert	PROPN
hls-5011	27	3	mtb	mtb	PROPN
hls-5011	27	4	/	/	SYM
hls-5011	27	5	rif	rif	PROPN
hls-5011	27	6	®	®	NOUN
hls-5011	27	7	was	be	AUX
hls-5011	27	8	generously	generously	ADV
hls-5011	27	9	donated	donate	VERB
hls-5011	27	10	and	and	CCONJ
hls-5011	27	11	is	be	AUX
hls-5011	27	12	being	be	AUX
hls-5011	27	13	maintained	maintain	VERB
hls-5011	27	14	path	path	NOUN
hls-5011	27	15	tanzania	tanzania	PROPN
hls-5011	27	16	under	under	ADP
hls-5011	27	17	usaid	usaid	PROPN
hls-5011	27	18	tb	tb	ADP
hls-5011	27	19	to	to	ADP
hls-5011	27	20	2015	2015	NUM
hls-5011	27	21	funds	fund	NOUN
hls-5011	27	22	.	.	PUNCT
hls-5011	28	1	part	part	NOUN
hls-5011	28	2	of	of	ADP
hls-5011	28	3	this	this	DET
hls-5011	28	4	work	work	NOUN
hls-5011	28	5	was	be	AUX
hls-5011	28	6	presented	present	VERB
hls-5011	28	7	at	at	ADP
hls-5011	28	8	the	the	DET
hls-5011	28	9	6th	6th	ADJ
hls-5011	28	10	cuhas	cuhas	ADJ
hls-5011	28	11	scientific	scientific	ADJ
hls-5011	28	12	graduation	graduation	NOUN
hls-5011	28	13	symposium	symposium	NOUN
hls-5011	28	14	:	:	PUNCT
hls-5011	28	15	abstract	abstract	ADJ
hls-5011	28	16	book	book	NOUN
hls-5011	28	17	,	,	PUNCT
hls-5011	28	18	november	november	PROPN
hls-5011	28	19	2014	2014	NUM
hls-5011	28	20	,	,	PUNCT
hls-5011	28	21	mwanza	mwanza	ADJ
hls-5011	28	22	.	.	PUNCT
hls-5011	29	1	tanzania	tanzania	PROPN
hls-5011	29	2	.	.	PUNCT
hls-5011	29	3	received	receive	VERB
hls-5011	29	4	for	for	ADP
hls-5011	29	5	publication	publication	NOUN
hls-5011	29	6	:	:	PUNCT
hls-5011	29	7	17	17	NUM
hls-5011	29	8	january	january	PROPN
hls-5011	29	9	2015	2015	NUM
hls-5011	29	10	.	.	PUNCT
hls-5011	30	1	revision	revision	NOUN
hls-5011	30	2	received	receive	VERB
hls-5011	30	3	:	:	PUNCT
hls-5011	30	4	21	21	NUM
hls-5011	30	5	march	march	NOUN
hls-5011	30	6	2015	2015	NUM
hls-5011	30	7	.	.	PUNCT
hls-5011	31	1	accepted	accept	VERB
hls-5011	31	2	for	for	ADP
hls-5011	31	3	publication	publication	NOUN
hls-5011	31	4	:	:	PUNCT
hls-5011	31	5	26	26	NUM
hls-5011	31	6	march	march	NOUN
hls-5011	31	7	2015	2015	NUM
hls-5011	31	8	.	.	PUNCT
hls-5011	32	1	this	this	DET
hls-5011	32	2	work	work	NOUN
hls-5011	32	3	is	be	AUX
hls-5011	32	4	licensed	license	VERB
hls-5011	32	5	under	under	ADP
hls-5011	32	6	a	a	DET
hls-5011	32	7	creative	creative	ADJ
hls-5011	32	8	commons	common	NOUN
hls-5011	32	9	attribution	attribution	NOUN
hls-5011	32	10	3.0	3.0	NUM
hls-5011	32	11	license	license	NOUN
hls-5011	32	12	(	(	PUNCT
hls-5011	32	13	by	by	ADP
hls-5011	32	14	-	-	PUNCT
hls-5011	32	15	nc	nc	PROPN
hls-5011	32	16	3.0	3.0	NUM
hls-5011	32	17	)	)	PUNCT
hls-5011	32	18	.	.	PUNCT
hls-5011	33	1	©	©	PROPN
hls-5011	33	2	copyright	copyright	PROPN
hls-5011	33	3	j.	j.	PROPN
hls-5011	33	4	seni	seni	PROPN
hls-5011	33	5	et	et	PROPN
hls-5011	33	6	al	al	PROPN
hls-5011	33	7	.	.	PROPN
hls-5011	33	8	,	,	PUNCT
hls-5011	33	9	2015	2015	NUM
hls-5011	33	10	licensee	licensee	NOUN
hls-5011	33	11	pagepress	pagepress	NOUN
hls-5011	33	12	,	,	PUNCT
hls-5011	33	13	italy	italy	PROPN
hls-5011	33	14	healthcare	healthcare	PROPN
hls-5011	33	15	in	in	ADP
hls-5011	33	16	low	low	ADJ
hls-5011	33	17	-	-	PUNCT
hls-5011	33	18	resource	resource	NOUN
hls-5011	33	19	settings	setting	NOUN
hls-5011	33	20	2015	2015	NUM
hls-5011	33	21	;	;	PUNCT
hls-5011	33	22	3:5011	3:5011	NUM
hls-5011	33	23	doi:10.4081	doi:10.4081	NOUN
hls-5011	33	24	/	/	SYM
hls-5011	33	25	hls.2015.5011	hls.2015.5011	X
hls-5011	33	26	non	non	X
hls-5011	33	27	co	co	X
hls-5011	33	28	mmerc	mmerc	PROPN
hls-5011	33	29	ial	ial	PROPN
hls-5011	33	30	us	us	PROPN
hls-5011	33	31	e	e	NOUN
hls-5011	33	32	o	o	NOUN
hls-5011	34	1	nly	nly	ADV
hls-5011	34	2	[	[	X
hls-5011	34	3	healthcare	healthcare	NOUN
hls-5011	34	4	in	in	ADP
hls-5011	34	5	low	low	ADJ
hls-5011	34	6	-	-	PUNCT
hls-5011	34	7	resource	resource	NOUN
hls-5011	34	8	settings	setting	NOUN
hls-5011	34	9	2015	2015	NUM
hls-5011	34	10	;	;	PUNCT
hls-5011	34	11	3:5011	3:5011	NUM
hls-5011	34	12	]	]	PUNCT
hls-5011	35	1	[	[	X
hls-5011	35	2	page	page	NOUN
hls-5011	35	3	11	11	NUM
hls-5011	35	4	]	]	PUNCT
hls-5011	35	5	materials	material	NOUN
hls-5011	35	6	and	and	CCONJ
hls-5011	35	7	methods	method	NOUN
hls-5011	35	8	study	study	NOUN
hls-5011	35	9	design	design	NOUN
hls-5011	35	10	and	and	CCONJ
hls-5011	35	11	area	area	NOUN
hls-5011	35	12	this	this	PRON
hls-5011	35	13	was	be	AUX
hls-5011	35	14	an	an	DET
hls-5011	35	15	operational	operational	ADJ
hls-5011	35	16	prospective	prospective	ADJ
hls-5011	35	17	laboratory	laboratory	NOUN
hls-5011	35	18	based	base	VERB
hls-5011	35	19	study	study	NOUN
hls-5011	35	20	carried	carry	VERB
hls-5011	35	21	out	out	ADP
hls-5011	35	22	at	at	ADP
hls-5011	35	23	srrh	srrh	NOUN
hls-5011	35	24	in	in	ADP
hls-5011	35	25	mwanza	mwanza	PROPN
hls-5011	35	26	,	,	PUNCT
hls-5011	35	27	tanzania	tanzania	PROPN
hls-5011	35	28	from	from	ADP
hls-5011	35	29	june	june	PROPN
hls-5011	35	30	2013	2013	NUM
hls-5011	35	31	to	to	ADP
hls-5011	35	32	november	november	PROPN
hls-5011	35	33	2013	2013	NUM
hls-5011	35	34	involving	involve	VERB
hls-5011	35	35	1946	1946	NUM
hls-5011	35	36	ptb	ptb	PROPN
hls-5011	35	37	patients	patient	NOUN
hls-5011	35	38	submitting	submit	VERB
hls-5011	35	39	their	their	PRON
hls-5011	35	40	sputum	sputum	NOUN
hls-5011	35	41	for	for	ADP
hls-5011	35	42	analysis	analysis	NOUN
hls-5011	35	43	at	at	ADP
hls-5011	35	44	srrh	srrh	ADJ
hls-5011	35	45	.	.	PUNCT
hls-5011	36	1	of	of	ADP
hls-5011	36	2	these	these	PRON
hls-5011	36	3	,	,	PUNCT
hls-5011	36	4	806	806	NUM
hls-5011	36	5	(	(	PUNCT
hls-5011	36	6	41.4	41.4	NUM
hls-5011	36	7	%	%	NOUN
hls-5011	36	8	)	)	PUNCT
hls-5011	36	9	had	have	VERB
hls-5011	36	10	dual	dual	ADJ
hls-5011	36	11	results	result	NOUN
hls-5011	36	12	(	(	PUNCT
hls-5011	36	13	i.e.	i.e.	X
hls-5011	36	14	led	lead	VERB
hls-5011	36	15	fm	fm	PROPN
hls-5011	36	16	and	and	CCONJ
hls-5011	36	17	genexpert	genexpert	PROPN
hls-5011	36	18	mtb	mtb	PROPN
hls-5011	36	19	/	/	SYM
hls-5011	36	20	rif	rif	PROPN
hls-5011	36	21	®	®	NOUN
hls-5011	36	22	results	result	NOUN
hls-5011	36	23	)	)	PUNCT
hls-5011	36	24	fulfilling	fulfil	VERB
hls-5011	36	25	the	the	DET
hls-5011	36	26	inclusion	inclusion	NOUN
hls-5011	36	27	criteria	criterion	NOUN
hls-5011	36	28	,	,	PUNCT
hls-5011	36	29	and	and	CCONJ
hls-5011	36	30	1140	1140	NUM
hls-5011	36	31	(	(	PUNCT
hls-5011	36	32	58.6	58.6	NUM
hls-5011	36	33	%	%	NOUN
hls-5011	36	34	)	)	PUNCT
hls-5011	36	35	patients	patient	NOUN
hls-5011	36	36	were	be	AUX
hls-5011	36	37	excluded	exclude	VERB
hls-5011	36	38	for	for	ADP
hls-5011	36	39	various	various	ADJ
hls-5011	36	40	reasons	reason	NOUN
hls-5011	36	41	(	(	PUNCT
hls-5011	36	42	figure	figure	NOUN
hls-5011	36	43	1	1	NUM
hls-5011	36	44	)	)	PUNCT
hls-5011	36	45	.	.	PUNCT
hls-5011	37	1	sample	sample	NOUN
hls-5011	37	2	collection	collection	NOUN
hls-5011	37	3	,	,	PUNCT
hls-5011	37	4	processing	processing	NOUN
hls-5011	37	5	and	and	CCONJ
hls-5011	37	6	data	datum	NOUN
hls-5011	37	7	analysis	analysis	NOUN
hls-5011	37	8	sputum	sputum	NOUN
hls-5011	37	9	samples	sample	NOUN
hls-5011	37	10	were	be	AUX
hls-5011	37	11	collected	collect	VERB
hls-5011	37	12	from	from	ADP
hls-5011	37	13	ptb	ptb	PROPN
hls-5011	37	14	patients	patient	NOUN
hls-5011	37	15	following	follow	VERB
hls-5011	37	16	the	the	DET
hls-5011	37	17	ntlp	ntlp	PROPN
hls-5011	37	18	guidelines,1	guidelines,1	PUNCT
hls-5011	37	19	and	and	CCONJ
hls-5011	37	20	analyzed	analyze	VERB
hls-5011	37	21	based	base	VERB
hls-5011	37	22	on	on	ADP
hls-5011	37	23	the	the	DET
hls-5011	37	24	standard	standard	ADJ
hls-5011	37	25	operating	operating	NOUN
hls-5011	37	26	procedures	procedure	NOUN
hls-5011	37	27	by	by	ADP
hls-5011	37	28	led	lead	VERB
hls-5011	37	29	fm	fm	PROPN
hls-5011	37	30	and	and	CCONJ
hls-5011	37	31	genexpert	genexpert	PROPN
hls-5011	37	32	mtb	mtb	PROPN
hls-5011	37	33	/	/	SYM
hls-5011	37	34	rif	rif	PROPN
hls-5011	37	35	®	®	PROPN
hls-5011	37	36	.8,9,15,20	.8,9,15,20	PROPN
hls-5011	37	37	for	for	ADP
hls-5011	37	38	comparison	comparison	NOUN
hls-5011	37	39	purposes	purpose	NOUN
hls-5011	37	40	of	of	ADP
hls-5011	37	41	the	the	DET
hls-5011	37	42	two	two	NUM
hls-5011	37	43	diagnostic	diagnostic	ADJ
hls-5011	37	44	techniques	technique	NOUN
hls-5011	37	45	,	,	PUNCT
hls-5011	37	46	one	one	NUM
hls-5011	37	47	sputum	sputum	NOUN
hls-5011	37	48	sample	sample	NOUN
hls-5011	37	49	per	per	ADP
hls-5011	37	50	patient	patient	NOUN
hls-5011	37	51	was	be	AUX
hls-5011	37	52	used	use	VERB
hls-5011	37	53	.	.	PUNCT
hls-5011	38	1	in	in	ADP
hls-5011	38	2	case	case	NOUN
hls-5011	38	3	the	the	DET
hls-5011	38	4	sample	sample	NOUN
hls-5011	38	5	was	be	AUX
hls-5011	38	6	negative	negative	ADJ
hls-5011	38	7	requiring	require	VERB
hls-5011	38	8	the	the	DET
hls-5011	38	9	second	second	ADJ
hls-5011	38	10	sputum	sputum	NOUN
hls-5011	38	11	sample	sample	NOUN
hls-5011	38	12	as	as	SCONJ
hls-5011	38	13	per	per	ADP
hls-5011	38	14	ntlp	ntlp	PROPN
hls-5011	38	15	guideline,1	guideline,1	VERB
hls-5011	38	16	the	the	DET
hls-5011	38	17	latter	latter	ADJ
hls-5011	38	18	was	be	AUX
hls-5011	38	19	analyzed	analyze	VERB
hls-5011	38	20	to	to	PART
hls-5011	38	21	guide	guide	VERB
hls-5011	38	22	patient	patient	NOUN
hls-5011	38	23	’s	’s	PART
hls-5011	38	24	management	management	NOUN
hls-5011	38	25	but	but	CCONJ
hls-5011	38	26	not	not	PART
hls-5011	38	27	used	use	VERB
hls-5011	38	28	for	for	ADP
hls-5011	38	29	the	the	DET
hls-5011	38	30	index	index	NOUN
hls-5011	38	31	study	study	NOUN
hls-5011	38	32	.	.	PUNCT
hls-5011	39	1	patients	patient	NOUN
hls-5011	39	2	’	'	PUNCT
hls-5011	39	3	information	information	NOUN
hls-5011	39	4	was	be	AUX
hls-5011	39	5	obtained	obtain	VERB
hls-5011	39	6	from	from	ADP
hls-5011	39	7	laboratory	laboratory	NOUN
hls-5011	39	8	request	request	NOUN
hls-5011	39	9	forms	form	NOUN
hls-5011	39	10	and	and	CCONJ
hls-5011	39	11	the	the	DET
hls-5011	39	12	tb	tb	X
hls-5011	39	13	registry	registry	NOUN
hls-5011	39	14	book	book	NOUN
hls-5011	39	15	.	.	PUNCT
hls-5011	40	1	analysis	analysis	NOUN
hls-5011	40	2	was	be	AUX
hls-5011	40	3	done	do	VERB
hls-5011	40	4	using	use	VERB
hls-5011	40	5	stata	stata	NOUN
hls-5011	40	6	software	software	NOUN
hls-5011	40	7	version	version	NOUN
hls-5011	40	8	11	11	NUM
hls-5011	40	9	(	(	PUNCT
hls-5011	40	10	college	college	NOUN
hls-5011	40	11	station	station	NOUN
hls-5011	40	12	,	,	PUNCT
hls-5011	40	13	tx	tx	PROPN
hls-5011	40	14	,	,	PUNCT
hls-5011	40	15	usa	usa	PROPN
hls-5011	40	16	)	)	PUNCT
hls-5011	40	17	according	accord	VERB
hls-5011	40	18	to	to	ADP
hls-5011	40	19	the	the	DET
hls-5011	40	20	objectives	objective	NOUN
hls-5011	40	21	of	of	ADP
hls-5011	40	22	the	the	DET
hls-5011	40	23	study	study	NOUN
hls-5011	40	24	.	.	PUNCT
hls-5011	41	1	continuous	continuous	ADJ
hls-5011	41	2	variables	variable	NOUN
hls-5011	41	3	were	be	AUX
hls-5011	41	4	described	describe	VERB
hls-5011	41	5	as	as	ADP
hls-5011	41	6	mean	mean	ADJ
hls-5011	41	7	(	(	PUNCT
hls-5011	41	8	±standard	±standard	ADJ
hls-5011	41	9	deviation	deviation	NOUN
hls-5011	41	10	)	)	PUNCT
hls-5011	41	11	.	.	PUNCT
hls-5011	42	1	categorical	categorical	ADJ
hls-5011	42	2	variables	variable	NOUN
hls-5011	42	3	were	be	AUX
hls-5011	42	4	described	describe	VERB
hls-5011	42	5	as	as	ADP
hls-5011	42	6	proportions	proportion	NOUN
hls-5011	42	7	(	(	PUNCT
hls-5011	42	8	percentages	percentage	NOUN
hls-5011	42	9	)	)	PUNCT
hls-5011	42	10	and	and	CCONJ
hls-5011	42	11	were	be	AUX
hls-5011	42	12	analyzed	analyze	VERB
hls-5011	42	13	to	to	PART
hls-5011	42	14	compare	compare	VERB
hls-5011	42	15	the	the	DET
hls-5011	42	16	distribution	distribution	NOUN
hls-5011	42	17	of	of	ADP
hls-5011	42	18	ptb	ptb	PROPN
hls-5011	42	19	positive	positive	ADJ
hls-5011	42	20	and	and	CCONJ
hls-5011	42	21	negative	negative	ADJ
hls-5011	42	22	patients	patient	NOUN
hls-5011	42	23	with	with	ADP
hls-5011	42	24	variables	variable	NOUN
hls-5011	42	25	.	.	PUNCT
hls-5011	43	1	study	study	NOUN
hls-5011	43	2	clearance	clearance	NOUN
hls-5011	43	3	and	and	CCONJ
hls-5011	43	4	ethical	ethical	ADJ
hls-5011	43	5	considerations	consideration	NOUN
hls-5011	43	6	the	the	DET
hls-5011	43	7	study	study	NOUN
hls-5011	43	8	was	be	AUX
hls-5011	43	9	approved	approve	VERB
hls-5011	43	10	by	by	ADP
hls-5011	43	11	the	the	DET
hls-5011	43	12	joint	joint	ADJ
hls-5011	43	13	bugando	bugando	ADJ
hls-5011	43	14	medical	medical	ADJ
hls-5011	43	15	centre	centre	NOUN
hls-5011	43	16	and	and	CCONJ
hls-5011	43	17	catholic	catholic	PROPN
hls-5011	43	18	university	university	PROPN
hls-5011	43	19	of	of	ADP
hls-5011	43	20	health	health	PROPN
hls-5011	43	21	and	and	CCONJ
hls-5011	43	22	allied	ally	VERB
hls-5011	43	23	sciences	sciences	PROPN
hls-5011	43	24	institutional	institutional	ADJ
hls-5011	43	25	review	review	PROPN
hls-5011	43	26	board	board	NOUN
hls-5011	43	27	.	.	PUNCT
hls-5011	44	1	permission	permission	NOUN
hls-5011	44	2	to	to	PART
hls-5011	44	3	conduct	conduct	VERB
hls-5011	44	4	the	the	DET
hls-5011	44	5	study	study	NOUN
hls-5011	44	6	was	be	AUX
hls-5011	44	7	obtained	obtain	VERB
hls-5011	44	8	from	from	ADP
hls-5011	44	9	srrh	srrh	ADJ
hls-5011	44	10	medical	medical	ADJ
hls-5011	44	11	officer	officer	NOUN
hls-5011	44	12	in	in	ADP
hls-5011	44	13	charge	charge	NOUN
hls-5011	44	14	,	,	PUNCT
hls-5011	44	15	tb	tb	ADP
hls-5011	44	16	coordinator	coordinator	NOUN
hls-5011	44	17	and	and	CCONJ
hls-5011	44	18	laboratory	laboratory	NOUN
hls-5011	44	19	manager	manager	NOUN
hls-5011	44	20	.	.	PUNCT
hls-5011	45	1	all	all	DET
hls-5011	45	2	patients	patient	NOUN
hls-5011	45	3	’	'	PUNCT
hls-5011	45	4	information	information	NOUN
hls-5011	45	5	was	be	AUX
hls-5011	45	6	kept	keep	VERB
hls-5011	45	7	confidential	confidential	ADJ
hls-5011	45	8	and	and	CCONJ
hls-5011	45	9	anonymous	anonymous	ADJ
hls-5011	45	10	using	use	VERB
hls-5011	45	11	study	study	NOUN
hls-5011	45	12	codes	code	NOUN
hls-5011	45	13	.	.	PUNCT
hls-5011	46	1	presumptive	presumptive	ADJ
hls-5011	46	2	patients	patient	NOUN
hls-5011	46	3	found	find	VERB
hls-5011	46	4	to	to	PART
hls-5011	46	5	have	have	VERB
hls-5011	46	6	ptb	ptb	PROPN
hls-5011	46	7	were	be	AUX
hls-5011	46	8	treated	treat	VERB
hls-5011	46	9	in	in	ADP
hls-5011	46	10	their	their	PRON
hls-5011	46	11	respective	respective	ADJ
hls-5011	46	12	treatment	treatment	NOUN
hls-5011	46	13	units	unit	NOUN
hls-5011	46	14	basing	base	VERB
hls-5011	46	15	on	on	ADP
hls-5011	46	16	the	the	DET
hls-5011	46	17	ntlp	ntlp	PROPN
hls-5011	46	18	guidelines1	guidelines1	NOUN
hls-5011	46	19	and	and	CCONJ
hls-5011	46	20	those	those	PRON
hls-5011	46	21	with	with	ADP
hls-5011	46	22	rif	rif	PROPN
hls-5011	46	23	resistance	resistance	PROPN
hls-5011	46	24	were	be	AUX
hls-5011	46	25	referred	refer	VERB
hls-5011	46	26	to	to	ADP
hls-5011	46	27	kibong’oto	kibong’oto	PROPN
hls-5011	46	28	national	national	ADJ
hls-5011	46	29	tuberculosis	tuberculosis	NOUN
hls-5011	46	30	hospital	hospital	NOUN
hls-5011	46	31	for	for	ADP
hls-5011	46	32	confirmation	confirmation	NOUN
hls-5011	46	33	and	and	CCONJ
hls-5011	46	34	further	far	ADV
hls-5011	46	35	expertize	expertize	VERB
hls-5011	46	36	management	management	NOUN
hls-5011	46	37	.	.	PUNCT
hls-5011	47	1	results	result	NOUN
hls-5011	47	2	we	we	PRON
hls-5011	47	3	involved	involve	VERB
hls-5011	47	4	806	806	NUM
hls-5011	47	5	ptb	ptb	PROPN
hls-5011	47	6	patients	patient	NOUN
hls-5011	47	7	in	in	ADP
hls-5011	47	8	this	this	DET
hls-5011	47	9	study	study	NOUN
hls-5011	47	10	with	with	ADP
hls-5011	47	11	the	the	DET
hls-5011	47	12	mean	mean	ADJ
hls-5011	47	13	age	age	NOUN
hls-5011	47	14	(	(	PUNCT
hls-5011	47	15	±standard	±standard	ADJ
hls-5011	47	16	deviation	deviation	NOUN
hls-5011	47	17	)	)	PUNCT
hls-5011	47	18	of	of	ADP
hls-5011	47	19	39.6±16.0	39.6±16.0	NUM
hls-5011	47	20	years	year	NOUN
hls-5011	47	21	(	(	PUNCT
hls-5011	47	22	age	age	NOUN
hls-5011	47	23	range	range	NOUN
hls-5011	47	24	1	1	NUM
hls-5011	47	25	-	-	SYM
hls-5011	47	26	96	96	NUM
hls-5011	47	27	years	year	NOUN
hls-5011	47	28	)	)	PUNCT
hls-5011	47	29	;	;	PUNCT
hls-5011	47	30	males	male	NOUN
hls-5011	47	31	accounted	account	VERB
hls-5011	47	32	for	for	ADP
hls-5011	47	33	50.5	50.5	NUM
hls-5011	47	34	%	%	NOUN
hls-5011	47	35	(	(	PUNCT
hls-5011	47	36	407/806	407/806	PROPN
hls-5011	47	37	)	)	PUNCT
hls-5011	47	38	.	.	PUNCT
hls-5011	48	1	majority	majority	NOUN
hls-5011	48	2	of	of	ADP
hls-5011	48	3	patients	patient	NOUN
hls-5011	48	4	(	(	PUNCT
hls-5011	48	5	97.5	97.5	NUM
hls-5011	48	6	%	%	NOUN
hls-5011	48	7	)	)	PUNCT
hls-5011	48	8	were	be	AUX
hls-5011	48	9	new	new	ADJ
hls-5011	48	10	cases	case	NOUN
hls-5011	48	11	and	and	CCONJ
hls-5011	48	12	were	be	AUX
hls-5011	48	13	residing	reside	VERB
hls-5011	48	14	within	within	ADP
hls-5011	48	15	mwanza	mwanza	PROPN
hls-5011	48	16	city	city	NOUN
hls-5011	48	17	,	,	PUNCT
hls-5011	48	18	81.7	81.7	NUM
hls-5011	48	19	%	%	NOUN
hls-5011	48	20	(	(	PUNCT
hls-5011	48	21	658/806	658/806	NOUN
hls-5011	48	22	)	)	PUNCT
hls-5011	48	23	.	.	PUNCT
hls-5011	49	1	the	the	DET
hls-5011	49	2	proportion	proportion	NOUN
hls-5011	49	3	of	of	ADP
hls-5011	49	4	ptb	ptb	PROPN
hls-5011	49	5	patients	patient	NOUN
hls-5011	49	6	confirmed	confirm	VERB
hls-5011	49	7	to	to	PART
hls-5011	49	8	have	have	VERB
hls-5011	49	9	ptb	ptb	PROPN
hls-5011	49	10	disease	disease	NOUN
hls-5011	49	11	by	by	ADP
hls-5011	49	12	either	either	CCONJ
hls-5011	49	13	fm	fm	PROPN
hls-5011	49	14	or	or	CCONJ
hls-5011	49	15	genexpert	genexpert	PROPN
hls-5011	49	16	mtb	mtb	PROPN
hls-5011	49	17	/	/	SYM
hls-5011	49	18	rif	rif	PROPN
hls-5011	49	19	®	®	NOUN
hls-5011	49	20	was	be	AUX
hls-5011	49	21	24.8	24.8	NUM
hls-5011	49	22	%	%	NOUN
hls-5011	49	23	(	(	PUNCT
hls-5011	49	24	200/806	200/806	NUM
hls-5011	49	25	)	)	PUNCT
hls-5011	49	26	(	(	PUNCT
hls-5011	49	27	table	table	NOUN
hls-5011	49	28	1	1	NUM
hls-5011	49	29	)	)	PUNCT
hls-5011	49	30	.	.	PUNCT
hls-5011	50	1	of	of	ADP
hls-5011	50	2	these	these	PRON
hls-5011	50	3	,	,	PUNCT
hls-5011	50	4	14.1	14.1	NUM
hls-5011	50	5	%	%	NOUN
hls-5011	50	6	(	(	PUNCT
hls-5011	50	7	114/806	114/806	NUM
hls-5011	50	8	)	)	PUNCT
hls-5011	50	9	and	and	CCONJ
hls-5011	50	10	23.7	23.7	NUM
hls-5011	50	11	%	%	NOUN
hls-5011	50	12	(	(	PUNCT
hls-5011	50	13	191/806	191/806	PROPN
hls-5011	50	14	)	)	PUNCT
hls-5011	50	15	were	be	AUX
hls-5011	50	16	detected	detect	VERB
hls-5011	50	17	by	by	ADP
hls-5011	50	18	fm	fm	PROPN
hls-5011	50	19	and	and	CCONJ
hls-5011	50	20	genexpert	genexpert	PROPN
hls-5011	50	21	mtb	mtb	PROPN
hls-5011	50	22	/	/	SYM
hls-5011	50	23	rif	rif	NOUN
hls-5011	50	24	®	®	NOUN
hls-5011	50	25	respectively	respectively	ADV
hls-5011	50	26	.	.	PUNCT
hls-5011	51	1	this	this	PRON
hls-5011	51	2	resulted	result	VERB
hls-5011	51	3	into	into	ADP
hls-5011	51	4	9.6	9.6	NUM
hls-5011	51	5	%	%	NOUN
hls-5011	51	6	incremental	incremental	ADJ
hls-5011	51	7	detection	detection	NOUN
hls-5011	51	8	rate	rate	NOUN
hls-5011	51	9	by	by	ADP
hls-5011	51	10	genexpert	genexpert	ADJ
hls-5011	51	11	mtb	mtb	PROPN
hls-5011	51	12	/	/	SYM
hls-5011	51	13	rif	rif	PROPN
hls-5011	51	14	®	®	NOUN
hls-5011	51	15	over	over	ADP
hls-5011	51	16	led	lead	VERB
hls-5011	51	17	fm	fm	PROPN
hls-5011	51	18	(	(	PUNCT
hls-5011	51	19	figure	figure	VERB
hls-5011	51	20	1	1	NUM
hls-5011	51	21	and	and	CCONJ
hls-5011	51	22	table	table	NOUN
hls-5011	51	23	1	1	NUM
hls-5011	51	24	)	)	PUNCT
hls-5011	51	25	.	.	PUNCT
hls-5011	52	1	the	the	DET
hls-5011	52	2	detection	detection	NOUN
hls-5011	52	3	rate	rate	NOUN
hls-5011	52	4	of	of	ADP
hls-5011	52	5	genexpert	genexpert	ADJ
hls-5011	52	6	mtb	mtb	PROPN
hls-5011	52	7	/	/	SYM
hls-5011	52	8	rif	rif	PROPN
hls-5011	52	9	®	®	NOUN
hls-5011	52	10	was	be	AUX
hls-5011	52	11	higher	high	ADJ
hls-5011	52	12	compared	compare	VERB
hls-5011	52	13	to	to	ADP
hls-5011	52	14	led	lead	VERB
hls-5011	52	15	fm	fm	PROPN
hls-5011	52	16	in	in	ADP
hls-5011	52	17	both	both	DET
hls-5011	52	18	children	child	NOUN
hls-5011	52	19	(	(	PUNCT
hls-5011	52	20	≤17	≤17	NUM
hls-5011	52	21	years	year	NOUN
hls-5011	52	22	)	)	PUNCT
hls-5011	53	1	[	[	X
hls-5011	53	2	8.3	8.3	NUM
hls-5011	53	3	%	%	NOUN
hls-5011	53	4	(	(	PUNCT
hls-5011	53	5	6/72	6/72	NUM
hls-5011	53	6	)	)	PUNCT
hls-5011	53	7	vs	vs	ADP
hls-5011	53	8	4.2	4.2	NUM
hls-5011	53	9	%	%	NOUN
hls-5011	53	10	(	(	PUNCT
hls-5011	53	11	4/72	4/72	NOUN
hls-5011	53	12	)	)	PUNCT
hls-5011	53	13	]	]	PUNCT
hls-5011	53	14	and	and	CCONJ
hls-5011	53	15	adults	adult	NOUN
hls-5011	54	1	[	[	X
hls-5011	54	2	25.2	25.2	NUM
hls-5011	54	3	%	%	NOUN
hls-5011	54	4	(	(	PUNCT
hls-5011	54	5	185/734	185/734	NUM
hls-5011	54	6	)	)	PUNCT
hls-5011	54	7	vs	vs	ADP
hls-5011	54	8	15.1	15.1	NUM
hls-5011	54	9	%	%	NOUN
hls-5011	54	10	(	(	PUNCT
hls-5011	54	11	111/734	111/734	NUM
hls-5011	54	12	)	)	PUNCT
hls-5011	54	13	]	]	PUNCT
hls-5011	54	14	respectively	respectively	ADV
hls-5011	54	15	resulting	result	VERB
hls-5011	54	16	into	into	ADP
hls-5011	54	17	the	the	DET
hls-5011	54	18	incremental	incremental	ADJ
hls-5011	54	19	detections	detection	NOUN
hls-5011	54	20	of	of	ADP
hls-5011	54	21	4.1	4.1	NUM
hls-5011	54	22	%	%	NOUN
hls-5011	54	23	and	and	CCONJ
hls-5011	54	24	10.1	10.1	NUM
hls-5011	54	25	%	%	NOUN
hls-5011	54	26	for	for	ADP
hls-5011	54	27	children	child	NOUN
hls-5011	54	28	and	and	CCONJ
hls-5011	54	29	adults	adult	NOUN
hls-5011	54	30	respectively	respectively	ADV
hls-5011	54	31	.	.	PUNCT
hls-5011	55	1	the	the	DET
hls-5011	55	2	detection	detection	NOUN
hls-5011	55	3	rate	rate	NOUN
hls-5011	55	4	among	among	ADP
hls-5011	55	5	hiv	hiv	PROPN
hls-5011	55	6	positive	positive	ADJ
hls-5011	55	7	individuals	individual	NOUN
hls-5011	55	8	was	be	AUX
hls-5011	55	9	also	also	ADV
hls-5011	55	10	higher	higher	ADV
hls-5011	55	11	using	use	VERB
hls-5011	55	12	genexpert	genexpert	ADJ
hls-5011	55	13	mtb	mtb	PROPN
hls-5011	55	14	/	/	SYM
hls-5011	55	15	rif	rif	NOUN
hls-5011	55	16	®	®	NOUN
hls-5011	55	17	compared	compare	VERB
hls-5011	55	18	to	to	ADP
hls-5011	55	19	fm	fm	PROPN
hls-5011	56	1	[	[	X
hls-5011	56	2	23.6	23.6	NUM
hls-5011	56	3	%	%	NOUN
hls-5011	56	4	(	(	PUNCT
hls-5011	56	5	63/267	63/267	NUM
hls-5011	56	6	)	)	PUNCT
hls-5011	56	7	vs	vs	ADP
hls-5011	56	8	14.2	14.2	NUM
hls-5011	56	9	%	%	NOUN
hls-5011	56	10	(	(	PUNCT
hls-5011	56	11	38/267	38/267	NUM
hls-5011	56	12	)	)	PUNCT
hls-5011	56	13	respectively	respectively	ADV
hls-5011	56	14	]	]	PUNCT
hls-5011	56	15	,	,	PUNCT
hls-5011	56	16	with	with	ADP
hls-5011	56	17	an	an	DET
hls-5011	56	18	incremental	incremental	ADJ
hls-5011	56	19	detection	detection	NOUN
hls-5011	56	20	of	of	ADP
hls-5011	56	21	9.4	9.4	NUM
hls-5011	56	22	%	%	NOUN
hls-5011	56	23	.	.	PUNCT
hls-5011	57	1	moreover	moreover	ADV
hls-5011	57	2	,	,	PUNCT
hls-5011	57	3	the	the	DET
hls-5011	57	4	genexpert	genexpert	ADJ
hls-5011	57	5	mtb	mtb	PROPN
hls-5011	57	6	/	/	SYM
hls-5011	57	7	rif	rif	NOUN
hls-5011	57	8	®	®	NOUN
hls-5011	57	9	detected	detect	VERB
hls-5011	57	10	12.4	12.4	NUM
hls-5011	57	11	%	%	NOUN
hls-5011	57	12	(	(	PUNCT
hls-5011	57	13	86/692	86/692	NUM
hls-5011	57	14	)	)	PUNCT
hls-5011	57	15	and	and	CCONJ
hls-5011	57	16	12.2	12.2	NUM
hls-5011	57	17	%	%	NOUN
hls-5011	57	18	(	(	PUNCT
hls-5011	57	19	28/229	28/229	NUM
hls-5011	57	20	)	)	PUNCT
hls-5011	57	21	among	among	ADP
hls-5011	57	22	all	all	DET
hls-5011	57	23	smear	smear	NOUN
hls-5011	57	24	negative	negative	ADJ
hls-5011	57	25	irrespective	irrespective	ADV
hls-5011	57	26	of	of	ADP
hls-5011	57	27	hiv	hiv	PROPN
hls-5011	57	28	serostatus	serostatus	NOUN
hls-5011	57	29	and	and	CCONJ
hls-5011	57	30	smear	smear	VERB
hls-5011	57	31	negative	negative	ADJ
hls-5011	57	32	hiv	hiv	PROPN
hls-5011	57	33	positive	positive	ADJ
hls-5011	57	34	ptb	ptb	PROPN
hls-5011	57	35	patients	patient	NOUN
hls-5011	57	36	were	be	AUX
hls-5011	57	37	respectively	respectively	ADV
hls-5011	57	38	.	.	PUNCT
hls-5011	58	1	the	the	DET
hls-5011	58	2	rif	rif	PROPN
hls-5011	58	3	resistance	resistance	NOUN
hls-5011	58	4	was	be	AUX
hls-5011	58	5	found	find	VERB
hls-5011	58	6	in	in	ADP
hls-5011	58	7	2	2	NUM
hls-5011	58	8	(	(	PUNCT
hls-5011	58	9	1.1	1.1	NUM
hls-5011	58	10	%	%	NOUN
hls-5011	58	11	)	)	PUNCT
hls-5011	58	12	patients	patient	NOUN
hls-5011	58	13	,	,	PUNCT
hls-5011	58	14	5	5	NUM
hls-5011	58	15	(	(	PUNCT
hls-5011	58	16	2.6	2.6	NUM
hls-5011	58	17	%	%	NOUN
hls-5011	58	18	)	)	PUNCT
hls-5011	58	19	had	have	VERB
hls-5011	58	20	indeterminate	indeterminate	ADJ
hls-5011	58	21	resistance	resistance	NOUN
hls-5011	58	22	,	,	PUNCT
hls-5011	58	23	whereas	whereas	SCONJ
hls-5011	58	24	in	in	ADP
hls-5011	58	25	184	184	NUM
hls-5011	58	26	(	(	PUNCT
hls-5011	58	27	96.3	96.3	NUM
hls-5011	58	28	%	%	NOUN
hls-5011	58	29	)	)	PUNCT
hls-5011	58	30	there	there	PRON
hls-5011	58	31	was	be	VERB
hls-5011	58	32	no	no	DET
hls-5011	58	33	rifampin	rifampin	NOUN
hls-5011	58	34	resistance	resistance	NOUN
hls-5011	58	35	detected	detect	VERB
hls-5011	58	36	.	.	PUNCT
hls-5011	59	1	of	of	ADP
hls-5011	59	2	200	200	NUM
hls-5011	59	3	ptb	ptb	PROPN
hls-5011	59	4	positive	positive	ADJ
hls-5011	59	5	patients	patient	NOUN
hls-5011	59	6	,	,	PUNCT
hls-5011	59	7	majority	majority	NOUN
hls-5011	59	8	were	be	AUX
hls-5011	59	9	found	find	VERB
hls-5011	59	10	to	to	PART
hls-5011	59	11	be	be	AUX
hls-5011	59	12	in	in	ADP
hls-5011	59	13	the	the	DET
hls-5011	59	14	age	age	NOUN
hls-5011	59	15	group	group	NOUN
hls-5011	59	16	of	of	ADP
hls-5011	59	17	more	more	ADJ
hls-5011	59	18	than	than	ADP
hls-5011	59	19	18	18	NUM
hls-5011	59	20	years	year	NOUN
hls-5011	59	21	(	(	PUNCT
hls-5011	59	22	96.5	96.5	NUM
hls-5011	59	23	%	%	NOUN
hls-5011	59	24	)	)	PUNCT
hls-5011	59	25	,	,	PUNCT
hls-5011	59	26	males	male	NOUN
hls-5011	59	27	(	(	PUNCT
hls-5011	59	28	60	60	NUM
hls-5011	59	29	%	%	NOUN
hls-5011	59	30	)	)	PUNCT
hls-5011	59	31	,	,	PUNCT
hls-5011	59	32	residents	resident	NOUN
hls-5011	59	33	of	of	ADP
hls-5011	59	34	mwanza	mwanza	ADJ
hls-5011	59	35	city	city	NOUN
hls-5011	59	36	(	(	PUNCT
hls-5011	59	37	69.4	69.4	NUM
hls-5011	59	38	%	%	NOUN
hls-5011	59	39	)	)	PUNCT
hls-5011	59	40	,	,	PUNCT
hls-5011	59	41	new	new	ADJ
hls-5011	59	42	cases	case	NOUN
hls-5011	59	43	(	(	PUNCT
hls-5011	59	44	94.5	94.5	NUM
hls-5011	59	45	%	%	NOUN
hls-5011	59	46	)	)	PUNCT
hls-5011	59	47	and	and	CCONJ
hls-5011	59	48	hiv	hiv	PROPN
hls-5011	59	49	positive	positive	ADJ
hls-5011	59	50	(	(	PUNCT
hls-5011	59	51	86.8	86.8	NUM
hls-5011	59	52	%	%	NOUN
hls-5011	59	53	)	)	PUNCT
hls-5011	59	54	(	(	PUNCT
hls-5011	59	55	table	table	NOUN
hls-5011	59	56	2	2	NUM
hls-5011	59	57	)	)	PUNCT
hls-5011	59	58	.	.	PUNCT
hls-5011	60	1	discussion	discussion	NOUN
hls-5011	60	2	the	the	DET
hls-5011	60	3	low	low	ADJ
hls-5011	60	4	performance	performance	NOUN
hls-5011	60	5	of	of	ADP
hls-5011	60	6	sputum	sputum	PROPN
hls-5011	60	7	smear	smear	NOUN
hls-5011	60	8	microscopy	microscopy	NOUN
hls-5011	60	9	in	in	ADP
hls-5011	60	10	developing	develop	VERB
hls-5011	60	11	countries	country	NOUN
hls-5011	60	12	with	with	ADP
hls-5011	60	13	high	high	ADJ
hls-5011	60	14	article	article	NOUN
hls-5011	60	15	table	table	NOUN
hls-5011	60	16	1	1	NUM
hls-5011	60	17	.	.	PUNCT
hls-5011	61	1	diagnostic	diagnostic	ADJ
hls-5011	61	2	performance	performance	NOUN
hls-5011	61	3	of	of	ADP
hls-5011	61	4	genexpert	genexpert	ADJ
hls-5011	61	5	mtb	mtb	PROPN
hls-5011	61	6	/	/	SYM
hls-5011	61	7	rif	rif	PROPN
hls-5011	61	8	®	®	NOUN
hls-5011	61	9	vs	vs	ADP
hls-5011	61	10	light	light	ADJ
hls-5011	61	11	emitting	emit	VERB
hls-5011	61	12	diode	diode	NOUN
hls-5011	61	13	fluorescent	fluorescent	ADJ
hls-5011	61	14	microscopy	microscopy	NOUN
hls-5011	61	15	.	.	PUNCT
hls-5011	62	1	led	lead	VERB
hls-5011	62	2	fm	fm	PROPN
hls-5011	62	3	genexpert	genexpert	PROPN
hls-5011	62	4	mtb	mtb	PROPN
hls-5011	62	5	/	/	SYM
hls-5011	62	6	rif	rif	PROPN
hls-5011	62	7	®	®	NOUN
hls-5011	62	8	total	total	ADJ
hls-5011	62	9	mtb	mtb	NOUN
hls-5011	62	10	detected	detect	VERB
hls-5011	62	11	mtb	mtb	NOUN
hls-5011	62	12	not	not	PART
hls-5011	62	13	detected	detect	VERB
hls-5011	62	14	afb	afb	NOUN
hls-5011	62	15	detected	detect	VERB
hls-5011	62	16	105	105	NUM
hls-5011	62	17	9	9	NUM
hls-5011	62	18	114	114	NUM
hls-5011	62	19	afb	afb	NOUN
hls-5011	62	20	not	not	PART
hls-5011	62	21	detected	detect	VERB
hls-5011	62	22	86	86	NUM
hls-5011	62	23	606	606	NUM
hls-5011	62	24	692	692	NUM
hls-5011	62	25	total	total	NOUN
hls-5011	62	26	191	191	NUM
hls-5011	62	27	615	615	NUM
hls-5011	62	28	806	806	NUM
hls-5011	62	29	led	lead	VERB
hls-5011	62	30	fm	fm	PROPN
hls-5011	62	31	,	,	PUNCT
hls-5011	62	32	light	light	ADJ
hls-5011	62	33	emitting	emit	VERB
hls-5011	62	34	diode	diode	NOUN
hls-5011	62	35	fluorescent	fluorescent	ADJ
hls-5011	62	36	microscopy	microscopy	NOUN
hls-5011	62	37	;	;	PUNCT
hls-5011	62	38	mtb	mtb	NOUN
hls-5011	62	39	,	,	PUNCT
hls-5011	62	40	mycobacterium	mycobacterium	NOUN
hls-5011	62	41	tuberculosis	tuberculosis	NOUN
hls-5011	62	42	;	;	PUNCT
hls-5011	62	43	rif	rif	PROPN
hls-5011	62	44	,	,	PUNCT
hls-5011	62	45	rifampicin	rifampicin	VERB
hls-5011	62	46	;	;	PUNCT
hls-5011	62	47	afb	afb	NOUN
hls-5011	62	48	,	,	PUNCT
hls-5011	62	49	acid	acid	NOUN
hls-5011	62	50	fast	fast	ADJ
hls-5011	62	51	bacilli	bacilli	NOUN
hls-5011	62	52	.	.	PUNCT
hls-5011	63	1	figure	figure	NOUN
hls-5011	63	2	1	1	NUM
hls-5011	63	3	.	.	PUNCT
hls-5011	64	1	flow	flow	NOUN
hls-5011	64	2	chart	chart	NOUN
hls-5011	64	3	showing	show	VERB
hls-5011	64	4	series	series	NOUN
hls-5011	64	5	of	of	ADP
hls-5011	64	6	events	event	NOUN
hls-5011	64	7	in	in	ADP
hls-5011	64	8	the	the	DET
hls-5011	64	9	recruitment	recruitment	NOUN
hls-5011	64	10	procedures	procedure	NOUN
hls-5011	64	11	and	and	CCONJ
hls-5011	64	12	results	result	NOUN
hls-5011	64	13	.	.	PUNCT
hls-5011	65	1	led	lead	VERB
hls-5011	65	2	fm	fm	PROPN
hls-5011	65	3	,	,	PUNCT
hls-5011	65	4	light	light	ADJ
hls-5011	65	5	emitting	emit	VERB
hls-5011	65	6	diode	diode	NOUN
hls-5011	65	7	fluorescent	fluorescent	ADJ
hls-5011	65	8	microscopy	microscopy	NOUN
hls-5011	65	9	;	;	PUNCT
hls-5011	65	10	ptb	ptb	PROPN
hls-5011	65	11	,	,	PUNCT
hls-5011	65	12	pulmonary	pulmonary	ADJ
hls-5011	65	13	tuberculosis	tuberculosis	NOUN
hls-5011	65	14	;	;	PUNCT
hls-5011	65	15	mtb	mtb	NOUN
hls-5011	65	16	,	,	PUNCT
hls-5011	65	17	mycobacterium	mycobacterium	NOUN
hls-5011	65	18	tuberculosis	tuberculosis	NOUN
hls-5011	65	19	;	;	PUNCT
hls-5011	65	20	rif	rif	PROPN
hls-5011	65	21	,	,	PUNCT
hls-5011	65	22	rifampicin	rifampicin	VERB
hls-5011	65	23	;	;	PUNCT
hls-5011	65	24	srrh	srrh	PROPN
hls-5011	65	25	,	,	PUNCT
hls-5011	65	26	sekou	sekou	PROPN
hls-5011	65	27	toure	toure	NOUN
hls-5011	65	28	regional	regional	ADJ
hls-5011	65	29	referral	referral	ADJ
hls-5011	65	30	hospital	hospital	NOUN
hls-5011	65	31	.	.	PUNCT
hls-5011	66	1	non	non	PROPN
hls-5011	66	2	co	co	PROPN
hls-5011	66	3	mmerc	mmerc	PROPN
hls-5011	66	4	ial	ial	PROPN
hls-5011	66	5	us	us	PROPN
hls-5011	67	1	e	e	NOUN
hls-5011	67	2	o	o	NOUN
hls-5011	67	3	nly	nly	ADV
hls-5011	67	4	[	[	X
hls-5011	67	5	page	page	NOUN
hls-5011	67	6	12	12	NUM
hls-5011	67	7	]	]	PUNCT
hls-5011	68	1	[	[	X
hls-5011	68	2	healthcare	healthcare	NOUN
hls-5011	68	3	in	in	ADP
hls-5011	68	4	low	low	ADJ
hls-5011	68	5	-	-	PUNCT
hls-5011	68	6	resource	resource	NOUN
hls-5011	68	7	settings	setting	NOUN
hls-5011	68	8	2015	2015	NUM
hls-5011	68	9	;	;	PUNCT
hls-5011	68	10	3:5011	3:5011	NUM
hls-5011	68	11	]	]	PUNCT
hls-5011	68	12	tb	tb	ADP
hls-5011	68	13	burden	burden	NOUN
hls-5011	68	14	has	have	AUX
hls-5011	68	15	been	be	AUX
hls-5011	68	16	widely	widely	ADV
hls-5011	68	17	documented	document	VERB
hls-5011	68	18	and	and	CCONJ
hls-5011	68	19	if	if	SCONJ
hls-5011	68	20	unchecked	unchecked	ADJ
hls-5011	68	21	,	,	PUNCT
hls-5011	68	22	it	it	PRON
hls-5011	68	23	can	can	AUX
hls-5011	68	24	result	result	VERB
hls-5011	68	25	into	into	ADP
hls-5011	68	26	uninterrupted	uninterrupted	ADJ
hls-5011	68	27	transmission	transmission	NOUN
hls-5011	68	28	of	of	ADP
hls-5011	68	29	this	this	DET
hls-5011	68	30	deadly	deadly	ADJ
hls-5011	68	31	infectious	infectious	ADJ
hls-5011	68	32	disease.2,5,6	disease.2,5,6	NOUN
hls-5011	68	33	despite	despite	SCONJ
hls-5011	68	34	a	a	DET
hls-5011	68	35	number	number	NOUN
hls-5011	68	36	of	of	ADP
hls-5011	68	37	new	new	ADJ
hls-5011	68	38	technological	technological	ADJ
hls-5011	68	39	advancement	advancement	NOUN
hls-5011	68	40	on	on	ADP
hls-5011	68	41	the	the	DET
hls-5011	68	42	diagnosis	diagnosis	NOUN
hls-5011	68	43	of	of	ADP
hls-5011	68	44	tb	tb	NOUN
hls-5011	68	45	,	,	PUNCT
hls-5011	68	46	the	the	DET
hls-5011	68	47	local	local	ADJ
hls-5011	68	48	evaluations	evaluation	NOUN
hls-5011	68	49	of	of	ADP
hls-5011	68	50	their	their	PRON
hls-5011	68	51	performance	performance	NOUN
hls-5011	68	52	remain	remain	VERB
hls-5011	68	53	a	a	DET
hls-5011	68	54	challenge	challenge	NOUN
hls-5011	68	55	in	in	ADP
hls-5011	68	56	most	most	ADJ
hls-5011	68	57	developing	develop	VERB
hls-5011	68	58	countries.10,11,13,21	countries.10,11,13,21	PROPN
hls-5011	68	59	the	the	DET
hls-5011	68	60	incremental	incremental	ADJ
hls-5011	68	61	detection	detection	NOUN
hls-5011	68	62	of	of	ADP
hls-5011	68	63	9.6	9.6	NUM
hls-5011	68	64	%	%	NOUN
hls-5011	68	65	among	among	ADP
hls-5011	68	66	ptb	ptb	PROPN
hls-5011	68	67	patients	patient	NOUN
hls-5011	68	68	at	at	ADP
hls-5011	68	69	srrh	srrh	NOUN
hls-5011	68	70	by	by	ADP
hls-5011	68	71	genexpert	genexpert	PROPN
hls-5011	68	72	mtb	mtb	PROPN
hls-5011	68	73	/	/	SYM
hls-5011	68	74	rif	rif	PROPN
hls-5011	68	75	®	®	NOUN
hls-5011	68	76	over	over	ADP
hls-5011	68	77	led	lead	VERB
hls-5011	68	78	fm	fm	NOUN
hls-5011	68	79	in	in	ADP
hls-5011	68	80	the	the	DET
hls-5011	68	81	present	present	ADJ
hls-5011	68	82	study	study	NOUN
hls-5011	68	83	along	along	ADP
hls-5011	68	84	with	with	ADP
hls-5011	68	85	the	the	DET
hls-5011	68	86	23	23	NUM
hls-5011	68	87	%	%	NOUN
hls-5011	68	88	from	from	ADP
hls-5011	68	89	a	a	DET
hls-5011	68	90	review	review	NOUN
hls-5011	68	91	involving	involve	VERB
hls-5011	68	92	8880	8880	NUM
hls-5011	68	93	participants	participant	NOUN
hls-5011	68	94	in	in	ADP
hls-5011	68	95	21	21	NUM
hls-5011	68	96	studies,12	studies,12	NOUN
hls-5011	68	97	8.0	8.0	NUM
hls-5011	68	98	%	%	NOUN
hls-5011	68	99	among	among	ADP
hls-5011	68	100	children	child	NOUN
hls-5011	68	101	in	in	ADP
hls-5011	68	102	uganda,17	uganda,17	ADJ
hls-5011	68	103	and	and	CCONJ
hls-5011	68	104	9.7	9.7	NUM
hls-5011	68	105	%	%	NOUN
hls-5011	68	106	in	in	ADP
hls-5011	68	107	a	a	DET
hls-5011	68	108	recent	recent	ADJ
hls-5011	68	109	multicenter	multicenter	NOUN
hls-5011	68	110	,	,	PUNCT
hls-5011	68	111	randomized	randomize	VERB
hls-5011	68	112	controlled	control	VERB
hls-5011	68	113	trial	trial	NOUN
hls-5011	68	114	involving	involve	VERB
hls-5011	68	115	south	south	PROPN
hls-5011	68	116	africa	africa	PROPN
hls-5011	68	117	,	,	PUNCT
hls-5011	68	118	zimbabwe	zimbabwe	PROPN
hls-5011	68	119	,	,	PUNCT
hls-5011	68	120	zambia	zambia	PROPN
hls-5011	68	121	and	and	CCONJ
hls-5011	68	122	tanzania,16	tanzania,16	NUM
hls-5011	68	123	emphasizes	emphasize	VERB
hls-5011	68	124	the	the	DET
hls-5011	68	125	utility	utility	NOUN
hls-5011	68	126	of	of	ADP
hls-5011	68	127	genexpert	genexpert	ADJ
hls-5011	68	128	mtb	mtb	PROPN
hls-5011	68	129	/	/	SYM
hls-5011	68	130	rif	rif	PROPN
hls-5011	68	131	®	®	NOUN
hls-5011	68	132	over	over	ADP
hls-5011	68	133	microscopy	microscopy	NOUN
hls-5011	68	134	in	in	ADP
hls-5011	68	135	the	the	DET
hls-5011	68	136	diagnosis	diagnosis	NOUN
hls-5011	68	137	of	of	ADP
hls-5011	68	138	tb	tb	ADP
hls-5011	68	139	patients	patient	NOUN
hls-5011	68	140	.	.	PUNCT
hls-5011	69	1	but	but	CCONJ
hls-5011	69	2	the	the	DET
hls-5011	69	3	cost	cost	NOUN
hls-5011	69	4	-	-	PUNCT
hls-5011	69	5	related	relate	VERB
hls-5011	69	6	challenges	challenge	NOUN
hls-5011	69	7	for	for	ADP
hls-5011	69	8	the	the	DET
hls-5011	69	9	universal	universal	ADJ
hls-5011	69	10	introduction	introduction	NOUN
hls-5011	69	11	of	of	ADP
hls-5011	69	12	genexpert	genexpert	ADJ
hls-5011	69	13	mtb	mtb	PROPN
hls-5011	69	14	/	/	SYM
hls-5011	69	15	rif	rif	NOUN
hls-5011	69	16	®	®	NOUN
hls-5011	69	17	in	in	ADP
hls-5011	69	18	many	many	ADJ
hls-5011	69	19	health	health	NOUN
hls-5011	69	20	facilities	facility	NOUN
hls-5011	69	21	in	in	ADP
hls-5011	69	22	developing	develop	VERB
hls-5011	69	23	countries	country	NOUN
hls-5011	69	24	reiterate	reiterate	VERB
hls-5011	69	25	the	the	DET
hls-5011	69	26	need	need	NOUN
hls-5011	69	27	to	to	PART
hls-5011	69	28	continue	continue	VERB
hls-5011	69	29	strengthening	strengthen	VERB
hls-5011	69	30	the	the	DET
hls-5011	69	31	pre	pre	ADJ
hls-5011	69	32	-	-	ADJ
hls-5011	69	33	existing	exist	VERB
hls-5011	69	34	microscopy	microscopy	NOUN
hls-5011	69	35	-	-	PUNCT
hls-5011	69	36	based	base	VERB
hls-5011	69	37	tb	tb	ADP
hls-5011	69	38	diagnostic	diagnostic	ADJ
hls-5011	69	39	methods	method	NOUN
hls-5011	69	40	,	,	PUNCT
hls-5011	69	41	so	so	SCONJ
hls-5011	69	42	that	that	SCONJ
hls-5011	69	43	the	the	DET
hls-5011	69	44	newer	new	ADJ
hls-5011	69	45	technique	technique	NOUN
hls-5011	69	46	remains	remain	VERB
hls-5011	69	47	reserved	reserved	ADJ
hls-5011	69	48	to	to	ADP
hls-5011	69	49	risky	risky	ADJ
hls-5011	69	50	groups	group	NOUN
hls-5011	69	51	like	like	ADP
hls-5011	69	52	smear	smear	VERB
hls-5011	69	53	negative	negative	ADJ
hls-5011	69	54	plwh	plwh	PROPN
hls-5011	69	55	,	,	PUNCT
hls-5011	69	56	ptb	ptb	PROPN
hls-5011	69	57	patients	patient	NOUN
hls-5011	69	58	who	who	PRON
hls-5011	69	59	recently	recently	ADV
hls-5011	69	60	contacted	contact	VERB
hls-5011	69	61	mdr	mdr	PROPN
hls-5011	69	62	,	,	PUNCT
hls-5011	69	63	and	and	CCONJ
hls-5011	69	64	children.3	children.3	VERB
hls-5011	69	65	the	the	DET
hls-5011	69	66	incremental	incremental	ADJ
hls-5011	69	67	detection	detection	NOUN
hls-5011	69	68	of	of	ADP
hls-5011	69	69	tb	tb	NOUN
hls-5011	69	70	among	among	ADP
hls-5011	69	71	smear	smear	NOUN
hls-5011	69	72	negative	negative	ADJ
hls-5011	69	73	plwh	plwh	NOUN
hls-5011	69	74	in	in	ADP
hls-5011	69	75	this	this	PRON
hls-5011	69	76	and	and	CCONJ
hls-5011	69	77	other	other	ADJ
hls-5011	69	78	studies17,18,21,22	studies17,18,21,22	PROPN
hls-5011	69	79	further	far	ADV
hls-5011	69	80	justifies	justify	VERB
hls-5011	69	81	its	its	PRON
hls-5011	69	82	utility	utility	NOUN
hls-5011	69	83	in	in	ADP
hls-5011	69	84	this	this	DET
hls-5011	69	85	risky	risky	ADJ
hls-5011	69	86	group	group	NOUN
hls-5011	69	87	as	as	SCONJ
hls-5011	69	88	recommended	recommend	VERB
hls-5011	69	89	by	by	ADP
hls-5011	69	90	the	the	DET
hls-5011	69	91	new	new	ADJ
hls-5011	69	92	ntlp	ntlp	NOUN
hls-5011	69	93	guidelines.3	guidelines.3	VERB
hls-5011	69	94	the	the	DET
hls-5011	69	95	use	use	NOUN
hls-5011	69	96	of	of	ADP
hls-5011	69	97	genexpert	genexpert	ADJ
hls-5011	69	98	mtb	mtb	PROPN
hls-5011	69	99	/	/	SYM
hls-5011	69	100	rif	rif	PROPN
hls-5011	69	101	®	®	NOUN
hls-5011	69	102	to	to	PART
hls-5011	69	103	detect	detect	VERB
hls-5011	69	104	rif	rif	PROPN
hls-5011	69	105	resistance	resistance	NOUN
hls-5011	69	106	as	as	ADP
hls-5011	69	107	a	a	DET
hls-5011	69	108	surrogate	surrogate	ADJ
hls-5011	69	109	marker	marker	NOUN
hls-5011	69	110	of	of	ADP
hls-5011	69	111	mdr	mdr	PROPN
hls-5011	69	112	has	have	AUX
hls-5011	69	113	been	be	AUX
hls-5011	69	114	suggested	suggest	VERB
hls-5011	69	115	in	in	ADP
hls-5011	69	116	many	many	ADJ
hls-5011	69	117	studies	study	NOUN
hls-5011	69	118	,	,	PUNCT
hls-5011	69	119	with	with	ADP
hls-5011	69	120	concordance	concordance	NOUN
hls-5011	69	121	ranging	range	VERB
hls-5011	69	122	from	from	ADP
hls-5011	69	123	88	88	NUM
hls-5011	69	124	to	to	ADP
hls-5011	69	125	100%.14,23,24	100%.14,23,24	NUM
hls-5011	69	126	in	in	ADP
hls-5011	69	127	the	the	DET
hls-5011	69	128	light	light	NOUN
hls-5011	69	129	of	of	ADP
hls-5011	69	130	these	these	PRON
hls-5011	69	131	,	,	PUNCT
hls-5011	69	132	rif	rif	PROPN
hls-5011	69	133	resistance	resistance	NOUN
hls-5011	69	134	in	in	ADP
hls-5011	69	135	the	the	DET
hls-5011	69	136	present	present	ADJ
hls-5011	69	137	study	study	NOUN
hls-5011	69	138	(	(	PUNCT
hls-5011	69	139	2.2	2.2	NUM
hls-5011	69	140	%	%	NOUN
hls-5011	69	141	)	)	PUNCT
hls-5011	69	142	is	be	AUX
hls-5011	69	143	higher	high	ADJ
hls-5011	69	144	than	than	ADP
hls-5011	69	145	0.86	0.86	NUM
hls-5011	69	146	(	(	PUNCT
hls-5011	69	147	4/464	4/464	NUM
hls-5011	69	148	)	)	PUNCT
hls-5011	69	149	and	and	CCONJ
hls-5011	70	1	0.17	0.17	NUM
hls-5011	70	2	%	%	NOUN
hls-5011	70	3	(	(	PUNCT
hls-5011	70	4	2/1167	2/1167	NUM
hls-5011	70	5	)	)	PUNCT
hls-5011	70	6	from	from	ADP
hls-5011	70	7	a	a	DET
hls-5011	70	8	study	study	NOUN
hls-5011	70	9	in	in	ADP
hls-5011	70	10	mwanza	mwanza	PROPN
hls-5011	70	11	and	and	CCONJ
hls-5011	70	12	national	national	ADJ
hls-5011	70	13	survey	survey	NOUN
hls-5011	70	14	in	in	ADP
hls-5011	70	15	tanzania	tanzania	PROPN
hls-5011	70	16	respectively25,26	respectively25,26	NOUN
hls-5011	70	17	but	but	CCONJ
hls-5011	70	18	lower	low	ADJ
hls-5011	70	19	than	than	ADP
hls-5011	70	20	3.5	3.5	NUM
hls-5011	70	21	to	to	PART
hls-5011	70	22	7.3	7.3	NUM
hls-5011	70	23	%	%	NOUN
hls-5011	70	24	in	in	ADP
hls-5011	70	25	different	different	ADJ
hls-5011	70	26	african	african	ADJ
hls-5011	70	27	countries.19	countries.19	PROPN
hls-5011	70	28	interestingly	interestingly	ADV
hls-5011	70	29	,	,	PUNCT
hls-5011	70	30	no	no	DET
hls-5011	70	31	rif	rif	PROPN
hls-5011	70	32	resistance	resistance	NOUN
hls-5011	70	33	has	have	AUX
hls-5011	70	34	been	be	AUX
hls-5011	70	35	detected	detect	VERB
hls-5011	70	36	in	in	ADP
hls-5011	70	37	three	three	NUM
hls-5011	70	38	studies	study	NOUN
hls-5011	70	39	from	from	ADP
hls-5011	70	40	mbeya	mbeya	NOUN
hls-5011	70	41	,	,	PUNCT
hls-5011	70	42	tanzania.16,21,27	tanzania.16,21,27	PUNCT
hls-5011	70	43	the	the	DET
hls-5011	70	44	finding	finding	NOUN
hls-5011	70	45	of	of	ADP
hls-5011	70	46	rif	rif	PROPN
hls-5011	70	47	resistance	resistance	NOUN
hls-5011	70	48	in	in	ADP
hls-5011	70	49	mwanza	mwanza	ADJ
hls-5011	70	50	region	region	NOUN
hls-5011	70	51	which	which	PRON
hls-5011	70	52	is	be	AUX
hls-5011	70	53	second	second	ADJ
hls-5011	70	54	to	to	ADP
hls-5011	70	55	dar	dar	PROPN
hls-5011	70	56	es	es	X
hls-5011	70	57	salaam	salaam	NOUN
hls-5011	70	58	in	in	ADP
hls-5011	70	59	terms	term	NOUN
hls-5011	70	60	of	of	ADP
hls-5011	70	61	tb	tb	ADP
hls-5011	70	62	case	case	NOUN
hls-5011	70	63	notification	notification	NOUN
hls-5011	70	64	calls	call	VERB
hls-5011	70	65	for	for	ADP
hls-5011	70	66	strengthening	strengthening	NOUN
hls-5011	70	67	of	of	ADP
hls-5011	70	68	surveillance	surveillance	NOUN
hls-5011	70	69	system	system	NOUN
hls-5011	70	70	in	in	ADP
hls-5011	70	71	this	this	DET
hls-5011	70	72	region	region	NOUN
hls-5011	70	73	to	to	PART
hls-5011	70	74	enable	enable	VERB
hls-5011	70	75	timely	timely	ADJ
hls-5011	70	76	detection	detection	NOUN
hls-5011	70	77	of	of	ADP
hls-5011	70	78	patients	patient	NOUN
hls-5011	70	79	with	with	ADP
hls-5011	70	80	rif	rif	PROPN
hls-5011	70	81	resistant	resistant	ADJ
hls-5011	70	82	and	and	CCONJ
hls-5011	70	83	mdr	mdr	PROPN
hls-5011	70	84	tb	tb	PROPN
hls-5011	70	85	,	,	PUNCT
hls-5011	70	86	thereby	thereby	ADV
hls-5011	70	87	interrupting	interrupt	VERB
hls-5011	70	88	further	further	ADJ
hls-5011	70	89	transmission	transmission	NOUN
hls-5011	70	90	by	by	ADP
hls-5011	70	91	provision	provision	NOUN
hls-5011	70	92	of	of	ADP
hls-5011	70	93	prompt	prompt	ADJ
hls-5011	70	94	management	management	NOUN
hls-5011	70	95	.	.	PUNCT
hls-5011	71	1	based	base	VERB
hls-5011	71	2	on	on	ADP
hls-5011	71	3	the	the	DET
hls-5011	71	4	nature	nature	NOUN
hls-5011	71	5	of	of	ADP
hls-5011	71	6	works	work	NOUN
hls-5011	71	7	and	and	CCONJ
hls-5011	71	8	likelihood	likelihood	NOUN
hls-5011	71	9	of	of	ADP
hls-5011	71	10	exposure	exposure	NOUN
hls-5011	71	11	,	,	PUNCT
hls-5011	71	12	the	the	DET
hls-5011	71	13	preponderance	preponderance	NOUN
hls-5011	71	14	of	of	ADP
hls-5011	71	15	males	male	NOUN
hls-5011	71	16	and	and	CCONJ
hls-5011	71	17	city	city	NOUN
hls-5011	71	18	dwelling	dwell	VERB
hls-5011	71	19	residents	resident	NOUN
hls-5011	71	20	to	to	PART
hls-5011	71	21	be	be	AUX
hls-5011	71	22	infected	infect	VERB
hls-5011	71	23	with	with	ADP
hls-5011	71	24	ptb	ptb	PROPN
hls-5011	71	25	in	in	ADP
hls-5011	71	26	this	this	DET
hls-5011	71	27	study	study	NOUN
hls-5011	71	28	is	be	AUX
hls-5011	71	29	also	also	ADV
hls-5011	71	30	similar	similar	ADJ
hls-5011	71	31	to	to	ADP
hls-5011	71	32	other	other	ADJ
hls-5011	71	33	reports.3,28	reports.3,28	NOUN
hls-5011	71	34	the	the	DET
hls-5011	71	35	high	high	ADJ
hls-5011	71	36	proportion	proportion	NOUN
hls-5011	71	37	of	of	ADP
hls-5011	71	38	ptb	ptb	PROPN
hls-5011	71	39	patients	patient	NOUN
hls-5011	71	40	to	to	PART
hls-5011	71	41	be	be	AUX
hls-5011	71	42	co	co	VERB
hls-5011	71	43	-	-	VERB
hls-5011	71	44	infected	infected	ADJ
hls-5011	71	45	with	with	ADP
hls-5011	71	46	hiv	hiv	PROPN
hls-5011	71	47	in	in	ADP
hls-5011	71	48	the	the	DET
hls-5011	71	49	present	present	ADJ
hls-5011	71	50	study	study	NOUN
hls-5011	71	51	relates	relate	VERB
hls-5011	71	52	to	to	ADP
hls-5011	71	53	another	another	DET
hls-5011	71	54	study.17	study.17	NOUN
hls-5011	71	55	these	these	DET
hls-5011	71	56	findings	finding	NOUN
hls-5011	71	57	are	be	AUX
hls-5011	71	58	also	also	ADV
hls-5011	71	59	supported	support	VERB
hls-5011	71	60	by	by	ADP
hls-5011	71	61	other	other	ADJ
hls-5011	71	62	studies	study	NOUN
hls-5011	71	63	which	which	PRON
hls-5011	71	64	have	have	AUX
hls-5011	71	65	shown	show	VERB
hls-5011	71	66	association	association	NOUN
hls-5011	71	67	of	of	ADP
hls-5011	71	68	development	development	NOUN
hls-5011	71	69	of	of	ADP
hls-5011	71	70	active	active	ADJ
hls-5011	71	71	tb	tb	NOUN
hls-5011	71	72	with	with	ADP
hls-5011	71	73	hiv	hiv	PROPN
hls-5011	71	74	/	/	SYM
hls-5011	71	75	aids	aids	PROPN
hls-5011	71	76	,	,	PUNCT
hls-5011	71	77	smoking	smoking	NOUN
hls-5011	71	78	,	,	PUNCT
hls-5011	71	79	co	co	NOUN
hls-5011	71	80	-	-	NOUN
hls-5011	71	81	morbidity	morbidity	NOUN
hls-5011	71	82	such	such	ADJ
hls-5011	71	83	as	as	ADP
hls-5011	71	84	diabetes	diabetes	NOUN
hls-5011	71	85	mellitus	mellitus	NOUN
hls-5011	71	86	,	,	PUNCT
hls-5011	71	87	indoor	indoor	ADJ
hls-5011	71	88	air	air	NOUN
hls-5011	71	89	pollution	pollution	NOUN
hls-5011	71	90	and	and	CCONJ
hls-5011	71	91	young	young	ADJ
hls-5011	71	92	age.2,29	age.2,29	PROPN
hls-5011	71	93	limitations	limitation	VERB
hls-5011	71	94	the	the	DET
hls-5011	71	95	culture	culture	NOUN
hls-5011	71	96	method	method	NOUN
hls-5011	71	97	which	which	PRON
hls-5011	71	98	is	be	AUX
hls-5011	71	99	a	a	DET
hls-5011	71	100	gold	gold	ADJ
hls-5011	71	101	standard	standard	NOUN
hls-5011	71	102	for	for	ADP
hls-5011	71	103	laboratory	laboratory	NOUN
hls-5011	71	104	diagnosis	diagnosis	NOUN
hls-5011	71	105	of	of	ADP
hls-5011	71	106	tb	tb	NOUN
hls-5011	71	107	is	be	AUX
hls-5011	71	108	not	not	PART
hls-5011	71	109	done	do	VERB
hls-5011	71	110	at	at	ADP
hls-5011	71	111	srrh	srrh	PROPN
hls-5011	71	112	.	.	PUNCT
hls-5011	72	1	thus	thus	ADV
hls-5011	72	2	,	,	PUNCT
hls-5011	72	3	this	this	DET
hls-5011	72	4	operational	operational	ADJ
hls-5011	72	5	study	study	NOUN
hls-5011	72	6	did	do	AUX
hls-5011	72	7	not	not	PART
hls-5011	72	8	compare	compare	VERB
hls-5011	72	9	the	the	DET
hls-5011	72	10	performance	performance	NOUN
hls-5011	72	11	of	of	ADP
hls-5011	72	12	genexpert	genexpert	ADJ
hls-5011	72	13	mtb	mtb	PROPN
hls-5011	72	14	/	/	SYM
hls-5011	72	15	rif	rif	NOUN
hls-5011	72	16	®	®	NOUN
hls-5011	72	17	and	and	CCONJ
hls-5011	72	18	led	lead	VERB
hls-5011	72	19	fm	fm	PROPN
hls-5011	72	20	with	with	ADP
hls-5011	72	21	culture	culture	NOUN
hls-5011	72	22	.	.	PUNCT
hls-5011	73	1	also	also	ADV
hls-5011	73	2	,	,	PUNCT
hls-5011	73	3	the	the	DET
hls-5011	73	4	impact	impact	NOUN
hls-5011	73	5	of	of	ADP
hls-5011	73	6	other	other	ADJ
hls-5011	73	7	predictor	predictor	NOUN
hls-5011	73	8	variables	variable	NOUN
hls-5011	73	9	on	on	ADP
hls-5011	73	10	diagnostic	diagnostic	ADJ
hls-5011	73	11	performance	performance	NOUN
hls-5011	73	12	such	such	ADJ
hls-5011	73	13	as	as	ADP
hls-5011	73	14	cd4	cd4	PROPN
hls-5011	73	15	+	+	CCONJ
hls-5011	73	16	count	count	NOUN
hls-5011	73	17	was	be	AUX
hls-5011	73	18	not	not	PART
hls-5011	73	19	evaluated	evaluate	VERB
hls-5011	73	20	.	.	PUNCT
hls-5011	74	1	conclusions	conclusion	NOUN
hls-5011	74	2	there	there	PRON
hls-5011	74	3	is	be	VERB
hls-5011	74	4	an	an	DET
hls-5011	74	5	approximately	approximately	ADV
hls-5011	74	6	10	10	NUM
hls-5011	74	7	%	%	NOUN
hls-5011	74	8	incremental	incremental	ADJ
hls-5011	74	9	detection	detection	NOUN
hls-5011	74	10	of	of	ADP
hls-5011	74	11	tb	tb	NOUN
hls-5011	74	12	among	among	ADP
hls-5011	74	13	ptb	ptb	PROPN
hls-5011	74	14	patients	patient	NOUN
hls-5011	74	15	by	by	ADP
hls-5011	74	16	genexpert	genexpert	PROPN
hls-5011	74	17	mtb	mtb	PROPN
hls-5011	74	18	/	/	SYM
hls-5011	74	19	rif	rif	NOUN
hls-5011	74	20	®	®	NOUN
hls-5011	74	21	compared	compare	VERB
hls-5011	74	22	to	to	ADP
hls-5011	74	23	led	lead	VERB
hls-5011	74	24	fm	fm	PROPN
hls-5011	74	25	,	,	PUNCT
hls-5011	74	26	with	with	ADP
hls-5011	74	27	more	more	ADJ
hls-5011	74	28	detection	detection	NOUN
hls-5011	74	29	also	also	ADV
hls-5011	74	30	among	among	ADP
hls-5011	74	31	smear	smear	NOUN
hls-5011	74	32	negative	negative	ADJ
hls-5011	74	33	plwh	plwh	NOUN
hls-5011	74	34	who	who	PRON
hls-5011	74	35	are	be	AUX
hls-5011	74	36	apparently	apparently	ADV
hls-5011	74	37	targeted	target	VERB
hls-5011	74	38	by	by	ADP
hls-5011	74	39	ntlp	ntlp	PROPN
hls-5011	74	40	to	to	PART
hls-5011	74	41	be	be	AUX
hls-5011	74	42	among	among	ADP
hls-5011	74	43	beneficiaries	beneficiary	NOUN
hls-5011	74	44	of	of	ADP
hls-5011	74	45	this	this	DET
hls-5011	74	46	new	new	ADJ
hls-5011	74	47	technology	technology	NOUN
hls-5011	74	48	.	.	PUNCT
hls-5011	75	1	therefore	therefore	ADV
hls-5011	75	2	,	,	PUNCT
hls-5011	75	3	we	we	PRON
hls-5011	75	4	recommend	recommend	VERB
hls-5011	75	5	the	the	DET
hls-5011	75	6	expansion	expansion	NOUN
hls-5011	75	7	of	of	ADP
hls-5011	75	8	its	its	PRON
hls-5011	75	9	use	use	NOUN
hls-5011	75	10	to	to	PART
hls-5011	75	11	increase	increase	VERB
hls-5011	75	12	detection	detection	NOUN
hls-5011	75	13	of	of	ADP
hls-5011	75	14	ptb	ptb	PROPN
hls-5011	75	15	among	among	ADP
hls-5011	75	16	smear	smear	NOUN
hls-5011	75	17	negative	negative	ADJ
hls-5011	75	18	plwh	plwh	NOUN
hls-5011	75	19	at	at	ADP
hls-5011	75	20	srrh	srrh	ADJ
hls-5011	75	21	and	and	CCONJ
hls-5011	75	22	other	other	ADJ
hls-5011	75	23	settings	setting	NOUN
hls-5011	75	24	in	in	ADP
hls-5011	75	25	the	the	DET
hls-5011	75	26	lake	lake	PROPN
hls-5011	75	27	victoria	victoria	PROPN
hls-5011	75	28	zone	zone	PROPN
hls-5011	75	29	.	.	PUNCT
hls-5011	76	1	evaluation	evaluation	NOUN
hls-5011	76	2	of	of	ADP
hls-5011	76	3	genexpert	genexpert	ADJ
hls-5011	76	4	mtb	mtb	PROPN
hls-5011	76	5	/	/	SYM
hls-5011	76	6	rif	rif	NOUN
hls-5011	76	7	®	®	NOUN
hls-5011	76	8	performance	performance	NOUN
hls-5011	76	9	among	among	ADP
hls-5011	76	10	people	people	NOUN
hls-5011	76	11	with	with	ADP
hls-5011	76	12	extra	extra	ADJ
hls-5011	76	13	pulmonary	pulmonary	NOUN
hls-5011	76	14	tb	tb	NOUN
hls-5011	76	15	and	and	CCONJ
hls-5011	76	16	the	the	DET
hls-5011	76	17	impact	impact	NOUN
hls-5011	76	18	of	of	ADP
hls-5011	76	19	various	various	ADJ
hls-5011	76	20	predictor	predictor	NOUN
hls-5011	76	21	variables	variable	NOUN
hls-5011	76	22	on	on	ADP
hls-5011	76	23	this	this	DET
hls-5011	76	24	diagnostic	diagnostic	ADJ
hls-5011	76	25	assay	assay	NOUN
hls-5011	76	26	will	will	AUX
hls-5011	76	27	be	be	AUX
hls-5011	76	28	of	of	ADP
hls-5011	76	29	interest	interest	NOUN
hls-5011	76	30	to	to	PART
hls-5011	76	31	further	far	ADV
hls-5011	76	32	delineate	delineate	VERB
hls-5011	76	33	its	its	PRON
hls-5011	76	34	utility	utility	NOUN
hls-5011	76	35	in	in	ADP
hls-5011	76	36	this	this	DET
hls-5011	76	37	setting	setting	NOUN
hls-5011	76	38	.	.	PUNCT
hls-5011	77	1	references	reference	NOUN
hls-5011	77	2	1	1	NUM
hls-5011	77	3	.	.	PUNCT
hls-5011	78	1	ministry	ministry	PROPN
hls-5011	78	2	of	of	ADP
hls-5011	78	3	health	health	PROPN
hls-5011	78	4	and	and	CCONJ
hls-5011	78	5	social	social	ADJ
hls-5011	78	6	welfare	welfare	NOUN
hls-5011	78	7	,	,	PUNCT
hls-5011	78	8	united	united	PROPN
hls-5011	78	9	republic	republic	PROPN
hls-5011	78	10	of	of	ADP
hls-5011	78	11	tanzania	tanzania	PROPN
hls-5011	78	12	.	.	PUNCT
hls-5011	79	1	manual	manual	NOUN
hls-5011	79	2	of	of	ADP
hls-5011	79	3	the	the	DET
hls-5011	79	4	national	national	ADJ
hls-5011	79	5	tuberculosis	tuberculosis	NOUN
hls-5011	79	6	and	and	CCONJ
hls-5011	79	7	leprosy	leprosy	NOUN
hls-5011	79	8	programme	programme	NOUN
hls-5011	79	9	in	in	ADP
hls-5011	79	10	tanzania	tanzania	PROPN
hls-5011	79	11	.	.	PUNCT
hls-5011	80	1	dar	dar	PROPN
hls-5011	80	2	es	es	PROPN
hls-5011	80	3	salaam	salaam	PROPN
hls-5011	80	4	,	,	PUNCT
hls-5011	80	5	tanzania	tanzania	PROPN
hls-5011	80	6	:	:	PUNCT
hls-5011	80	7	ministry	ministry	PROPN
hls-5011	80	8	of	of	ADP
hls-5011	80	9	health	health	PROPN
hls-5011	80	10	and	and	CCONJ
hls-5011	80	11	social	social	ADJ
hls-5011	80	12	welfare	welfare	NOUN
hls-5011	80	13	;	;	PUNCT
hls-5011	80	14	2006	2006	NUM
hls-5011	80	15	.	.	PUNCT
hls-5011	81	1	2	2	NUM
hls-5011	81	2	.	.	X
hls-5011	82	1	who	who	PRON
hls-5011	82	2	.	.	PUNCT
hls-5011	83	1	global	global	ADJ
hls-5011	83	2	tuberculosis	tuberculosis	NOUN
hls-5011	83	3	control	control	NOUN
hls-5011	83	4	:	:	PUNCT
hls-5011	83	5	who	who	PRON
hls-5011	83	6	report	report	VERB
hls-5011	83	7	2011	2011	NUM
hls-5011	83	8	.	.	PUNCT
hls-5011	84	1	geneva	geneva	PROPN
hls-5011	84	2	,	,	PUNCT
hls-5011	84	3	switzerland	switzerland	PROPN
hls-5011	84	4	:	:	PUNCT
hls-5011	84	5	world	world	PROPN
hls-5011	84	6	health	health	PROPN
hls-5011	84	7	organization	organization	NOUN
hls-5011	84	8	;	;	PUNCT
hls-5011	84	9	2011	2011	NUM
hls-5011	84	10	.	.	PUNCT
hls-5011	84	11	available	available	ADJ
hls-5011	84	12	from	from	ADP
hls-5011	84	13	:	:	PUNCT
hls-5011	84	14	http://whqlibdoc.who.int/publications/2011	http://whqlibdoc.who.int/publications/2011	PROPN
hls-5011	84	15	/9789241564380_eng.pdf	/9789241564380_eng.pdf	PUNCT
hls-5011	84	16	3	3	X
hls-5011	84	17	.	.	X
hls-5011	84	18	ministry	ministry	PROPN
hls-5011	84	19	of	of	ADP
hls-5011	84	20	health	health	PROPN
hls-5011	84	21	and	and	CCONJ
hls-5011	84	22	social	social	ADJ
hls-5011	84	23	welfare	welfare	NOUN
hls-5011	84	24	,	,	PUNCT
hls-5011	84	25	united	united	PROPN
hls-5011	84	26	republic	republic	PROPN
hls-5011	84	27	of	of	ADP
hls-5011	84	28	tanzania	tanzania	PROPN
hls-5011	84	29	.	.	PUNCT
hls-5011	84	30	manual	manual	PROPN
hls-5011	84	31	for	for	ADP
hls-5011	84	32	the	the	DET
hls-5011	84	33	management	management	NOUN
hls-5011	84	34	of	of	ADP
hls-5011	84	35	tuberculosis	tuberculosis	NOUN
hls-5011	84	36	and	and	CCONJ
hls-5011	84	37	leprosy	leprosy	NOUN
hls-5011	84	38	.	.	PUNCT
hls-5011	85	1	national	national	ADJ
hls-5011	85	2	tuberculosis	tuberculosis	NOUN
hls-5011	85	3	and	and	CCONJ
hls-5011	85	4	leprosy	leprosy	NOUN
hls-5011	85	5	programme	programme	NOUN
hls-5011	85	6	.	.	PUNCT
hls-5011	86	1	dar	dar	PROPN
hls-5011	86	2	es	es	NOUN
hls-5011	86	3	salaam	salaam	PROPN
hls-5011	86	4	,	,	PUNCT
hls-5011	86	5	tanzania	tanzania	PROPN
hls-5011	86	6	:	:	PUNCT
hls-5011	86	7	ministry	ministry	PROPN
hls-5011	86	8	of	of	ADP
hls-5011	86	9	health	health	PROPN
hls-5011	86	10	and	and	CCONJ
hls-5011	86	11	social	social	ADJ
hls-5011	86	12	welfare	welfare	NOUN
hls-5011	86	13	;	;	PUNCT
hls-5011	86	14	2013	2013	NUM
hls-5011	86	15	.	.	PUNCT
hls-5011	87	1	4	4	NUM
hls-5011	87	2	.	.	X
hls-5011	87	3	zumla	zumla	NOUN
hls-5011	87	4	a	a	PRON
hls-5011	87	5	,	,	PUNCT
hls-5011	87	6	raviglione	raviglione	NOUN
hls-5011	87	7	m	m	NOUN
hls-5011	87	8	,	,	PUNCT
hls-5011	87	9	hafner	hafner	PROPN
hls-5011	87	10	r	r	PROPN
hls-5011	87	11	,	,	PUNCT
hls-5011	87	12	von	von	PROPN
hls-5011	87	13	reyn	reyn	PROPN
hls-5011	87	14	cf	cf	PROPN
hls-5011	87	15	.	.	PUNCT
hls-5011	88	1	tuberculosis	tuberculosis	NOUN
hls-5011	88	2	.	.	PUNCT
hls-5011	89	1	new	new	ADJ
hls-5011	89	2	engl	engl	PROPN
hls-5011	89	3	j	j	PROPN
hls-5011	89	4	med	med	PROPN
hls-5011	89	5	2013;368:745	2013;368:745	PROPN
hls-5011	89	6	-	-	SYM
hls-5011	89	7	55	55	NUM
hls-5011	89	8	.	.	PUNCT
hls-5011	90	1	5	5	X
hls-5011	90	2	.	.	X
hls-5011	90	3	steingart	steingart	PROPN
hls-5011	90	4	kr	kr	PROPN
hls-5011	90	5	,	,	PUNCT
hls-5011	90	6	henry	henry	PROPN
hls-5011	90	7	m	m	PROPN
hls-5011	90	8	,	,	PUNCT
hls-5011	90	9	ng	ng	PROPN
hls-5011	90	10	v	v	PROPN
hls-5011	90	11	,	,	PUNCT
hls-5011	90	12	et	et	PROPN
hls-5011	90	13	al	al	PROPN
hls-5011	90	14	.	.	PROPN
hls-5011	90	15	fluorescence	fluorescence	PROPN
hls-5011	90	16	.	.	PUNCT
hls-5011	91	1	conventional	conventional	ADJ
hls-5011	91	2	sputum	sputum	PROPN
hls-5011	91	3	smear	smear	NOUN
hls-5011	91	4	microscopy	microscopy	NOUN
hls-5011	91	5	for	for	ADP
hls-5011	91	6	tuberculosis	tuberculosis	NOUN
hls-5011	91	7	:	:	PUNCT
hls-5011	91	8	a	a	DET
hls-5011	91	9	systematic	systematic	ADJ
hls-5011	91	10	review	review	NOUN
hls-5011	91	11	.	.	PUNCT
hls-5011	92	1	lancet	lancet	PROPN
hls-5011	92	2	infect	infect	PROPN
hls-5011	92	3	dis	dis	PROPN
hls-5011	92	4	2006;6:570	2006;6:570	NUM
hls-5011	92	5	-	-	SYM
hls-5011	92	6	81	81	NUM
hls-5011	92	7	.	.	NOUN
hls-5011	93	1	6	6	NUM
hls-5011	93	2	.	.	X
hls-5011	93	3	seni	seni	PROPN
hls-5011	93	4	j	j	PROPN
hls-5011	93	5	,	,	PUNCT
hls-5011	93	6	kidenya	kidenya	PROPN
hls-5011	93	7	br	br	PROPN
hls-5011	93	8	,	,	PUNCT
hls-5011	93	9	obassy	obassy	PROPN
hls-5011	93	10	e	e	NOUN
hls-5011	93	11	,	,	PUNCT
hls-5011	93	12	et	et	PROPN
hls-5011	93	13	al	al	PROPN
hls-5011	93	14	.	.	PROPN
hls-5011	93	15	low	low	PROPN
hls-5011	93	16	sputum	sputum	PROPN
hls-5011	93	17	smear	smear	NOUN
hls-5011	93	18	positive	positive	ADJ
hls-5011	93	19	tuberculosis	tuberculosis	NOUN
hls-5011	93	20	among	among	ADP
hls-5011	93	21	pulmonary	pulmonary	ADJ
hls-5011	93	22	tuberculosis	tuberculosis	NOUN
hls-5011	93	23	suspects	suspect	NOUN
hls-5011	93	24	in	in	ADP
hls-5011	93	25	a	a	DET
hls-5011	93	26	tertiary	tertiary	ADJ
hls-5011	93	27	hospital	hospital	NOUN
hls-5011	93	28	in	in	ADP
hls-5011	93	29	mwanza	mwanza	PROPN
hls-5011	93	30	,	,	PUNCT
hls-5011	93	31	tanzania	tanzania	PROPN
hls-5011	93	32	.	.	PUNCT
hls-5011	94	1	tanzania	tanzania	PROPN
hls-5011	94	2	j	j	PROPN
hls-5011	94	3	health	health	PROPN
hls-5011	94	4	res	re	NOUN
hls-5011	94	5	2012;14:1	2012;14:1	NOUN
hls-5011	94	6	-	-	SYM
hls-5011	94	7	9	9	NUM
hls-5011	94	8	.	.	NOUN
hls-5011	94	9	7	7	X
hls-5011	94	10	.	.	X
hls-5011	94	11	cattamanchi	cattamanchi	PROPN
hls-5011	95	1	a	a	PROPN
hls-5011	95	2	,	,	PUNCT
hls-5011	95	3	davis	davis	PROPN
hls-5011	95	4	jl	jl	PROPN
hls-5011	95	5	,	,	PUNCT
hls-5011	95	6	worodria	worodria	PROPN
hls-5011	95	7	w	w	PROPN
hls-5011	95	8	,	,	PUNCT
hls-5011	95	9	et	et	PROPN
hls-5011	95	10	al	al	PROPN
hls-5011	95	11	.	.	PROPN
hls-5011	95	12	sensitivity	sensitivity	NOUN
hls-5011	95	13	and	and	CCONJ
hls-5011	95	14	specificity	specificity	NOUN
hls-5011	95	15	of	of	ADP
hls-5011	95	16	fluorescence	fluorescence	NOUN
hls-5011	95	17	microscopy	microscopy	NOUN
hls-5011	95	18	for	for	ADP
hls-5011	95	19	diagnosing	diagnose	VERB
hls-5011	95	20	pulmonary	pulmonary	ADJ
hls-5011	95	21	tuberculosis	tuberculosis	NOUN
hls-5011	95	22	in	in	ADP
hls-5011	95	23	a	a	DET
hls-5011	95	24	high	high	ADJ
hls-5011	95	25	hiv	hiv	PROPN
hls-5011	95	26	prevalence	prevalence	NOUN
hls-5011	95	27	setting	set	VERB
hls-5011	95	28	.	.	PUNCT
hls-5011	96	1	int	int	PROPN
hls-5011	96	2	j	j	PROPN
hls-5011	96	3	tuberc	tuberc	PROPN
hls-5011	96	4	lung	lung	PROPN
hls-5011	96	5	d	d	PROPN
hls-5011	96	6	2009	2009	NUM
hls-5011	96	7	;	;	PUNCT
hls-5011	96	8	13:1130	13:1130	NUM
hls-5011	96	9	-	-	SYM
hls-5011	96	10	6	6	NUM
hls-5011	96	11	.	.	NOUN
hls-5011	96	12	8	8	NUM
hls-5011	96	13	.	.	PUNCT
hls-5011	97	1	who	who	PRON
hls-5011	97	2	.	.	PUNCT
hls-5011	98	1	fluorescent	fluorescent	ADJ
hls-5011	98	2	light	light	ADV
hls-5011	98	3	-	-	PUNCT
hls-5011	98	4	emitting	emit	VERB
hls-5011	98	5	diode	diode	NOUN
hls-5011	98	6	(	(	PUNCT
hls-5011	98	7	led	lead	VERB
hls-5011	98	8	)	)	PUNCT
hls-5011	98	9	microscopy	microscopy	NOUN
hls-5011	98	10	for	for	ADP
hls-5011	98	11	diagnosis	diagnosis	NOUN
hls-5011	98	12	of	of	ADP
hls-5011	98	13	tuberculosis	tuberculosis	NOUN
hls-5011	98	14	:	:	PUNCT
hls-5011	98	15	policy	policy	NOUN
hls-5011	98	16	statement	statement	NOUN
hls-5011	98	17	.	.	PUNCT
hls-5011	99	1	geneva	geneva	PROPN
hls-5011	99	2	,	,	PUNCT
hls-5011	99	3	switzerland	switzerland	PROPN
hls-5011	99	4	:	:	PUNCT
hls-5011	99	5	world	world	PROPN
hls-5011	99	6	health	health	PROPN
hls-5011	99	7	organization	organization	NOUN
hls-5011	99	8	;	;	PUNCT
hls-5011	99	9	2011	2011	NUM
hls-5011	99	10	.	.	PUNCT
hls-5011	99	11	available	available	ADJ
hls-5011	99	12	from	from	ADP
hls-5011	99	13	:	:	PUNCT
hls-5011	99	14	http://whqlibdoc.who	http://whqlibdoc.who	PROPN
hls-5011	99	15	.	.	PUNCT
hls-5011	100	1	article	article	NOUN
hls-5011	100	2	table	table	VERB
hls-5011	100	3	2	2	NUM
hls-5011	100	4	.	.	PUNCT
hls-5011	101	1	distribution	distribution	NOUN
hls-5011	101	2	of	of	ADP
hls-5011	101	3	pulmonary	pulmonary	ADJ
hls-5011	101	4	tuberculosis	tuberculosis	NOUN
hls-5011	101	5	positive	positive	ADJ
hls-5011	101	6	and	and	CCONJ
hls-5011	101	7	negative	negative	ADJ
hls-5011	101	8	patients	patient	NOUN
hls-5011	101	9	with	with	ADP
hls-5011	101	10	variables	variable	NOUN
hls-5011	101	11	.	.	PUNCT
hls-5011	102	1	variables	variable	NOUN
hls-5011	102	2	ptb	ptb	PROPN
hls-5011	102	3	patients	patient	NOUN
hls-5011	102	4	(	(	PUNCT
hls-5011	102	5	total=806	total=806	NOUN
hls-5011	102	6	)	)	PUNCT
hls-5011	102	7	positive	positive	ADJ
hls-5011	102	8	(	(	PUNCT
hls-5011	102	9	total=200)*n	total=200)*n	X
hls-5011	102	10	(	(	PUNCT
hls-5011	102	11	%	%	INTJ
hls-5011	102	12	)	)	PUNCT
hls-5011	102	13	negative	negative	ADJ
hls-5011	102	14	(	(	PUNCT
hls-5011	102	15	total=606	total=606	NOUN
hls-5011	102	16	)	)	PUNCT
hls-5011	102	17	n	n	CCONJ
hls-5011	102	18	(	(	PUNCT
hls-5011	102	19	%	%	INTJ
hls-5011	102	20	)	)	PUNCT
hls-5011	102	21	mean	mean	NOUN
hls-5011	102	22	age	age	NOUN
hls-5011	102	23	(	(	PUNCT
hls-5011	102	24	years	year	NOUN
hls-5011	102	25	)	)	PUNCT
hls-5011	103	1	39.4±14.0	39.4±14.0	NUM
hls-5011	103	2	°	°	NOUN
hls-5011	103	3	39.7±16.7	39.7±16.7	NUM
hls-5011	103	4	°	°	NOUN
hls-5011	103	5	age	age	NOUN
hls-5011	103	6	groups	group	NOUN
hls-5011	103	7	(	(	PUNCT
hls-5011	103	8	years	year	NOUN
hls-5011	103	9	)	)	PUNCT
hls-5011	103	10	≤8	≤8	NOUN
hls-5011	103	11	4	4	NUM
hls-5011	103	12	(	(	PUNCT
hls-5011	103	13	2.0	2.0	NUM
hls-5011	103	14	)	)	PUNCT
hls-5011	103	15	17	17	NUM
hls-5011	103	16	(	(	PUNCT
hls-5011	103	17	2.8	2.8	NUM
hls-5011	103	18	)	)	PUNCT
hls-5011	103	19	9	9	NUM
hls-5011	103	20	-	-	SYM
hls-5011	103	21	17	17	NUM
hls-5011	103	22	3	3	NUM
hls-5011	103	23	(	(	PUNCT
hls-5011	103	24	1.5	1.5	NUM
hls-5011	103	25	)	)	PUNCT
hls-5011	103	26	48	48	NUM
hls-5011	103	27	(	(	PUNCT
hls-5011	103	28	7.9	7.9	NUM
hls-5011	103	29	)	)	PUNCT
hls-5011	103	30	≥18	≥18	SYM
hls-5011	103	31	193	193	NUM
hls-5011	103	32	(	(	PUNCT
hls-5011	103	33	96.5	96.5	NUM
hls-5011	103	34	)	)	PUNCT
hls-5011	103	35	541	541	NUM
hls-5011	103	36	(	(	PUNCT
hls-5011	103	37	89.3	89.3	NUM
hls-5011	103	38	)	)	PUNCT
hls-5011	103	39	sex	sex	NOUN
hls-5011	103	40	female	female	NOUN
hls-5011	103	41	80	80	NUM
hls-5011	103	42	(	(	PUNCT
hls-5011	103	43	40.0	40.0	NUM
hls-5011	103	44	)	)	PUNCT
hls-5011	103	45	319	319	NUM
hls-5011	103	46	(	(	PUNCT
hls-5011	103	47	52.6	52.6	NUM
hls-5011	103	48	)	)	PUNCT
hls-5011	103	49	males	male	NOUN
hls-5011	103	50	120	120	NUM
hls-5011	103	51	(	(	PUNCT
hls-5011	103	52	60.0	60.0	NUM
hls-5011	103	53	)	)	SYM
hls-5011	103	54	287	287	NUM
hls-5011	103	55	(	(	PUNCT
hls-5011	103	56	47.4	47.4	NUM
hls-5011	103	57	)	)	PUNCT
hls-5011	103	58	residence	residence	NOUN
hls-5011	103	59	mwanza	mwanza	ADJ
hls-5011	103	60	city	city	NOUN
hls-5011	103	61	138	138	NUM
hls-5011	103	62	(	(	PUNCT
hls-5011	103	63	69.4	69.4	NUM
hls-5011	103	64	)	)	PUNCT
hls-5011	103	65	520	520	NUM
hls-5011	103	66	(	(	PUNCT
hls-5011	103	67	85.8	85.8	NUM
hls-5011	103	68	)	)	PUNCT
hls-5011	103	69	outside	outside	ADP
hls-5011	103	70	mwanza	mwanza	PROPN
hls-5011	103	71	city	city	NOUN
hls-5011	103	72	61	61	NUM
hls-5011	103	73	(	(	PUNCT
hls-5011	103	74	30.6	30.6	NUM
hls-5011	103	75	)	)	PUNCT
hls-5011	103	76	86	86	NUM
hls-5011	103	77	(	(	PUNCT
hls-5011	103	78	14.2	14.2	NUM
hls-5011	103	79	)	)	PUNCT
hls-5011	103	80	treatment	treatment	NOUN
hls-5011	103	81	category	category	NOUN
hls-5011	103	82	new	new	ADJ
hls-5011	103	83	cases	case	NOUN
hls-5011	103	84	189	189	NUM
hls-5011	103	85	(	(	PUNCT
hls-5011	103	86	94.5	94.5	NUM
hls-5011	103	87	)	)	PUNCT
hls-5011	103	88	597	597	NUM
hls-5011	103	89	(	(	PUNCT
hls-5011	103	90	98.5	98.5	NUM
hls-5011	103	91	)	)	PUNCT
hls-5011	103	92	follow	follow	VERB
hls-5011	103	93	up	up	ADP
hls-5011	103	94	11	11	NUM
hls-5011	103	95	(	(	PUNCT
hls-5011	103	96	5.5	5.5	NUM
hls-5011	103	97	)	)	PUNCT
hls-5011	103	98	9	9	NUM
hls-5011	103	99	(	(	PUNCT
hls-5011	103	100	1.5	1.5	NUM
hls-5011	103	101	)	)	PUNCT
hls-5011	103	102	hiv	hiv	PROPN
hls-5011	103	103	serostatus	serostatus	ADJ
hls-5011	103	104	#	#	NOUN
hls-5011	103	105	positive	positive	ADJ
hls-5011	103	106	66	66	NUM
hls-5011	103	107	(	(	PUNCT
hls-5011	103	108	86.8	86.8	NUM
hls-5011	103	109	)	)	PUNCT
hls-5011	103	110	201	201	NUM
hls-5011	103	111	(	(	PUNCT
hls-5011	103	112	87.0	87.0	NUM
hls-5011	103	113	)	)	PUNCT
hls-5011	103	114	negative	negative	ADJ
hls-5011	103	115	10	10	NUM
hls-5011	103	116	(	(	PUNCT
hls-5011	103	117	13.2	13.2	NUM
hls-5011	103	118	)	)	PUNCT
hls-5011	103	119	30	30	NUM
hls-5011	103	120	(	(	PUNCT
hls-5011	103	121	13.0	13.0	NUM
hls-5011	103	122	)	)	PUNCT
hls-5011	103	123	ptb	ptb	PROPN
hls-5011	103	124	,	,	PUNCT
hls-5011	103	125	presumptive	presumptive	ADJ
hls-5011	103	126	tuberculosis	tuberculosis	NOUN
hls-5011	103	127	.	.	PUNCT
hls-5011	104	1	*	*	PUNCT
hls-5011	104	2	diagnosed	diagnose	VERB
hls-5011	104	3	by	by	ADP
hls-5011	104	4	either	either	CCONJ
hls-5011	104	5	led	lead	VERB
hls-5011	104	6	fm	fm	PROPN
hls-5011	104	7	or	or	CCONJ
hls-5011	104	8	genexpert	genexpert	PROPN
hls-5011	104	9	mtb	mtb	PROPN
hls-5011	104	10	/	/	SYM
hls-5011	104	11	rif	rif	NOUN
hls-5011	104	12	®	®	NOUN
hls-5011	104	13	;	;	PUNCT
hls-5011	104	14	°	°	NUM
hls-5011	104	15	continuous	continuous	ADJ
hls-5011	104	16	variable	variable	NOUN
hls-5011	104	17	;	;	PUNCT
hls-5011	104	18	#	#	SYM
hls-5011	104	19	only	only	ADV
hls-5011	104	20	307	307	NUM
hls-5011	104	21	patients	patient	NOUN
hls-5011	104	22	knew	know	VERB
hls-5011	104	23	hiv	hiv	PROPN
hls-5011	104	24	serostatus	serostatus	PROPN
hls-5011	104	25	.	.	PUNCT
hls-5011	105	1	non	non	PROPN
hls-5011	105	2	co	co	PROPN
hls-5011	105	3	mmerc	mmerc	PROPN
hls-5011	105	4	ial	ial	PROPN
hls-5011	105	5	us	us	PROPN
hls-5011	106	1	e	e	NOUN
hls-5011	106	2	o	o	NOUN
hls-5011	106	3	nly	nly	ADV
hls-5011	106	4	[	[	X
hls-5011	106	5	healthcare	healthcare	NOUN
hls-5011	106	6	in	in	ADP
hls-5011	106	7	low	low	ADJ
hls-5011	106	8	-	-	PUNCT
hls-5011	106	9	resource	resource	NOUN
hls-5011	106	10	settings	setting	NOUN
hls-5011	106	11	2015	2015	NUM
hls-5011	106	12	;	;	PUNCT
hls-5011	106	13	3:5011	3:5011	NUM
hls-5011	106	14	]	]	PUNCT
hls-5011	107	1	[	[	X
hls-5011	107	2	page	page	NOUN
hls-5011	107	3	13	13	NUM
hls-5011	107	4	]	]	SYM
hls-5011	107	5	int	int	PROPN
hls-5011	107	6	/	/	SYM
hls-5011	107	7	publications/2011/9789241501613_eng	publications/2011/9789241501613_eng	PROPN
hls-5011	107	8	.pdf	.pdf	PUNCT
hls-5011	107	9	9	9	X
hls-5011	107	10	.	.	PUNCT
hls-5011	108	1	who	who	PRON
hls-5011	108	2	.	.	PUNCT
hls-5011	109	1	policy	policy	NOUN
hls-5011	109	2	statement	statement	NOUN
hls-5011	109	3	:	:	PUNCT
hls-5011	109	4	automated	automate	VERB
hls-5011	109	5	realtime	realtime	ADJ
hls-5011	109	6	nucleic	nucleic	ADJ
hls-5011	109	7	acid	acid	NOUN
hls-5011	109	8	amplification	amplification	NOUN
hls-5011	109	9	technology	technology	NOUN
hls-5011	109	10	for	for	ADP
hls-5011	109	11	rapid	rapid	ADJ
hls-5011	109	12	and	and	CCONJ
hls-5011	109	13	simultaneous	simultaneous	ADJ
hls-5011	109	14	detection	detection	NOUN
hls-5011	109	15	of	of	ADP
hls-5011	109	16	tuberculosis	tuberculosis	NOUN
hls-5011	109	17	and	and	CCONJ
hls-5011	109	18	rifampicin	rifampicin	VERB
hls-5011	109	19	resistance	resistance	NOUN
hls-5011	109	20	:	:	PUNCT
hls-5011	109	21	xpert	xpert	PROPN
hls-5011	109	22	mtb	mtb	PROPN
hls-5011	109	23	/	/	SYM
hls-5011	109	24	rif	rif	PROPN
hls-5011	109	25	system	system	NOUN
hls-5011	109	26	.	.	PUNCT
hls-5011	110	1	geneva	geneva	PROPN
hls-5011	110	2	,	,	PUNCT
hls-5011	110	3	switzerland	switzerland	PROPN
hls-5011	110	4	:	:	PUNCT
hls-5011	110	5	world	world	PROPN
hls-5011	110	6	health	health	PROPN
hls-5011	110	7	organization	organization	NOUN
hls-5011	110	8	;	;	PUNCT
hls-5011	110	9	2011	2011	NUM
hls-5011	110	10	.	.	PUNCT
hls-5011	110	11	available	available	ADJ
hls-5011	110	12	from	from	ADP
hls-5011	110	13	:	:	PUNCT
hls-5011	110	14	http://whqlibdoc.who.int/publications/2011	http://whqlibdoc.who.int/publications/2011	PROPN
hls-5011	110	15	/9789241501545_eng.pdf	/9789241501545_eng.pdf	PUNCT
hls-5011	110	16	10	10	NUM
hls-5011	110	17	.	.	PUNCT
hls-5011	110	18	parsons	parson	NOUN
hls-5011	110	19	lm	lm	PROPN
hls-5011	110	20	,	,	PUNCT
hls-5011	110	21	somoskovi	somoskovi	VERB
hls-5011	110	22	a	a	PRON
hls-5011	110	23	,	,	PUNCT
hls-5011	110	24	gutierrez	gutierrez	PROPN
hls-5011	110	25	c	c	PROPN
hls-5011	110	26	,	,	PUNCT
hls-5011	110	27	et	et	PROPN
hls-5011	110	28	al	al	PROPN
hls-5011	110	29	.	.	PUNCT
hls-5011	111	1	laboratory	laboratory	NOUN
hls-5011	111	2	diagnosis	diagnosis	NOUN
hls-5011	111	3	of	of	ADP
hls-5011	111	4	tuberculosis	tuberculosis	NOUN
hls-5011	111	5	in	in	ADP
hls-5011	111	6	resource	resource	NOUN
hls-5011	111	7	-	-	PUNCT
hls-5011	111	8	poor	poor	ADJ
hls-5011	111	9	countries	country	NOUN
hls-5011	111	10	:	:	PUNCT
hls-5011	111	11	challenges	challenge	NOUN
hls-5011	111	12	and	and	CCONJ
hls-5011	111	13	opportunities	opportunity	NOUN
hls-5011	111	14	.	.	PUNCT
hls-5011	112	1	clin	clin	PROPN
hls-5011	112	2	microbiol	microbiol	PROPN
hls-5011	112	3	rev	rev	VERB
hls-5011	112	4	2011;24:314	2011;24:314	PROPN
hls-5011	112	5	-	-	SYM
hls-5011	112	6	50	50	NUM
hls-5011	112	7	.	.	PUNCT
hls-5011	113	1	11	11	NUM
hls-5011	113	2	.	.	X
hls-5011	114	1	pantoja	pantoja	PROPN
hls-5011	114	2	a	a	PROPN
hls-5011	114	3	,	,	PUNCT
hls-5011	114	4	fitzpatrick	fitzpatrick	PROPN
hls-5011	114	5	c	c	PROPN
hls-5011	114	6	,	,	PUNCT
hls-5011	114	7	vassall	vassall	NOUN
hls-5011	114	8	a	a	NOUN
hls-5011	114	9	,	,	PUNCT
hls-5011	114	10	et	et	PROPN
hls-5011	114	11	al	al	PROPN
hls-5011	114	12	.	.	PUNCT
hls-5011	115	1	xpert	xpert	PROPN
hls-5011	115	2	mtb	mtb	PROPN
hls-5011	115	3	/	/	SYM
hls-5011	115	4	rif	rif	PROPN
hls-5011	115	5	for	for	ADP
hls-5011	115	6	diagnosis	diagnosis	NOUN
hls-5011	115	7	of	of	ADP
hls-5011	115	8	tuberculosis	tuberculosis	NOUN
hls-5011	115	9	and	and	CCONJ
hls-5011	115	10	drug	drug	NOUN
hls-5011	115	11	-	-	PUNCT
hls-5011	115	12	resistant	resistant	ADJ
hls-5011	115	13	tuberculosis	tuberculosis	NOUN
hls-5011	115	14	:	:	PUNCT
hls-5011	115	15	a	a	DET
hls-5011	115	16	cost	cost	NOUN
hls-5011	115	17	and	and	CCONJ
hls-5011	115	18	affordability	affordability	NOUN
hls-5011	115	19	analysis	analysis	NOUN
hls-5011	115	20	.	.	PUNCT
hls-5011	116	1	eur	eur	PROPN
hls-5011	116	2	respir	respir	PROPN
hls-5011	116	3	j	j	PROPN
hls-5011	116	4	2011;42:708	2011;42:708	NOUN
hls-5011	116	5	-	-	SYM
hls-5011	116	6	20	20	NUM
hls-5011	116	7	.	.	PUNCT
hls-5011	117	1	12	12	NUM
hls-5011	117	2	.	.	PUNCT
hls-5011	118	1	steingart	steingart	PROPN
hls-5011	118	2	kr	kr	PROPN
hls-5011	118	3	,	,	PUNCT
hls-5011	118	4	schiller	schiller	PROPN
hls-5011	118	5	i	i	PROPN
hls-5011	118	6	,	,	PUNCT
hls-5011	118	7	horne	horne	PROPN
hls-5011	118	8	dj	dj	PROPN
hls-5011	118	9	,	,	PUNCT
hls-5011	118	10	et	et	PROPN
hls-5011	118	11	al	al	PROPN
hls-5011	118	12	.	.	PROPN
hls-5011	119	1	xpert(r	xpert(r	NUM
hls-5011	119	2	)	)	PUNCT
hls-5011	119	3	mtb	mtb	PROPN
hls-5011	119	4	/	/	SYM
hls-5011	119	5	rif	rif	PROPN
hls-5011	119	6	assay	assay	NOUN
hls-5011	119	7	for	for	ADP
hls-5011	119	8	pulmonary	pulmonary	ADJ
hls-5011	119	9	tuberculosis	tuberculosis	NOUN
hls-5011	119	10	and	and	CCONJ
hls-5011	119	11	rifampicin	rifampicin	VERB
hls-5011	119	12	resistance	resistance	NOUN
hls-5011	119	13	in	in	ADP
hls-5011	119	14	adults	adult	NOUN
hls-5011	119	15	.	.	PUNCT
hls-5011	120	1	cochrane	cochrane	PROPN
hls-5011	120	2	db	db	PROPN
hls-5011	120	3	syst	syst	PROPN
hls-5011	120	4	rev	rev	PROPN
hls-5011	120	5	2014	2014	NUM
hls-5011	120	6	:	:	PUNCT
hls-5011	120	7	cd009593	cd009593	PROPN
hls-5011	120	8	.	.	PUNCT
hls-5011	121	1	13	13	NUM
hls-5011	121	2	.	.	PUNCT
hls-5011	121	3	lawn	lawn	NOUN
hls-5011	121	4	sd	sd	PROPN
hls-5011	121	5	,	,	PUNCT
hls-5011	121	6	nicol	nicol	PROPN
hls-5011	121	7	mp	mp	PROPN
hls-5011	121	8	.	.	PROPN
hls-5011	121	9	xpert(r	xpert(r	NUM
hls-5011	121	10	)	)	PUNCT
hls-5011	121	11	mtb	mtb	PROPN
hls-5011	121	12	/	/	SYM
hls-5011	121	13	rif	rif	PROPN
hls-5011	121	14	assay	assay	PROPN
hls-5011	121	15	:	:	PUNCT
hls-5011	121	16	development	development	NOUN
hls-5011	121	17	,	,	PUNCT
hls-5011	121	18	evaluation	evaluation	NOUN
hls-5011	121	19	and	and	CCONJ
hls-5011	121	20	implementation	implementation	NOUN
hls-5011	121	21	of	of	ADP
hls-5011	121	22	a	a	DET
hls-5011	121	23	new	new	ADJ
hls-5011	121	24	rapid	rapid	ADJ
hls-5011	121	25	molecular	molecular	ADJ
hls-5011	121	26	diagnostic	diagnostic	NOUN
hls-5011	121	27	for	for	ADP
hls-5011	121	28	tuberculosis	tuberculosis	NOUN
hls-5011	121	29	and	and	CCONJ
hls-5011	121	30	rifampicin	rifampicin	VERB
hls-5011	121	31	resistance	resistance	NOUN
hls-5011	121	32	.	.	PUNCT
hls-5011	122	1	future	future	ADJ
hls-5011	122	2	microbiol	microbiol	PROPN
hls-5011	122	3	2011;6:106782	2011;6:106782	NUM
hls-5011	122	4	.	.	PUNCT
hls-5011	123	1	14	14	NUM
hls-5011	123	2	.	.	X
hls-5011	123	3	boehme	boehme	PROPN
hls-5011	123	4	cc	cc	PROPN
hls-5011	123	5	,	,	PUNCT
hls-5011	123	6	nabeta	nabeta	ADV
hls-5011	123	7	p	p	X
hls-5011	123	8	,	,	PUNCT
hls-5011	123	9	hillemann	hillemann	PROPN
hls-5011	123	10	d	d	NOUN
hls-5011	123	11	,	,	PUNCT
hls-5011	123	12	et	et	PROPN
hls-5011	123	13	al	al	PROPN
hls-5011	123	14	.	.	PROPN
hls-5011	124	1	rapid	rapid	ADJ
hls-5011	124	2	molecular	molecular	ADJ
hls-5011	124	3	detection	detection	NOUN
hls-5011	124	4	of	of	ADP
hls-5011	124	5	tuberculosis	tuberculosis	NOUN
hls-5011	124	6	and	and	CCONJ
hls-5011	124	7	rifampin	rifampin	VERB
hls-5011	124	8	resistance	resistance	NOUN
hls-5011	124	9	.	.	PUNCT
hls-5011	125	1	new	new	ADJ
hls-5011	125	2	engl	engl	PROPN
hls-5011	125	3	j	j	PROPN
hls-5011	125	4	med	med	PROPN
hls-5011	125	5	2010;363:1005	2010;363:1005	NUM
hls-5011	125	6	-	-	SYM
hls-5011	125	7	15	15	NUM
hls-5011	125	8	.	.	NOUN
hls-5011	125	9	15	15	NUM
hls-5011	125	10	.	.	PUNCT
hls-5011	126	1	helb	helb	PROPN
hls-5011	126	2	d	d	PROPN
hls-5011	126	3	,	,	PUNCT
hls-5011	126	4	jones	jones	PROPN
hls-5011	126	5	m	m	PROPN
hls-5011	126	6	,	,	PUNCT
hls-5011	126	7	story	story	NOUN
hls-5011	126	8	e	e	NOUN
hls-5011	126	9	,	,	PUNCT
hls-5011	126	10	et	et	PROPN
hls-5011	126	11	al	al	PROPN
hls-5011	126	12	.	.	PROPN
hls-5011	127	1	rapid	rapid	ADJ
hls-5011	127	2	detection	detection	NOUN
hls-5011	127	3	of	of	ADP
hls-5011	127	4	mycobacterium	mycobacterium	NOUN
hls-5011	127	5	tuberculosis	tuberculosis	NOUN
hls-5011	127	6	and	and	CCONJ
hls-5011	127	7	rifampin	rifampin	VERB
hls-5011	127	8	resistance	resistance	NOUN
hls-5011	127	9	by	by	ADP
hls-5011	127	10	use	use	NOUN
hls-5011	127	11	of	of	ADP
hls-5011	127	12	ondemand	ondemand	NOUN
hls-5011	127	13	,	,	PUNCT
hls-5011	127	14	near	near	ADP
hls-5011	127	15	-	-	PUNCT
hls-5011	127	16	patient	patient	NOUN
hls-5011	127	17	technology	technology	NOUN
hls-5011	127	18	.	.	PUNCT
hls-5011	128	1	j	j	PROPN
hls-5011	128	2	clin	clin	PROPN
hls-5011	128	3	microbiol	microbiol	PROPN
hls-5011	128	4	2010;48:229	2010;48:229	PROPN
hls-5011	128	5	-	-	SYM
hls-5011	128	6	37	37	NUM
hls-5011	128	7	.	.	PUNCT
hls-5011	129	1	16	16	NUM
hls-5011	129	2	.	.	PUNCT
hls-5011	130	1	theron	theron	PROPN
hls-5011	130	2	g	g	PROPN
hls-5011	130	3	,	,	PUNCT
hls-5011	130	4	zijenah	zijenah	PROPN
hls-5011	130	5	l	l	PROPN
hls-5011	130	6	,	,	PUNCT
hls-5011	130	7	chanda	chanda	PROPN
hls-5011	131	1	d	d	PROPN
hls-5011	131	2	,	,	PUNCT
hls-5011	131	3	et	et	PROPN
hls-5011	131	4	al	al	PROPN
hls-5011	131	5	.	.	PUNCT
hls-5011	132	1	feasibility	feasibility	PROPN
hls-5011	132	2	,	,	PUNCT
hls-5011	132	3	accuracy	accuracy	NOUN
hls-5011	132	4	,	,	PUNCT
hls-5011	132	5	and	and	CCONJ
hls-5011	132	6	clinical	clinical	ADJ
hls-5011	132	7	effect	effect	NOUN
hls-5011	132	8	of	of	ADP
hls-5011	132	9	point	point	NOUN
hls-5011	132	10	-	-	PUNCT
hls-5011	132	11	of	of	ADP
hls-5011	132	12	-	-	PUNCT
hls-5011	132	13	care	care	NOUN
hls-5011	132	14	xpert	xpert	PROPN
hls-5011	132	15	mtb	mtb	PROPN
hls-5011	132	16	/	/	SYM
hls-5011	132	17	rif	rif	PROPN
hls-5011	132	18	testing	testing	NOUN
hls-5011	132	19	for	for	ADP
hls-5011	132	20	tuberculosis	tuberculosis	NOUN
hls-5011	132	21	in	in	ADP
hls-5011	132	22	primary	primary	ADJ
hls-5011	132	23	-	-	PUNCT
hls-5011	132	24	care	care	NOUN
hls-5011	132	25	settings	setting	NOUN
hls-5011	132	26	in	in	ADP
hls-5011	132	27	africa	africa	PROPN
hls-5011	132	28	:	:	PUNCT
hls-5011	132	29	a	a	DET
hls-5011	132	30	multicentre	multicentre	NOUN
hls-5011	132	31	,	,	PUNCT
hls-5011	132	32	randomised	randomise	VERB
hls-5011	132	33	,	,	PUNCT
hls-5011	132	34	controlled	control	VERB
hls-5011	132	35	trial	trial	NOUN
hls-5011	132	36	.	.	PUNCT
hls-5011	133	1	lancet	lancet	PROPN
hls-5011	133	2	2014;383:424	2014;383:424	NUM
hls-5011	133	3	-	-	SYM
hls-5011	133	4	35	35	NUM
hls-5011	133	5	.	.	PUNCT
hls-5011	133	6	17	17	NUM
hls-5011	133	7	.	.	PUNCT
hls-5011	134	1	sekadde	sekadde	PROPN
hls-5011	134	2	mp	mp	PROPN
hls-5011	134	3	,	,	PUNCT
hls-5011	134	4	wobudeya	wobudeya	NOUN
hls-5011	134	5	e	e	PROPN
hls-5011	134	6	,	,	PUNCT
hls-5011	134	7	joloba	joloba	PROPN
hls-5011	134	8	ml	ml	AUX
hls-5011	134	9	,	,	PUNCT
hls-5011	134	10	et	et	PROPN
hls-5011	134	11	al	al	PROPN
hls-5011	134	12	.	.	PUNCT
hls-5011	134	13	evaluation	evaluation	NOUN
hls-5011	134	14	of	of	ADP
hls-5011	134	15	the	the	DET
hls-5011	134	16	xpert	xpert	PROPN
hls-5011	134	17	mtb	mtb	PROPN
hls-5011	134	18	/	/	SYM
hls-5011	134	19	rif	rif	PROPN
hls-5011	134	20	test	test	NOUN
hls-5011	134	21	for	for	ADP
hls-5011	134	22	the	the	DET
hls-5011	134	23	diagnosis	diagnosis	NOUN
hls-5011	134	24	of	of	ADP
hls-5011	134	25	childhood	childhood	ADJ
hls-5011	134	26	pulmonary	pulmonary	ADJ
hls-5011	134	27	tuberculosis	tuberculosis	NOUN
hls-5011	134	28	in	in	ADP
hls-5011	134	29	uganda	uganda	PROPN
hls-5011	134	30	:	:	PUNCT
hls-5011	134	31	a	a	DET
hls-5011	134	32	cross	cross	ADJ
hls-5011	134	33	-	-	ADJ
hls-5011	134	34	sectional	sectional	ADJ
hls-5011	134	35	diagnostic	diagnostic	ADJ
hls-5011	134	36	study	study	NOUN
hls-5011	134	37	.	.	PUNCT
hls-5011	135	1	bmc	bmc	ADJ
hls-5011	135	2	infect	infect	PROPN
hls-5011	135	3	dis	dis	PROPN
hls-5011	135	4	2013;13:133	2013;13:133	NUM
hls-5011	135	5	.	.	PROPN
hls-5011	135	6	18	18	NUM
hls-5011	135	7	.	.	PUNCT
hls-5011	136	1	ssengooba	ssengooba	PROPN
hls-5011	136	2	w	w	PROPN
hls-5011	136	3	,	,	PUNCT
hls-5011	136	4	nakiyingi	nakiyingi	PROPN
hls-5011	136	5	l	l	PROPN
hls-5011	136	6	,	,	PUNCT
hls-5011	136	7	armstrong	armstrong	PROPN
hls-5011	136	8	dt	dt	PROPN
hls-5011	136	9	,	,	PUNCT
hls-5011	136	10	et	et	PROPN
hls-5011	136	11	al	al	PROPN
hls-5011	136	12	.	.	PROPN
hls-5011	136	13	clinical	clinical	ADJ
hls-5011	136	14	utility	utility	NOUN
hls-5011	136	15	of	of	ADP
hls-5011	136	16	a	a	DET
hls-5011	136	17	novel	novel	ADJ
hls-5011	136	18	molecular	molecular	ADJ
hls-5011	136	19	assay	assay	NOUN
hls-5011	136	20	in	in	ADP
hls-5011	136	21	various	various	ADJ
hls-5011	136	22	combination	combination	NOUN
hls-5011	136	23	strategies	strategy	NOUN
hls-5011	136	24	with	with	ADP
hls-5011	136	25	existing	exist	VERB
hls-5011	136	26	methods	method	NOUN
hls-5011	136	27	for	for	ADP
hls-5011	136	28	diagnosis	diagnosis	NOUN
hls-5011	136	29	of	of	ADP
hls-5011	136	30	hiv	hiv	PROPN
hls-5011	136	31	-	-	PUNCT
hls-5011	136	32	related	relate	VERB
hls-5011	136	33	tuberculosis	tuberculosis	NOUN
hls-5011	136	34	in	in	ADP
hls-5011	136	35	uganda	uganda	PROPN
hls-5011	136	36	.	.	PUNCT
hls-5011	137	1	plos	plos	PROPN
hls-5011	137	2	one	one	NUM
hls-5011	137	3	2014;9	2014;9	NUM
hls-5011	137	4	:	:	PUNCT
hls-5011	137	5	e107595	e107595	PROPN
hls-5011	137	6	.	.	PUNCT
hls-5011	138	1	19	19	NUM
hls-5011	138	2	.	.	PUNCT
hls-5011	139	1	creswell	creswell	PROPN
hls-5011	139	2	j	j	PROPN
hls-5011	139	3	,	,	PUNCT
hls-5011	139	4	codlin	codlin	PROPN
hls-5011	139	5	aj	aj	PROPN
hls-5011	139	6	,	,	PUNCT
hls-5011	139	7	andre	andre	PROPN
hls-5011	139	8	e	e	PROPN
hls-5011	139	9	,	,	PUNCT
hls-5011	139	10	et	et	PROPN
hls-5011	139	11	al	al	PROPN
hls-5011	139	12	.	.	PROPN
hls-5011	139	13	results	result	NOUN
hls-5011	139	14	from	from	ADP
hls-5011	139	15	early	early	ADJ
hls-5011	139	16	programmatic	programmatic	ADJ
hls-5011	139	17	implementation	implementation	NOUN
hls-5011	139	18	of	of	ADP
hls-5011	139	19	xpert	xpert	PROPN
hls-5011	139	20	mtb	mtb	PROPN
hls-5011	139	21	/	/	SYM
hls-5011	139	22	rif	rif	PROPN
hls-5011	139	23	testing	testing	NOUN
hls-5011	139	24	in	in	ADP
hls-5011	139	25	nine	nine	NUM
hls-5011	139	26	countries	country	NOUN
hls-5011	139	27	.	.	PUNCT
hls-5011	140	1	bmc	bmc	ADJ
hls-5011	140	2	infect	infect	NOUN
hls-5011	140	3	dis	dis	PROPN
hls-5011	140	4	2014;14:2	2014;14:2	NOUN
hls-5011	140	5	.	.	PUNCT
hls-5011	141	1	20	20	NUM
hls-5011	141	2	.	.	PUNCT
hls-5011	142	1	lumb	lumb	PROPN
hls-5011	142	2	r	r	PROPN
hls-5011	142	3	,	,	PUNCT
hls-5011	142	4	van	van	PROPN
hls-5011	142	5	deun	deun	PROPN
hls-5011	142	6	a	a	NOUN
hls-5011	142	7	,	,	PUNCT
hls-5011	142	8	bastlan	bastlan	NOUN
hls-5011	142	9	i	i	PROPN
hls-5011	142	10	,	,	PUNCT
hls-5011	142	11	fitz	fitz	PROPN
hls-5011	142	12	-	-	PUNCT
hls-5011	142	13	gerald	gerald	PROPN
hls-5011	142	14	m.	m.	PROPN
hls-5011	142	15	laboratory	laboratory	NOUN
hls-5011	142	16	diagnosis	diagnosis	NOUN
hls-5011	142	17	of	of	ADP
hls-5011	142	18	tuberculosis	tuberculosis	NOUN
hls-5011	142	19	by	by	ADP
hls-5011	142	20	sputum	sputum	PROPN
hls-5011	142	21	microscopy	microscopy	PROPN
hls-5011	142	22	.	.	PUNCT
hls-5011	143	1	adelaide	adelaide	PROPN
hls-5011	143	2	,	,	PUNCT
hls-5011	143	3	australia	australia	PROPN
hls-5011	143	4	:	:	PUNCT
hls-5011	143	5	sa	sa	PROPN
hls-5011	143	6	pathology	pathology	PROPN
hls-5011	143	7	;	;	PUNCT
hls-5011	143	8	2010	2010	NUM
hls-5011	143	9	.	.	PUNCT
hls-5011	144	1	available	available	ADJ
hls-5011	144	2	from	from	ADP
hls-5011	144	3	:	:	PUNCT
hls-5011	144	4	http://www.who.int/tb/laboratory/tb-sputum-microscopy-handbook.pdf	http://www.who.int/tb/laboratory/tb-sputum-microscopy-handbook.pdf	PROPN
hls-5011	144	5	21	21	NUM
hls-5011	144	6	.	.	PUNCT
hls-5011	145	1	rachow	rachow	PROPN
hls-5011	145	2	a	a	PROPN
hls-5011	145	3	,	,	PUNCT
hls-5011	145	4	zumla	zumla	PROPN
hls-5011	145	5	a	a	NOUN
hls-5011	145	6	,	,	PUNCT
hls-5011	145	7	heinrich	heinrich	NOUN
hls-5011	145	8	n	n	CCONJ
hls-5011	145	9	,	,	PUNCT
hls-5011	145	10	et	et	PROPN
hls-5011	145	11	al	al	PROPN
hls-5011	145	12	.	.	PROPN
hls-5011	145	13	rapid	rapid	ADJ
hls-5011	145	14	and	and	CCONJ
hls-5011	145	15	accurate	accurate	ADJ
hls-5011	145	16	detection	detection	NOUN
hls-5011	145	17	of	of	ADP
hls-5011	145	18	mycobacterium	mycobacterium	NOUN
hls-5011	145	19	tuberculosis	tuberculosis	NOUN
hls-5011	145	20	in	in	ADP
hls-5011	145	21	sputum	sputum	NOUN
hls-5011	145	22	samples	sample	NOUN
hls-5011	145	23	by	by	ADP
hls-5011	145	24	cepheid	cepheid	PROPN
hls-5011	145	25	xpert	xpert	PROPN
hls-5011	145	26	mtb	mtb	PROPN
hls-5011	145	27	/	/	SYM
hls-5011	145	28	rif	rif	PROPN
hls-5011	145	29	assay	assay	PROPN
hls-5011	145	30	:	:	PUNCT
hls-5011	145	31	a	a	DET
hls-5011	145	32	clinical	clinical	ADJ
hls-5011	145	33	validation	validation	NOUN
hls-5011	145	34	study	study	NOUN
hls-5011	145	35	.	.	PUNCT
hls-5011	146	1	plos	plos	PROPN
hls-5011	146	2	one	one	NUM
hls-5011	146	3	2011;6	2011;6	NUM
hls-5011	146	4	:	:	PUNCT
hls-5011	146	5	e20458	e20458	ADJ
hls-5011	146	6	.	.	PUNCT
hls-5011	147	1	22	22	NUM
hls-5011	147	2	.	.	PUNCT
hls-5011	148	1	lawn	lawn	NOUN
hls-5011	148	2	sd	sd	PROPN
hls-5011	148	3	,	,	PUNCT
hls-5011	148	4	brooks	brooks	PROPN
hls-5011	148	5	sv	sv	PROPN
hls-5011	148	6	,	,	PUNCT
hls-5011	148	7	kranzer	kranzer	PROPN
hls-5011	148	8	k	k	PROPN
hls-5011	148	9	,	,	PUNCT
hls-5011	148	10	et	et	PROPN
hls-5011	148	11	al	al	PROPN
hls-5011	148	12	.	.	PUNCT
hls-5011	149	1	screening	screen	VERB
hls-5011	149	2	for	for	ADP
hls-5011	149	3	hiv	hiv	PROPN
hls-5011	149	4	-	-	PUNCT
hls-5011	149	5	associated	associate	VERB
hls-5011	149	6	tuberculosis	tuberculosis	NOUN
hls-5011	149	7	and	and	CCONJ
hls-5011	149	8	rifampicin	rifampicin	VERB
hls-5011	149	9	resistance	resistance	NOUN
hls-5011	149	10	before	before	ADP
hls-5011	149	11	antiretroviral	antiretroviral	ADJ
hls-5011	149	12	therapy	therapy	NOUN
hls-5011	149	13	using	use	VERB
hls-5011	149	14	the	the	DET
hls-5011	149	15	xpert	xpert	PROPN
hls-5011	149	16	mtb	mtb	PROPN
hls-5011	149	17	/	/	SYM
hls-5011	149	18	rif	rif	PROPN
hls-5011	149	19	assay	assay	PROPN
hls-5011	149	20	:	:	PUNCT
hls-5011	149	21	a	a	DET
hls-5011	149	22	prospective	prospective	ADJ
hls-5011	149	23	study	study	NOUN
hls-5011	149	24	.	.	PUNCT
hls-5011	150	1	plos	plos	PROPN
hls-5011	150	2	med	med	PROPN
hls-5011	150	3	2011;8	2011;8	PROPN
hls-5011	150	4	:	:	PUNCT
hls-5011	150	5	e1001067	e1001067	NOUN
hls-5011	150	6	.	.	X
hls-5011	150	7	23	23	NUM
hls-5011	150	8	.	.	PUNCT
hls-5011	151	1	kidenya	kidenya	PROPN
hls-5011	151	2	br	br	PROPN
hls-5011	151	3	,	,	PUNCT
hls-5011	151	4	webster	webster	PROPN
hls-5011	151	5	le	le	PROPN
hls-5011	151	6	,	,	PUNCT
hls-5011	151	7	behan	behan	PROPN
hls-5011	151	8	s	s	PROPN
hls-5011	151	9	,	,	PUNCT
hls-5011	151	10	et	et	PROPN
hls-5011	151	11	al	al	PROPN
hls-5011	151	12	.	.	PUNCT
hls-5011	151	13	epidemiology	epidemiology	NOUN
hls-5011	151	14	and	and	CCONJ
hls-5011	151	15	genetic	genetic	ADJ
hls-5011	151	16	diversity	diversity	NOUN
hls-5011	151	17	of	of	ADP
hls-5011	151	18	multidrug	multidrug	NOUN
hls-5011	151	19	-	-	PUNCT
hls-5011	151	20	resistant	resistant	ADJ
hls-5011	151	21	tuberculosis	tuberculosis	NOUN
hls-5011	151	22	in	in	ADP
hls-5011	151	23	east	east	PROPN
hls-5011	151	24	africa	africa	PROPN
hls-5011	151	25	.	.	PUNCT
hls-5011	152	1	tuberculosis	tuberculosis	NOUN
hls-5011	152	2	2014;94:1	2014;94:1	NUM
hls-5011	152	3	-	-	SYM
hls-5011	152	4	7	7	NUM
hls-5011	152	5	.	.	NUM
hls-5011	152	6	24	24	NUM
hls-5011	152	7	.	.	PUNCT
hls-5011	153	1	blakemore	blakemore	VERB
hls-5011	153	2	r	r	NOUN
hls-5011	153	3	,	,	PUNCT
hls-5011	153	4	story	story	NOUN
hls-5011	153	5	e	e	NOUN
hls-5011	153	6	,	,	PUNCT
hls-5011	153	7	helb	helb	NOUN
hls-5011	153	8	d	d	PROPN
hls-5011	153	9	,	,	PUNCT
hls-5011	153	10	et	et	PROPN
hls-5011	153	11	al	al	PROPN
hls-5011	153	12	.	.	PUNCT
hls-5011	153	13	evaluation	evaluation	NOUN
hls-5011	153	14	of	of	ADP
hls-5011	153	15	the	the	DET
hls-5011	153	16	analytical	analytical	ADJ
hls-5011	153	17	performance	performance	NOUN
hls-5011	153	18	of	of	ADP
hls-5011	153	19	the	the	DET
hls-5011	153	20	xpert	xpert	PROPN
hls-5011	153	21	mtb	mtb	PROPN
hls-5011	153	22	/	/	SYM
hls-5011	153	23	rif	rif	PROPN
hls-5011	153	24	assay	assay	PROPN
hls-5011	153	25	.	.	PUNCT
hls-5011	154	1	j	j	PROPN
hls-5011	154	2	clin	clin	PROPN
hls-5011	154	3	microbiol	microbiol	PROPN
hls-5011	154	4	2011;48:2495	2011;48:2495	NUM
hls-5011	154	5	-	-	PUNCT
hls-5011	154	6	501	501	NUM
hls-5011	154	7	.	.	PUNCT
hls-5011	154	8	25	25	NUM
hls-5011	154	9	.	.	PUNCT
hls-5011	155	1	range	range	PROPN
hls-5011	155	2	n	n	CCONJ
hls-5011	155	3	,	,	PUNCT
hls-5011	155	4	friis	friis	NOUN
hls-5011	155	5	h	h	NOUN
hls-5011	155	6	,	,	PUNCT
hls-5011	155	7	mfaume	mfaume	PROPN
hls-5011	155	8	s	s	PROPN
hls-5011	155	9	,	,	PUNCT
hls-5011	156	1	et	et	PROPN
hls-5011	156	2	al	al	PROPN
hls-5011	156	3	.	.	PROPN
hls-5011	156	4	antituberculosis	antituberculosis	PROPN
hls-5011	156	5	drug	drug	NOUN
hls-5011	156	6	resistance	resistance	NOUN
hls-5011	156	7	pattern	pattern	NOUN
hls-5011	156	8	among	among	ADP
hls-5011	156	9	pulmonary	pulmonary	ADJ
hls-5011	156	10	tuberculosis	tuberculosis	NOUN
hls-5011	156	11	patients	patient	NOUN
hls-5011	156	12	with	with	ADP
hls-5011	156	13	or	or	CCONJ
hls-5011	156	14	without	without	ADP
hls-5011	156	15	hiv	hiv	PROPN
hls-5011	156	16	infection	infection	NOUN
hls-5011	156	17	in	in	ADP
hls-5011	156	18	mwanza	mwanza	PROPN
hls-5011	156	19	,	,	PUNCT
hls-5011	156	20	tanzania	tanzania	PROPN
hls-5011	156	21	.	.	PUNCT
hls-5011	157	1	tanzania	tanzania	PROPN
hls-5011	157	2	j	j	PROPN
hls-5011	157	3	health	health	PROPN
hls-5011	157	4	res	re	NOUN
hls-5011	157	5	2012;14:1	2012;14:1	NOUN
hls-5011	157	6	-	-	SYM
hls-5011	157	7	9	9	NUM
hls-5011	157	8	.	.	NOUN
hls-5011	157	9	26	26	NUM
hls-5011	157	10	.	.	PUNCT
hls-5011	158	1	chonde	chonde	PROPN
hls-5011	158	2	tm	tm	PROPN
hls-5011	158	3	,	,	PUNCT
hls-5011	158	4	basra	basra	PROPN
hls-5011	158	5	d	d	PROPN
hls-5011	158	6	,	,	PUNCT
hls-5011	158	7	mfinanga	mfinanga	NOUN
hls-5011	158	8	sg	sg	PROPN
hls-5011	158	9	,	,	PUNCT
hls-5011	158	10	et	et	PROPN
hls-5011	158	11	al	al	PROPN
hls-5011	158	12	.	.	PUNCT
hls-5011	159	1	national	national	ADJ
hls-5011	159	2	anti	anti	ADJ
hls-5011	159	3	-	-	ADJ
hls-5011	159	4	tuberculosis	tuberculosis	ADJ
hls-5011	159	5	drug	drug	NOUN
hls-5011	159	6	resistance	resistance	NOUN
hls-5011	159	7	study	study	NOUN
hls-5011	159	8	in	in	ADP
hls-5011	159	9	tanzania	tanzania	PROPN
hls-5011	159	10	.	.	PUNCT
hls-5011	160	1	int	int	PROPN
hls-5011	160	2	j	j	PROPN
hls-5011	160	3	tuberc	tuberc	PROPN
hls-5011	160	4	lung	lung	PROPN
hls-5011	160	5	d	d	NOUN
hls-5011	160	6	2010;14:967	2010;14:967	PROPN
hls-5011	160	7	-	-	SYM
hls-5011	160	8	72	72	NUM
hls-5011	160	9	.	.	PUNCT
hls-5011	160	10	27	27	NUM
hls-5011	160	11	.	.	PUNCT
hls-5011	160	12	ntinginya	ntinginya	PROPN
hls-5011	160	13	en	en	PROPN
hls-5011	160	14	,	,	PUNCT
hls-5011	160	15	squire	squire	PROPN
hls-5011	160	16	sb	sb	PROPN
hls-5011	160	17	,	,	PUNCT
hls-5011	160	18	millington	millington	PROPN
hls-5011	160	19	ka	ka	PROPN
hls-5011	160	20	,	,	PUNCT
hls-5011	160	21	et	et	PROPN
hls-5011	160	22	al	al	PROPN
hls-5011	160	23	.	.	PUNCT
hls-5011	160	24	performance	performance	NOUN
hls-5011	160	25	of	of	ADP
hls-5011	160	26	the	the	DET
hls-5011	160	27	xpert(r	xpert(r	PROPN
hls-5011	160	28	)	)	PUNCT
hls-5011	160	29	mtb	mtb	PROPN
hls-5011	160	30	/	/	SYM
hls-5011	160	31	rif	rif	PROPN
hls-5011	160	32	assay	assay	NOUN
hls-5011	160	33	in	in	ADP
hls-5011	160	34	an	an	DET
hls-5011	160	35	active	active	ADJ
hls-5011	160	36	case	case	NOUN
hls-5011	160	37	-	-	PUNCT
hls-5011	160	38	finding	find	VERB
hls-5011	160	39	strategy	strategy	NOUN
hls-5011	160	40	:	:	PUNCT
hls-5011	160	41	a	a	DET
hls-5011	160	42	pilot	pilot	NOUN
hls-5011	160	43	study	study	NOUN
hls-5011	160	44	from	from	ADP
hls-5011	160	45	tanzania	tanzania	PROPN
hls-5011	160	46	.	.	PUNCT
hls-5011	161	1	int	int	PROPN
hls-5011	161	2	j	j	PROPN
hls-5011	161	3	tuberc	tuberc	PROPN
hls-5011	161	4	lung	lung	PROPN
hls-5011	161	5	d	d	ADP
hls-5011	161	6	2012;16:1468	2012;16:1468	NUM
hls-5011	161	7	-	-	SYM
hls-5011	161	8	70	70	NUM
hls-5011	161	9	.	.	PUNCT
hls-5011	162	1	28	28	NUM
hls-5011	162	2	.	.	PUNCT
hls-5011	163	1	austin	austin	PROPN
hls-5011	163	2	jf	jf	PROPN
hls-5011	163	3	,	,	PUNCT
hls-5011	163	4	dick	dick	PROPN
hls-5011	163	5	jm	jm	PROPN
hls-5011	163	6	,	,	PUNCT
hls-5011	163	7	zwarenstein	zwarenstein	PROPN
hls-5011	163	8	m.	m.	NOUN
hls-5011	163	9	gender	gender	NOUN
hls-5011	163	10	disparity	disparity	NOUN
hls-5011	163	11	amongst	amongst	ADP
hls-5011	163	12	tb	tb	ADP
hls-5011	163	13	suspects	suspect	NOUN
hls-5011	163	14	and	and	CCONJ
hls-5011	163	15	new	new	ADJ
hls-5011	163	16	tb	tb	ADP
hls-5011	163	17	patients	patient	NOUN
hls-5011	163	18	according	accord	VERB
hls-5011	163	19	to	to	ADP
hls-5011	163	20	data	datum	NOUN
hls-5011	163	21	recorded	record	VERB
hls-5011	163	22	at	at	ADP
hls-5011	163	23	the	the	DET
hls-5011	163	24	south	south	PROPN
hls-5011	163	25	african	african	PROPN
hls-5011	163	26	institute	institute	PROPN
hls-5011	163	27	of	of	ADP
hls-5011	163	28	medical	medical	PROPN
hls-5011	163	29	research	research	NOUN
hls-5011	163	30	laboratory	laboratory	NOUN
hls-5011	163	31	for	for	ADP
hls-5011	163	32	the	the	DET
hls-5011	163	33	western	western	ADJ
hls-5011	163	34	cape	cape	NOUN
hls-5011	163	35	region	region	NOUN
hls-5011	163	36	of	of	ADP
hls-5011	163	37	south	south	PROPN
hls-5011	163	38	africa	africa	PROPN
hls-5011	163	39	.	.	PUNCT
hls-5011	164	1	int	int	PROPN
hls-5011	164	2	j	j	PROPN
hls-5011	164	3	tuberc	tuberc	PROPN
hls-5011	164	4	lung	lung	PROPN
hls-5011	165	1	d	d	NOUN
hls-5011	165	2	2004;8:435	2004;8:435	NUM
hls-5011	165	3	-	-	SYM
hls-5011	165	4	9	9	NUM
hls-5011	165	5	.	.	NOUN
hls-5011	165	6	29	29	NUM
hls-5011	165	7	.	.	PUNCT
hls-5011	166	1	narasimhan	narasimhan	PROPN
hls-5011	166	2	p	p	X
hls-5011	166	3	,	,	PUNCT
hls-5011	166	4	wood	wood	PROPN
hls-5011	166	5	j	j	PROPN
hls-5011	166	6	,	,	PUNCT
hls-5011	166	7	macintyre	macintyre	PROPN
hls-5011	166	8	cr	cr	PROPN
hls-5011	166	9	,	,	PUNCT
hls-5011	166	10	mathai	mathai	PROPN
hls-5011	166	11	d.	d.	PROPN
hls-5011	166	12	risk	risk	NOUN
hls-5011	166	13	factors	factor	NOUN
hls-5011	166	14	for	for	ADP
hls-5011	166	15	tuberculosis	tuberculosis	NOUN
hls-5011	166	16	.	.	PUNCT
hls-5011	167	1	pulm	pulm	NOUN
hls-5011	167	2	med	me	VERB
hls-5011	167	3	2013	2013	NUM
hls-5011	167	4	;	;	PUNCT
hls-5011	168	1	2013:828939	2013:828939	X
hls-5011	168	2	.	.	X
hls-5011	169	1	article	article	PROPN
hls-5011	169	2	non	non	X
hls-5011	169	3	co	co	PROPN
hls-5011	169	4	mmerc	mmerc	PROPN
hls-5011	169	5	ial	ial	PROPN
hls-5011	169	6	us	us	PROPN
hls-5011	169	7	e	e	NOUN
hls-5011	169	8	o	o	NOUN
hls-5011	169	9	nly	nly	ADV